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ABSTRACT

Stress associated psychiatric disorders such as depression, anxiety, and posttraumatic stress disorder affect a large proportion of the population. Reductions in the
complexity of neuronal morphology and reduced neurogenesis are commonly observed
outcomes following stress exposure in rodent models and may represent a mechanism for
the reduced brain volume in stress sensitive regions such as the hippocampus observed in
individuals diagnosed with stress associated disorders. Multiple lines of evidence suggest
that glycogen synthase kinase (GSK) 3β may play a role in the neurodegenerative
phenotype observed following stress exposure. GSK3β is atypical in that it is inhibited
by phosphorylation. This inhibitory phosphorylation has typically been studied by
examining the phosphorylation state of the serine 9 (S 9 ) site. Inhibition of GSK3β is
implicated in synaptic stabilization, increased expression of trophic factors that support
dendritic complexity and neurogenesis, reduced apoptosis, and the antidepressive effects
of currently implemented therapeutics. It is surprising then that little research has
examined the regulation of GSK3β by stress. A novel GSK3β phosphorylation site,
serine 389 (S389 ), has recently been described that is regulated by p38 mitogen activated
protein kinase (MAPK) and is independent of S9 phosphorylation by AKT. p38 MAPK
is implicated in the behavioral effects of stress exposure making an understanding of its
interaction with GSK3β S389 phosphorylation during stress a compelling research target.
The current studies examine GSK3β regulation following variate stress exposure in stress
reactive brain regions, describe the anatomical specificity of GSK3β S389 phosphorylation
in the brain, and detail the behavioral phenotype of a novel mutant mouse that cannot
inhibit GSK3β by S389 phosphorylation (GSK3β KI). Region specific changes in GSK3β
phosphorylation were observed following stress exposure, as well as voluntary exercise, a
behavior that confers stress resistance. Elevated GSK3β S 389 phosphorylation was
associated with increased levels of phosphorylated p38 MAPK. This pathway is
implicated in the response to DNA damage, and, surprisingly, we observed that histone
H2A-variant-X (ϒH2A.X), a marker of DNA damage, was elevated following stress and
exercise. Accumulated DNA damage is a proposed driver of neurodegeneration
suggesting that the pathway activated by stress may be engaged to protect against such
decline. Consistent with a role in the response to DNA damage, we observed a primarily
nuclear localization of GSK3β S 389 phosphorylation in the brain while S 9 phosphorylation
was found in nuclear and cytosolic compartments. Further, we observed
neurodegeneration in hippocampal and cortical regions of GSK3β KI mice supporting the
idea that the inhibition of GSK3β by S 389 phosphorylation observed following stress and
exercise may be protective. Though largely similar to wild type mice in behavioral tests,
increased auditory fear conditioning was evident in GSK3β KI mice. Contextual and
cued freezing was prolonged in GSK3β KI mice, a phenotype that is commonly observed
in stress models. Together these findings suggest that GSK3β S 389 phosphorylation is
playing a critical role in neuronal integrity that is independent of GSK3β S 9
phosphorylation, and that the subset of neurons protected by GSK3β S 389 phosphorylation
may play an important role in preventing a portion of the maladaptive behavioral changes
observed following stress exposure.
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CHAPTER 1: LITERATURE REVIEW
Depression and anxiety are commonly comorbid psychiatric disorders that affect a
broad portion of society. Recent estimates suggest that 16-25% of the population suffers
from depression, with as many as 60% having a comorbid anxiety disorder (Kessler et al.,
2003; Kessler et al., 2005). It is estimated that nearly 4% of the population seeks
treatment for depression, and that 75% of those with severe or very severe depression
receive inadequate treatment (Kessler et al., 2003). For those seeking treatment,
remission rates with typical pharmacological interventions are high, and comorbid
anxiety disorders predict negative outcomes (Trivedi et al., 2006). Inadequate mental
health treatment represents a social and fiscal burden, and the lack of adequate treatment
suggests that further research is necessary to understand the underlying causes of such
disorders as well as the changes occurring during successful treatment. Stress, an actual
or perceived challenge to homeostasis, has been associated with precipitating and
augmenting psychiatric disorders (Kendler et al., 1999; Holsboer, 2001; Gold and
Chrousos, 2002; Hettema et al., 2006) and can be utilized in rodents to model some of the
features of psychiatric disorders.
The Stress Response
The stereotypical stress response involves rapid activation of the sympathetic
nervous system followed by activation of the hypothalamic pituitary adrenal (HPA)-axis
(Sapolsky et al., 2000). HPA-axis activation leads to release of corticotropin releasing
hormone from the parvocellular nucleus of the hypothalamus. Within the anterior
pituitary, corticotropin releasing hormone activity causes release of adrenocorticotropic
1

hormone (ACTH). ACTH activation of fascicular cells in the adrenal cortex leads to
release of the glucocorticoid cortisol in humans, corticosterone in rodents.
Glucocorticoids act at receptor targets throughout the peripheral and central nervous
system. The central nervous system possesses both the high affinity mineralocorticoid
receptor (MR) and the lower affinity glucocorticoid receptor (GR). GRs are widely
expressed throughout the brain, while co-expression of MRs and GRs occurs mainly in
limbic structures (Reul and de Kloet, 1985). The MR has a higher affinity for
corticosterone than the GR and is thought to play a role in neuronal integrity and basal
excitability (Joels, Karst, DeRijk, & de Kloet, 2008). GR occupancy is associated with
stress levels of corticosterone and promotes termination of the HPA-axis response
through negative feedback initiation in limbic structures, as well as through direct action
in the hypothalamus and the pituitary (de Kloet et al., 2005; Herman, Ostrander, Mueller,
& Figueiredo, 2005).
The immediate actions of corticosterone are directed at surviving stress exposure
and include increased cardiovascular tone, energy mobilization, immune activation,
memory consolidation, and cerebral blood flow (Sapolksy et. al., 2000). The negative
impacts of stress exposure are largely attributed to failed negative feedback and
associated increased exposure to hormones associated with the stress response (Gold and
Chrousos, 2002). Beyond increased incidence of psychiatric disorders these effects
include immunosuppression (Dhabhar, 2009), visceral fat deposition (Peeke and
Chrousos, 1995), and impaired declarative memory (Conrad et al., 1996). Given the
necessity of mounting a stress response when met with homeostatic challenge, and the
2

negative consequences of exposure to stress hormones, a brain circuitry is in place to
regulate activation, and termination, of the stress response.
Limbic Brain Regions Involved in Stress Regulation
Brain regions that play an important role in emotional regulation are also involved
in control of the stress response. Research suggests that the amygdala, a brain region
implicated in fear regulation (Walker et al., 2003), activates the HPA-axis (Herman et al.,
2005). Acute stress induces immediate early gene expression in the amygdala (Cullinan
et al., 1995), and lesions of the central amygdala reduce ACTH levels during restraint
stress (Beaulieu et al., 1986). The bed nucleus of the stria terminalis (BNST) is
implicated in anxiety regulation and the anxiogenic response to corticotropin releasing
hormone (Lee and Davis, 1997). The BNST receives projections from brain regions
implicated in activation as well as inhibition of the HPA-axis and is therefore positioned
to integrate opposing signals (Herman et al., 2005). Consistent with this, a regional
specificity has been proposed for BNST regulation of the stress response where anterior
portions of the structure are associated with activation of the HPA-axis, and the posterior
portions are associated with inhibition (Herman et al., 2005; Radley and Sawchenko,
2011). For example, lesions of the anterior-dorsal BNST decrease corticotropin releasing
hormone expression in the paraventricular nucleus, while lesions of the posterior BNST
increase corticotropin releasing hormone expression (Herman et al., 1994). A similar
specificity is observed in the corticosterone response to restraint stress as anterior BNST
lesions reduce and posterior BNST lesions augment corticosterone output (Choi et al.,
2007). The hippocampus, a key area for memory encoding, especially that of the context
3

in which stimuli are occurring, is associated with inhibitory control over HPA-axis
activity. Lesions of the ventral subiculum portion of the hippocampus, a region that
sends projections to the BNST and amygdala, result in an increased corticosterone
response to restraint and open field stress (Herman et al., 1998). The medial prefrontal
cortex, a brain region involved in processing emotional stimuli and regulating the
subsequent response, is also implicated in inhibitory control over HPA-axis activity.
Medial prefrontal cortex immediate early gene activation in deep cortical layers (i.e., V
and VI) is observed in glucocorticoid receptor positive cells after restraint stress
(Ostrander et al., 2003), and lesions of this region augment, while corticosterone implants
reduce, the response to restraint (Diorio et al., 1993). As evidenced above, a complex
interplay exists between limbic brain structures that results in control over the stress
response. It is interesting then that some of the most robust findings in response to stress
exposure involve changes in the morphology and physiology of limbic brain regions,
particularly those involved with inhibitory control over HPA-axis responding.
Stress Effects on Neuronal Structure, Neurogenesis, and Trophic Support
Broadly, neuroimaging studies have shown increased activity in the amygdala,
decreased volume in hippocampus, and hypoactivation and decreased volume in the
medial prefrontal cortex in depressed individuals (Savitz and Drevets, 2009). Notably,
volume loss in the hippocampus has been negatively correlated with depression duration
(Sheline et al., 1999), as well as symptom severity (Vakili et al., 2000). Additionally,
post-mortem analyses have revealed decreased neuron size in the frontal cortex of
depressed patients (Rajkowska et al., 1999), as well as reduced synapse number, and
4

synapse related protein expression (Kang et al., 2012). Findings such as these have
pushed the focus of stress effects on psychological disorders towards mechanisms that
might account for volume loss such as neuronal death, reduced neurogenesis, and
dendritic and/or synaptic atrophy (Sapolsky, 2000; Duman and Monteggia, 2006).
Stress models in rodents support the idea that stress can result in degeneration of
neurons including impoverished neuronal morphology, and neuronal loss, as well as
reduced neurogenesis. Early work in this area focused on the effects of corticosterone and
stress on hippocampal neuron loss and vulnerability to damage. For example,
corticosterone administration over 30 days was shown to reduce neuron number in the
hippocampus (Sapolsky et al., 1985), and adrenalectomized rats provided with high
physiological range corticosterone pellets, and those that were exposed to variate stress
over three days, suffered more kainate-induced damage to the hippocampus than control
animals (Stein-Behrens et al., 1994). Neuronal degradation was also observed in fatally
stressed monkeys (Uno et al., 1989), a finding that was replicated with implanted cortisol
pellets (Sapolsky et al., 1990). Further work demonstrated that the number of branch
points and length of hippocampal dendrites were reduced by repeated restraint (Watanabe
et al., 1992) and 21 days of variate stress (Magarinos and McEwen, 1995). More
recently, it was demonstrated that escape deficits following inescapable stress were
concurrent with loss of hippocampal spine density (Hajszan et al., 2009).
Similar structural changes have been shown to occur in frontal cortex after stress
exposure. For example, 14 days of variate stress produced a reduction in dendritic
arborization and spine density in unlabeled cortical neurons, as well as those with
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retrograde labeling from anterior BNST, an effect that was associated with impaired
inhibitory HPA-axis tone after stress (Radley et al., 2013). Similar effects on dendritic
branching and spine density are observed after repeated restraint stress (Radley et al.,
2006). It has been observed that spine loss typically involves large spines suggesting
that stress associated changes in plasticity may reflect a decrease in spine stability as
larger spines are thought to represent a more mature variety (Radley et al., 2008; Shansky
and Morrison, 2009). Structural changes in the hippocampus and frontal cortex suggest
that stress produces an impoverished neuronal architecture at the level of dendritic and
synaptic complexity which may underlie some of the behavioral changes observed in
stress- associated disease.
Stress can also affect the generation of new neurons. The hippocampal subgranular zone is one of two identified sites of neurogenesis in the adult brain. New
neurons in the sub-granular zone extend axons to the hippocampal CA3 field, a region
where stress-associated atrophy is observed, and, like dendrites in the CA3, new neurons
are also impacted by stress and stress hormones (Schoenfeld and Gould, 2012). Acute
stress is not regularly shown to affect neurogenesis, though repeated inescapable shock
exposure, an acute stress that may be particularly intense, has been shown to reduce
neurogenesis. Rats receiving 100 inescapable tail shocks had decreased cell proliferation
7, but not 1, day after receiving shock (Fornal et al., 2007). A similar time course and
reduction in proliferation was observed in rats that received 60 inescapable shocks
(Malberg and Duman, 2003). Exposure to predator odor has also been shown to reduce
cell proliferation for up to one week, an effect that was blocked by adrenalectomy
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(Tanapat et al., 2001). Exposure to repeated stress is also associated with reduced
neurogenesis. Chronic restraint stress of three and six weeks decreased cell proliferation
and survival (Pham et al., 2003). Similarly, three and seven weeks of variate stress
reduced cell proliferation in mice (Alonso et al., 2004). Further, mice that conditionally
lack adult neurogenesis have a prolonged response to stress exposure while also
demonstrating impaired glucocorticoid negative feedback (Snyder et al., 2011).
Additionally, these animals display a depression-like phenotype in forced swim and
sucrose preference tests. Taken together, these findings suggest that stress and associated
glucocorticoid exposure may negatively impact generation of new cells in the
hippocampus. Impaired generation of new cells may impact regulation of the stress
response, as well as stress sensitive behaviors that model anxiety and depression.
Growth factor regulation by stress, particularly expression of brain derived
neurotrophic factor (BDNF), became a focus of research based upon the anti-neurogenic
and atrophy inducing effects of stress exposure. BDNF expression was reduced in the
frontal cortex and hippocampus of suicide victims with prior diagnosis of depression
(Karege et al., 2005), and was increased in post-mortem tissue of depressed patients
receiving treatment as compared to those that were untreated (Chen et al., 2001). BDNF
can increase neuronal growth and complexity (McAllister et al., 1997; Niblock et al.,
2000), and haploinsufficient BDNF mice demonstrate dendritic atrophy (Magarinos et al.,
2011) suggesting a role in stress associated neuronal changes. Indeed, stress has
commonly been found to reduce expression of BDNF in the hippocampus. One and
seven days of restraint stress produced marked reductions in BDNF expression (Smith et
7

al., 1995). Similarly, 10 days of unpredictable stress reduced BDNF expression (Nibuya
et al., 1999). Corticosterone administration to adrenalectomized rats is also sufficient to
reduce BDNF expression (Schaaf et al., 1998). The ability not only to produce, but also
release, BDNF seems to play a critical role in the response to stress. Mice containing a
gene polymorphism that limits BDNF release demonstrate increased depressive and
anxiety like behaviors, an increased HPA-axis response to stress, and augmented spine
loss in the frontal cortex after repeated restraint stress (Yu et al., 2012). Concurrent with
anxiety like behaviors, mice with limited BDNF release also show a reduction in
hippocampal dendritic complexity (Chen et al., 2006). In contrast to findings examining
BDNF insufficiency, hippocampal infusions of BDNF have been shown to reduce
immobility in forced swim test, and increase escape behavior following inescapable
shock exposure both indicative of an anti-depressant effect (Shirayama et al., 2002).
Together these findings suggest that down regulation of BDNF expression, and release,
by stress may play a mechanistic role in changes in neuronal morphology, genesis, and
behavioral changes observed after stress exposure.
Effects of Antidepressant Treatment, and Exercise, on Neuronal Structure, Neurogenesis,
and Trophic Support
That the physiological changes described above may play a role in stress-related
pathology is supported by findings with pharmacological manipulations that provide
relief for some afflicted individuals. Twenty one days of antidepressant treatment has
been shown to increase the expression of hippocampal BDNF and its membrane bound
receptor, and to block the restraint stress associated reduction in BDNF (Nibuya et al.,
8

1995). Similarly, antidepressant treatment increases proliferation and survival of new
neurons (Madsen et al., 2000; Malberg et al., 2000), an effect that is reduced when BDNF
signaling is knocked down (Sairanen et al., 2005). Reductions in anxiety and depressionlike behavior are not evident after chronic antidepressant treatment when BDNF
trafficking and release are impaired (Chen et al., 2006) nor are they evident when
hippocampal neurogenesis is ablated (Santarelli et al., 2003). Beyond neurogenesis,
antidepressant treatment supports synapse formation in the hippocampal regions affected
by stress associated atrophy after two weeks of treatment (Hajszan et al., 2009), and
protects against bulbectomy associated reductions in spine density (Norrholm and
Ouimet, 2001). Taken together, these findings suggest that increased expression of
trophic factors, as well as support of structural complexity and neurogenesis, are critical
components to the beneficial effects of antidepressant treatment in the hippocampus.
Work in the frontal cortex suggests that antidepressant treatment may also
alleviate the symptoms of stress pathology in this brain region.

In a double-blind study,

ketamine was shown to produce rapid antidepressant effects in human subjects (Berman
et al., 2000). Rapid antidepressant behavioral effects were also observed in rodent
models (Garcia et al., 2008; Engin et al., 2009). Extensions of this work have now
demonstrated that a single dose of ketamine after variate stress induces a rapid reversal of
dendritic spine deficits in the frontal cortex (Li et al., 2010; Li et al., 2011), and that
ketamine associated increases in apical dendrite spine density are lost in mice that are
impaired in their ability to release BDNF (Liu et al., 2012). Consistent with this, using
BDNF antibodies to block BDNF signaling after ketamine administration blocks the
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antidepressant effects of ketamine in the forced swim test (Lepack et al., 2014). Thus,
together with reports of the physiological effects of antidepressant in the hippocampus,
there is consistent evidence that treatments effective in treating stress associated disorders
regulate neuronal morphology and trophic support in the frontal cortex.
Physical activity may also alleviate the effects of stress exposure. In human and
animal models, the effects of exercise regularly oppose those of stress. The incidence of
stress associated disorders is reduced following exercise (Blumenthal et al., 1999; De
Moor, Beem, Stubbe, Boomsma, & De Geus, 2006; Harvey, Hotopf, Overland, &
Mykletun, 2010; Hoffman et al., 2011; Lawlor & Hopker, 2001). As a treatment for
stress associated disorders, exercise has been demonstrated to be as efficacious as
antidepressant treatment or cognitive behavioral therapy (Blumenthal et al., 1999; Lawlor
and Hopker, 2001), and sustain beneficial effects well after intervention (Babyak et al.,
2000). Rodent models demonstrate that engaging in wheel running activity results in
reduced anxiety and depression-like behaviors (Binder et al., 2004; Duman et al., 2008;
Fox et al., 2008; Salam et al., 2009; Sciolino et al., 2012). Startle amplitude, a measure
in which increased response magnitude is indicative of a more anxious subject, is reduced
in mice after two weeks of exercise (Salam et al., 2009; Hare et al., 2012; Hare et al.,
2013). Approach-avoidance anxiety tests also demonstrate an anxiolytic effect of
exercise (Binder et al., 2004; Salam et al., 2009). Immobility time in forced swim and
tail suspension testing is also reduced by exercise, indicative of an anti-depressant effect
of wheel access (Duman et al., 2008). Six weeks of wheel access blocks shuttle box
escape deficits and conditioned fear in learned helplessness models, measures of
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depression and anxiety respectively (Greenwood et al., 2003). Together, the results from
animal and human subject research suggest that exercise has the capacity to regulate
mood in a beneficial manner.
There are numerous ways in which exercise may exert its beneficial effects,
including enhancing trophic factor expression, neurogenesis, and neuronal complexity.
Exercise is associated with increased neurogenesis (van Praag et al., 1999b; van Praag et
al., 1999a; Marlatt et al., 2010) and expression of BDNF (Neeper et al., 1996; Fabel et al.,
2003; Duman et al., 2008; Trejo et al., 2008) which are typically observed to be reduced
after stress, or stress hormone exposure. Increased activation of the BDNF pathway
following exercise is associated with neuroprotection (Zhao et al., 2014), memory
enhancement (Intlekofer et al., 2013) and resistance to the negative effects of
corticosterone on neurogenesis and dendritic arborization (Yau et al., 2011). Exercise
has been shown to augment spine density in the frontal cortex (Sciolino et al., 2015),
striatum (Toy et al., 2014), and hippocampus (Yau et al., 2011). Increased mitochondrial
content in the dendritic portion of hippocampal neurons (Steib et al., 2014), as well as an
increase in BDNF transport to dendrites (Baj et al., 2012) may support exercise
associated changes in neuronal morphology.
Exercise associated changes in insulin- like growth factor 1 (IGF-1) may also play
an important role in neurotrophic support. IGF-1 is a peripherally and centrally
expressed growth factor that supports neurogenesis (Aberg et al., 2000). IGF-1 entry into
the brain is increased by exercise, and can acutely increase BDNF expression (Carro et
al., 2000). Blocking IGF-1 during exercise blocks the exercise associated reduction in
11

forced swim immobility time (Duman et al., 2009), the anxiolytic effect of exercise on
the elevated plus maze, and the exercise associated increase in markers of neurogenesis
(Llorens-Martin et al., 2010). There is also evidence supporting a role for IGF-1 in
stress-associated disease.

Stress associated anhedonia is reduced by IGF-1

administration during stress, and IGF-1 administration over 14 days was shown to reduce
depression-like behaviors (Duman et al., 2009). Additionally, dendritic spine density and
arborization are reduced in the frontal cortex of IGF-1 knockout mice (Cheng et al.,
2003). The role of IGF-1 as an indicator of peripheral, as well as central, metabolic
activity positions it well to signal when the energetic demands of neurogenesis or cellular
plasticity are feasible (Llorens-Martin et al., 2009) though more work needs to be done to
clarify its role, especially in stress-associated disorders.
Exercise may also generate beneficial effects through changes in the hormonal
responses to stress. Findings in exercising animals are consistent with a robustly
responsive, yet finely controlled, HPA-axis (Droste et al., 2003; Droste et al., 2006;
Fediuc et al., 2006; Sasse et al., 2008; Campbell et al., 2009; Campeau et al., 2010;
Nyhuis et al., 2010; Hare et al., 2013; Schoenfeld et al., 2013). The corticosterone
response to many types of stress is augmented following exercise (Droste et al., 2003;
Droste et al., 2006; Droste et al., 2007; Campbell et al., 2009; Hare et al., 2013), an effect
that may be driven by increased adrenal sensitivity to adrenocorticotropic hormone (Hare
et al., 2013). However, stress associated increases in corticosterone are of shorter
duration (Hare et al., 2013) and habituate at a faster rate (Sasse et al., 2008; Nyhuis et al.,
2010). Increased hippocampal glucocorticoid receptor expression (Droste et al., 2007)
12

and GABAergic inhibitory tone (Schoenfeld et al., 2013) following exercise may
contribute to efficient stress response termination. As many of the negative effects of
stress can be mimicked by stress hormone exposure exercise may serve to limit such
detrimental effects, while allowing a robust response when necessary.
The beneficial effects of exercise may also be mediated by changes in
neurotransmission. The reduction in learned helplessness in exercising animals is
associated with increased 5HT-1A receptor expression in the dorsal raphe nucleus which
could serve to limit serotonin release and sensitization associated with uncontrollable
stress exposure (Greenwood et al., 2003). Exercise has also been shown to reduce 5HT1B receptor expression in the raphe (Greenwood et al., 2005b) and attenuate the
anxiogenic response to 5HT-2C agonists administered into the amygdala (Greenwood et
al., 2012b) and peripherally (Fox et al., 2008). Thus, exercise may produce a brain that is
less responsive to stress associated serotonin neurotransmission. Increased expression of
markers for GABA neurotransmission are present throughout the brain including the
hippocampus and BNST of exercising rats (Hill et al., 2010), and increased GABAergic
tone was associated with a reduced response to stress exposure following exercise
(Schoenfeld et al., 2013). Exercise is also associated with changes in the noradrenergic
system. Increased brain noradrenaline after exercise in areas associated with
adrenocorticotropic hormone release may mediate the robust response to stress exposure
observed after exercise (Dishman et al., 2000). However, a concurrent increase in
expression of galanin, a negative regulator of noradrenaline release, is postulated to
reduce noradrenergic tone in the frontal cortex, an area important in the behavioral
13

response to stress exposure (Soares et al., 1999; Sciolino et al., 2012; Sciolino et al.,
2015).
Glycogen Synthase Kinase 3β: A Multifunctional Protein Kinase With Connections to
Stress and Exercise Related Outcomes
Stress exposure produces persistent behavioral and physiological changes that are
brought about by exposure(s) to stressful stimuli. This suggests changes in gene products
occurring due to cellular signals associated with stress exposure. Cellular signals affect
gene transcription following signal transduction by second messenger systems. The
diversity of cellular signals and pathological outcomes identified as contributing to stress
associated disease suggests that dysregulation of a factor tasked with integration of
multiple signals may contribute to pathology. Glycogen synthase kinase (GSK) 3β is a
serine/threonine protein kinase involved in second messenger systems initiated by signals
including growth factors, neurotransmitters, and inflammatory cytokines, placing it in a
privileged position to sense environmental stimuli and regulate a broad range of cellular
functions. Consistent with this, GSK3β is involved in regulation of cell functions
including metabolism, morphology, synaptic plasticity, neurogenesis, and apoptosis. As
might be expected based on its role in multiple signaling pathways and cellular processes,
dysregulation of GSK3β may play a role in many of the negative effects observed
following stress exposure, making understanding the function and regulation of GSK3β
critically important.
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GSK3 was first identified as a protein that negatively regulates glycogen synthase
(Embi et al., 1980), though it is now suggested that GSK3 interacts with well over 50
substrates resulting in both positive and negative regulation of substrate activity
(Kaidanovich-Beilin and Woodgett, 2011). GSK3 is expressed in two isoforms, GSK3α
and GSK3β, which are not redundant. Deletion of the gene encoding GSK3β, but not
that encoding GSK3α, is embryonically lethal due to liver hepatocyte apoptosis (Hoeflich
et al., 2000). GSK3β is present in peripheral and central tissues, though the brain is
particularly rich in GSK3β (Woodgett, 1990). In contrast to the majority of kinases,
GSK3β is constitutively active and inhibited by N- or C-terminus phosphorylation (Fig.
1). Activation is achieved through autophosphorylation of tyrosine 216 as GSK3β
passes from an intermediate to a mature, active form (Lochhead et al., 2006). Reversible
inhibition of GSK3β is achieved by
phosphorylation of the N- terminus serine
9 (S9 ) site by several kinases, though it is
most commonly associated with protein
kinase B/AKT (Stambolic and Woodgett,
1994; Cross et al., 1995). S9
phosphorylation of GSK3β results in a
conformational change that competes with
substrates for binding site access and
therefore limits GSK3β activity (Frame et

Figure 1. Regulation of GSK3β activity. Stress is
proposed to produce neuronal remodeling through
GSK3β activation. Antidepressants may produce
effects that oppose those of stress by augmenting
trophic support through inactivation of GSK3β by
S9 phosphorylation. The upstream signaling, and
cellular effects, of a recently described mechanism
for GSK3β inactivation by S389 phosphorylation are
unknown.

al., 2001). Reversal of phosphorylation is mediated by protein phosphatase-1 (PP1)
(Hernandez et al., 2010). Recently GSK3β was shown to be a substrate of p38 mitogen
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activated protein kinase (MAPK) at a novel inhibitory phosphorylation site. p38 MAPK
phosphorylation of GSK3β at the C-terminus serine 389 (S389 ) site was shown to be
distinct from AKT mediated phosphorylation at S9 , and was demonstrated to be enriched
in brain (Thornton et al., 2008). Though convenient, an understanding of GSK3β
regulation would be limited by considering only phosphorylation state.
Beyond phosphorylation, regulation of GSK3β activity is achieved by a
combination of localization, interaction with protein complexes, and, in many cases, the
requirement of substrate priming.

This is exemplified in the regulation of β-catenin by

GSK3β as part of the canonical WNT signaling pathway. β-catenin regulates aspects of
proliferation and cellular plasticity through transcription factor activation (Valvezan and
Klein, 2012), and was recently shown to be protective in a social defeat stress model
(Wilkinson et al., 2011). GSK3β inhibits the WNT signaling cascade as part of a protein
complex that forms between axin, adenomatous polyposis coli, casein kinase-1, and βcatenin. GSK3β is localized to this complex by its association with the cellular
scaffolding protein axin and represents a subcellular pool thought to act in isolation from
the remaining total fraction of GSK3β in the cell (Ding et al., 2000). In this complex,
casein kinase-1 phosphorylation of β-catenin acts as a prime that allows GSK3β to
phosphorylate β-catenin, targeting it for destruction (Amit et al., 2002). In the absence of
such a prime, or in the presence of WNT ligands, β-catenin is stabilized and can facilitate
transcription factor activation (Jho et al., 1999). β-catenin stabilization following
activation of the WNT pathway occurs in the absence of changes in inhibitory S9
phosphorylation of GSK3β, though a reduction in GSK3β activity is observed (Ding et
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al., 2000). Additionally, β-catenin levels are similar in wild type (WT) and mutant
animals in which the inhibitory GSK3β S 9 site cannot be phosphorylated (McManus et
al., 2005). Further, activation of pathways involving AKT, the prototypical inhibitor of
GSK3β, does not produce β-catenin accumulation (Ding et al., 2000; Ng et al., 2009).
These findings demonstrate that regulation of GSK3β activity can be achieved by
localization within an isolated protein complex, and availability of primed substrates,
even in the absence of changes in inhibitory phosphorylation.
The observation that lithium treatment, a mainstay in the treatment of bipolar
depression, inhibits GSK3β prompted interest in the therapeutic effects of GSK3β
regulation (Klein and Melton, 1996). Further work demonstrated that compounds useful
in the treatment of depression and anxiety, selective serotonin reuptake inhibitors and
tricyclic antidepressants, also inhibit GSK3β through S 9 phosphorylation (Li et al., 2004).
Consistent with the idea that compounds which have therapeutic efficacy may regulate
GSK3β, dysregulation of GSK3β has the potential to mediate many of the deleterious
effects of stress exposure described above. As a key mediator of apoptotic signaling in
peripheral cells and neurons, GSK3β is central to cell survival (Hetman et al., 2002;
Beurel and Jope, 2006). However, stress hypotheses that focused on neuronal death as a
factor in stress pathology have given way to those suggesting that stress results in
regionally distinct changes in neuronal morphology, and reduced neurogenesis, likely
through alterations in trophic factor expression (Duman and Monteggia, 2006; McEwen,
2007). GSK3β, through its role in cellular plasticity and neurogenesis, could mediate
these aspects of stress exposure.
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As described above, stress has been demonstrated to result in regionally distinct
alterations in neuronal morphology and synapse number that may underlie stress
pathology. There are multiple ways in which GSK3β may play a role in such effects.
GSK3β is one of the only serine/threonine protein kinases found to be involved in long
term depression (LTD), and also plays a role in long term potentiation (LTP) associated
inhibition of LTD (Peineau et al., 2007; Peineau et al., 2009). LTD involves the
weakening of AMPAR mediated glutamatergic transmission likely through removal of
receptors from the synapse (Collingridge et al., 2010). Inhibition of GSK3β is a critical
component in the ~1 hour period after LTP induction in which LTD induction is inhibited
(Peineau et al., 2007). In contrast, active GSK3β is necessary for induction of LTD
which is achieved through PP1 activation (Peineau et al., 2009). Collingridge and
colleagues (Collingridge et al., 2010) propose a “pathological plasticity” process by
which loss of GSK3β inhibitory tone impairs AMPA trafficking and, by doing so, may
reduce AMPAR mediated glutamatergic transmission as receptors turn over in the
synapse, likely through negative regulation of the kinesin cargo system (Du et al., 2010).
This “pathological plasticity” would destabilize synapses and could lead to the synaptic
reduction observed in chronic stress models.
The “pathological plasticity” proposed by Collingridge (2010) has the potential to
provide a GSK3β mediated second hit in stress models through GSK3β and AMPA
receptor interactions with BDNF signaling. As noted above, numerous stress protocols
have been shown to decrease BDNF expression. In contrast, antidepressant
administration and physical activity have been shown to increase BDNF expression.
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BDNF signaling has been shown to increase dendritic complexity (McAllister et al.,
1997; Niblock et al., 2000), and recent work with mice that conditionally overexpress
GSK3β in the dentate gyrus found that GSK3β overexpression reduced dendritic
complexity and synapse number (Llorens-Martin et al., 2013). BDNF signaling activates
the upstream GSK3β inhibitor AKT and produces activation of the transcription factor
cyclic-AMP response element binding protein (CREB) (Bullock and Habener, 1998; Mai
et al., 2002; Xia et al., 2010; Jiang and Salton, 2013). This pathway is implicated in cell
survival (Mayr and Montminy, 2001), and interestingly BDNF has been proposed to be a
target gene of CREB providing for a positive feedback loop whereby BDNF signaling
can result in BDNF transcription (Chen and Russo-Neustadt, 2005; Vogt et al., 2014).
Within this pathway, CREB is negatively regulated by active GSK3β (Mai et al., 2002;
Ahn et al., 2005; Tang et al., 2014) providing a mechanism through which active GSK3β
could negatively regulate BDNF levels. The importance of this GSK3β-BDNF
interaction is evident in recent work that suggests that the rapid antidepressant effect of
ketamine requires inhibition of GSK3β and BDNF release (Beurel et al., 2011; Liu et al.,
2012; Liu et al., 2013). GSK3β-mediated negative regulation of AMPA signaling could
also impact BDNF levels. AMPA receptor stimulation results in BDNF release and
activation of protein synthesis in dendrites (Jourdi et al., 2009), and AMPA mediated
release of BDNF was recently shown to provide a mechanism for the antidepressant
effect of ketamine (Lepack et al., 2014).

Thus, inhibition of GSK3β would in theory

maintain AMPA receptors in synapses thus permitting BDNF release, transcription, and
associated maintenance of protein synthesis in dendrites. In contrast, over-active GSK3β
could not only inhibit BDNF synthesis, but also its release due to inhibition of AMPA
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signalling, resulting in the morphological atrophy predicted in “pathological plasticity”,
and observed in stress models.
GSK3β regulation is also implicated in neurogenesis. There is abundant evidence
that stabilized β-catenin increases proliferation and neurogenesis in the brain providing
one avenue by which GSK3β activity could reduce new neuron number (Valvezan and
Klein, 2012). Further, growth factor signaling through IGF-1 and BDNF promote
neurogenesis and signaling associated with both factors produces inhibition of GSK3β
(Mai et al., 2002; Llorens-Martin et al., 2009). The neurogenesis promoting effect of
lithium (Chen et al., 2000; Boku et al., 2009; Schaeffer et al., 2014), fluoxetine (Malberg
et al., 2000; Santarelli et al., 2003), and leptin (Garza et al., 2012) occur on a background
of GSK3β inhibition (Klein and Melton, 1996; Li et al., 2004). In contrast, active GSK3β
seems to inhibit neurogenesis. Inflammatory signaling involving the transcription factor
Nuclear factor-kB (NF-kB), which is positively regulated by GSK3β, reduces
neurogenesis (Koo and Duman, 2008; Koo et al., 2010). Mice with an alanine to serine
substitution in both GSK3α and GSK3β that render the proteins incapable of N-terminus
inhibition have reduced neurogenesis (Kondratiuk et al., 2013) and are not responsive to
the neurogenesis promoting effects of fluoxetine (Eom and Jope, 2009). Inhibition of
GSK3β by S389 phosphorylation may also play a role in neurogenesis. In vitro analysis
demonstrated that hippocampal stem cell proliferation was augmented by GSK3β S389
phosphorylation that resulted in β-catenin stabilization (Zhang et al., 2011). Collectively,
the research points to GSK3β inhibition by S 9 or S389 phosphorylation as promoting
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neurogenesis likely through stabilization of β-catenin as well as through growth factor
pathways.
Numerous genetic manipulations have been employed to gain insight into the
function GSK3β activity on behavior. Complete knock-out of GSK3β results in inviable
offspring (Hoeflich et al., 2000). However, heterozygous mice (GSK3β HET) containing
a single copy of GSK3β, and thus reduced GSK3β expression, have been generated.
O'Brien et al. (2004) report that GSK3β HET mice and WT controls display similar
activity, acoustic startle response, and zero maze behavior. However, GSK3β HET mice
show reduced immobility in the forced swim test suggesting an anti-depressive
phenotype (O'Brien et al., 2004), though subsequent work failed to replicate this
phenotype (Bersudsky et al., 2008). Beaulieu (2008) found similar immobility times in
the tail suspension test when comparing GSK3β HET mice to WT controls, and reduced
latency to enter the light compartment of a light dark box, a phenotype that suggests
reduced anxiety. Taken together these results suggest that downregulating GSK3β
expression without modulating phosphorylation state produces and inconsistent
phenotype, though suggestions of reduced anxiety and depression-like behavior are
present.
Models that result in increased GSK3β levels or decreased phosphorylation
produce similarly complex results. O’Brien et. al (2011) reported no change in open field
behavior, zero maze open arm time, or forced swim immobility time in mice that
overexpress GSK3β, though lithium treatment failed to produce an antidepressant effect
in mice that overexpressors GSK3β . In mice that conditionally overexpress GSK3β in
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the hippocampus and frontal cortex, no change in anxiety behaviors was observed,
though object recognition impairment was evident along with dorsal hippocampal cell
death (Fuster-Matanzo et al., 2011). Mutant animals with GSK3β rendered constitutively
active through alanine substitution at the S 9 site are more active in an open field, have
elevated acoustic startle amplitude, and reduced forced swim immobility time (Prickaerts
et al., 2006). Notably, these mice were observed to have upregulated AKT and BDNF,
suggesting a compensatory response to increased active GSK3β. Mice with alanine
substitutions rendering GSK3β and the GSK3α isoform constitutively active are reported
to be more active in an open field, spend more time immobile in forced swim and tail
suspension tests, spend reduced time in the open arms of an elevated plus maze, display
increased contextual fear conditioning, and be more susceptible to foot shock induced
learned helplessness, though it is unclear what the contributions of the individual
isoforms are to this phenotype (Polter et al., 2010). Notably, these animals also fail to
produce LTD, a finding that would not be predicted by work that suggested active
GSK3β is critical to LTD induction (Peineau et al., 2009). Isoform specific constitutive
activation was reported by the same group to have no effect on contextual or tone fear
conditioning (Polter et al., 2012), and others have reported increased activity, reduced
anxiety, decreased susceptibility to stress effects, and reduced forced swim immobility
time in the combined GSK3β/GSK3α-active mutants (Ackermann et al., 2010).
While informative, it is important to note that as a molecule with a complex role
in development (Kim and Snider, 2011) genetic manipulations of GSK3β that globally
affect its regulation may not produce animals that reflect the complexity of GSK3
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function in a mature WT animal. Together, results from gain of function, and reduced
function, mutations suggest that GSK3β regulation may impact behaviors affected by
stress. To date, no studies have been conducted on animals with alternative regulation of
the inhibitory GSK3β S389 phosphorylation site. Inclusion of GSK3β S389 manipulations
into the above results may provide a clearer picture of how GSK3β affects behavior as
GSK3β S389 phosphorylation could also be involved in changes observed in GSK3β HET
animals, and GSK3β overexpressors.
Given the role GSK3β plays in cellular plasticity, it is reasonable to predict that
stress would alter GSK3β activity. There have been few studies assessing the effects of
stress or exercise on GSK3β, and none that include GSK3β S 389 phosphorylation. No
change in GSK3β levels were observed in frontal cortex tissue lysates after 1, 6, or 14
days of one hour cold restraint stress (Kozlovsky et al., 2002). Ten days of 4 hour
restraint that produced a depression-like behavioral phenotype did not change GSK3β
protein levels or GSK3β S9 phosphorylation in the hippocampus (Luo et al., 2015).
However, a separate group demonstrated that three weeks of six hour per day restraint
reduced GSK3β S9 phosphorylation and BNDF levels in the hippocampus, and treatments
associated with trophic support, olanzapine and aripiprizole, ameliorated the effects of
stress (Park et al., 2011). In a prenatal restraint stress model, in which pregnant dams are
stressed from day 14 of pregnancy to parturition, offspring had increased GSK3β in the
frontal cortex while S9 phosphorylation was reduced, effects not observed in hippocampal
lysates (Szymanska et al., 2009). Interestingly, the authors found no change in total
GSK3β or S9 phosphorylation in WT rats following three weeks of anti-depressant
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treatment, a manipulation previously shown to acutely regulate S 9 phosphorylation (Li et
al., 2004). However, anti-depressant treatment was shown to normalize frontal cortex
GSK3β levels and forced swim immobility time in stressed rats, again without affecting
hippocampal protein levels (Szymanska et al., 2009). Forced swim exposure did not
change GSK3β protein or S9 phosphorylation levels in the frontal cortex sampled 24
hours after swim. However, 14 days of repeated swim stress increased GSK3β protein
and reduced S9 phosphorylation concurrent with increased depression-like behavior
(Chen et al., 2012). Others have shown that a single forced swim exposure increased
GSK3β inhibition, though it is unclear at what time after stress the samples were obtained
(Courousse et al., 2014). In a learned helplessness paradigm mice given 180 mild
(0.3mA) footshocks and tested in a shuttle box escape procedure 24 hours later displayed
increased escape latency and reduced GSK3β S 9 phosphorylation (Polter et al., 2010). A
single 1.5mA footshock produced contextual fear 28 days after administration, and was
associated with elevated GSK3β S 9 phosphorylation in the amygdala 42 days after its
administration, hippocampal phosphorylation levels were unchanged (Dahlhoff et al.,
2010). Social defeat stress negatively regulated GSK3β S 9 phosphorylation, however this
was only observed in animals that were susceptible to the defeat paradigm (Wilkinson et
al., 2011). Studies employing variate stress procedures are fewer than those utilizing
repeated or acute stress. A 14 day variate stress paradigm was shown to increase GSK3β
mRNA in the hippocampus and reduce markers of neurogenesis, along with increasing
depression-like behavior, and these effects were reduced by treatment with lithium or a
GSK3β inhibitor during the stress paradigm (Silva et al., 2008). However, a second
group demonstrated that hippocampal GSK3β phosphorylation was unchanged after 8
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weeks of variate stress that produced a depression-like phenotype, though a robust
change in S9 phosphorylation was observed after a single stressor (Courousse et al.,
2014).
Though not entirely consistent, the results from acute and repeated stressor studies
described above suggest that stress may reduce GSK S 9 phosphorylation, or increase
protein levels, or both, in a brain region specific fashion. Such regulation would permit
greater GSK3β activity. Consistent with this, manipulations that would be expected to
limit GSK3β activity during stress exposure seem to protect against the effects of stress.
For example, conditional manipulations that increased GSK3β inhibition (Silva et al.,
2008; Wilkinson et al., 2011) or reduced protein levels (Omata et al., 2011) prior to stress
protected against the behavioral and physiological effects of stress exposure. Also,
variate stress in animals conditionally overexpressing GSK3β in the dentate gyrus was
associated with increased depression-like behaviors and markers of neuronal degradation
(Zhang et al., 2013). It is noteworthy that unlike inhibition during stress exposure, post
stress GSK3β inhibition did not alter stress-associated behavioral changes (Wilkinson et
al., 2011; Ma et al., 2013). This finding is consistent with the multiple roles of GSK3β as
a second messenger regulating the cellular response to diverse signals. Altering GSK3β
tone during stress exposure might be expected to change the outcomes of stress, as the
GSK3β manipulation would be augmenting or inhibiting the stress associated signals.
However, GSK3β manipulation would have no effect on those outcomes if the
manipulation was employed after stress exposure, as the change in activty would not
coincide with stress associated signalling. For example, the rapid antidepressant effects
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of ketamine require GSK3β inhibition (Beurel et al., 2011; Liu et al., 2013) and remedy
behavioral and physiological effects of stress exposure (Li et al., 2010; Ma et al., 2013),
but GSK3β inhibition alone does not have rapid beneficial effects. In this case, GSK3β
inhibition alone does not interact with a signal that produces beneficial effects, but when
second messenger systems are activated by ketamine GSK3β can impact the outcome of
those signals.
Research into the effects of exercise on GSK3β regulation is more limited than
that on stress. The sole studies involving voluntary exercise demonstrated that the
molecular pathway involved in BDNF signaling was activated following two weeks of
exercise. However, a non-significant increase in GSK3β phosphorylation was observed
(Chen and Russo-Neustadt, 2005). Hippocampal lysates from rats forced to run on a
treadmill for 15 minutes on five days had increased BDNF and GSK3β S9
phosphorylation levels, and 5 days of running during a 7 day restraint stress paradigm
ameliorated restraint induced decreases in BDNF and GSK3β S 9 phosphorylation (Fang
et al., 2013). Rats trained to run on a treadmill for 3 hours per day over 36 weeks starting
at 5 weeks of age, as well as those that were simply handled during that time, had
increased IGF-1 levels and reduced GSK3β tyrosine 216 phosphorylation in the
hippocampus, interpreted as reduced active GSK3β (Bayod et al., 2011). Using the same
procedure, the authors replicated their GSK3β activation finding in exercised and handled
rats but did not observed the reduction in GSK3β tyrosine 216 phosphorylation to be
associated with increased β-catenin accumulation in the hippocampus (Bayod et al.,
2014). Results from treadmill and voluntary exercise should be compared cautiously as
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the manipulations may not produce comparable results (Burghardt et al., 2004).
However, given the sparse research on the regulation of GSK3β by exercise, integration
of these findings with those suggesting exercise increases growth factor signaling
suggests that exercise may be expected to increase inhibition of GSK3β in brain regions
such as the hippocampus where increases in BDNF (Neeper et al., 1996; Russo-Neustadt
et al., 2000; Cotman and Engesser-Cesar, 2002; Adlard and Cotman, 2004) and IGF-1
(Trejo et al., 2008; Llorens-Martin et al., 2010; Cetinkaya et al., 2013) are observed
following exercise. If, as described above, active GSK3β during stress augments stress
signaling, increased inhibitory tone as a result of exercise may be expected to limit stress
signaling.
Aims of the Following Studies
As a multifunctional protein kinase GSK3β has the ability to act upon many cellular
signals and regulate cellular activity in ways that promote or degrade cell health. Stress studies
suggest that GSK3β may be negatively impacting cell health during stress exposure, while studies
in exercising animals suggest that exercise may produce a context in which greater inhibitory tone
over GSK3β activity may be present. Given the opposing effects of stress and exercise on
cellular plasticity in brain regions that regulate the response to stress, studies that expand our
understanding of the regulation of GSK3β by stress or exercise are warranted. Additionally, there
have been no studies examining the role of GSK3β S389 phosphorylation in the brain. As GSK3β
S389 phosphorylation has the ability to regulate β-catenin, and is itself regulated by p38 MAPK, a
kinase associated with stress signaling, understanding the effects of S389 phosphorylation may
open new avenues in treatment of stress-associated pathologies.
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The first aim of the research was to expand the understanding of GSK3β S389
phosphorylation by examining its cellular localization, regulation of GSK3β expression, and
impacts on behavior. This foundational work demonstrates that, as opposed to the cell wide
distribution of GSK3β S9 phosphorylation, S389 phosphorylation is primarily limited to the
nucleus of the cell, where it may limit the activity of a nuclear pool of GSK3β that has previously
been associated with the pro-apoptotic effects of DNA damaging agents (Watcharasit et al.,
2002). Consistent with a protective role of GSK3β S389 phosphorylation, restricted
neurodegeneration was observed in the hippocampi and cortex of animal generated to produce
deficient S389 phosphorylation. Behavioral testing in animals with deficient GSK3β S389
phosphorylation produced a phenotype that was largely similar to WT animals. However, a fear
conditioning phenotype that included exaggerated and overgeneralized fear upon testing suggests
that the degeneration observed may be impacting a neuronal population that regulates this
phenotype that is commonly observed in stress associated disorders, and rodents subjected to
stress exposure.
The second aim of the research was to further our understanding of the regulation of
GSK3β by stress and voluntary exercise exposure. Inhibitory phosphorylation of GSK3β was
examined in stress associated brain regions from mice subjected to variate stress or voluntary
exercise. Stress and exercise were found to similarly regulate GSK3β S9 phosphorylation, both
positively and negatively, in a regionally specific fashion. However, GSK3β S 389
phosphorylation was observed to increase in brain regions where changes were evident.
Importantly, levels of p38 MAPK phosphorylation, which would be expected to increase GSK3β
S389 phosphorylation, were increased in brain regions demonstrating increased GSK3β S 389
phosphorylation. Consistent with the protective role of GSK3β S389 phosphorylation that was
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postulated in the first study, increased GSK3β S389 inhibitory tone was associated with increased
levels of H2A-variant-X (ϒH2A.X) phosphorylation, a marker of DNA damage.

Together these studies demonstrate that GSK3β S 389 phosphorylation is likely
playing a role in cellular function that is separable from S9 phosphorylation.

Thus,

regulation of GSK3β activity by S389 phosphorylation may be an important component of
cellular plasticity observed following stress and exercise. Future studies are necessary to
understand the signals driving changes in GSK3β signaling following stress and exercise,
and cell types negatively impacted by deficient GSK3β S 389 phosphorylation. Although
foundational in nature, these studies provide an exciting avenue for future research. One
of the main difficulties of targeting kinases such as GSK3β for therapeutic effect is the
propensity to impact multiple pathways through overgeneralized inhibition or activation.
Given the differences observed between GSK3β S 389 and S9 regulation, and distinct
cellular distributions of the phosphorylation sites, targeting GSK3β S389 phosphorylation
may provide an avenue to limit stress signaling.
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Abstract
Glycogen synthase kinase-3 (GSK3β) plays an essential role in mediating cell death and
is emerging as a potential target for neurological diseases. Previous work has identified a
nuclear accumulation and activation of GSK3β in neurons in response to apoptotic
stimuli. The traditional means of inhibiting GSK3β through serine-9 (S9)
phosphorylation was not regulated in these models suggesting a separate means of
inhibiting nuclear GSK3β may promote survival after cellular stress. Here, we identify
that inhibitory regulation of GSK3β by the recently identified serine-389 (S389 )
phosphorylation site is phosphorylated independently of S9 phosphorylation. GSK3β S389
is primarily expressed in the nucleus, and the two phosphorylation sites limit the activity
of distinct pools of GSK3β. Mutation of S389 to Ala prevents inactivation of this nuclear
pool of GSK3β. Consistent with a role in cell survival, we show that GSK3β Ser389 Ala
knockin (KI) mice undergo focal neurodegeneration in limbic brain regions. A fear
conditioning phenotype that included overgeneralization of contextual fear and increased
tone fear, was observed in GSK3β KI mice in spite of the observed neurodegeneration.
This phenotype is similar to that observed in stress pathology. Thus, regulation of
GSK3β through S389 phosphorylation may provide a unique avenue in the treatment of
neurodegenerative and stress associated disease.
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Introduction
Glycogen synthase kinase (GSK)-3 is a constitutively active serine threonine
protein kinase that has emerged as a critical mediator of the balance between cell survival
and death (Beurel and Jope, 2006). GSK3 is present in two constitutively active nonreduntant isoforms, GSK3α and GSK3β (Hoeflich et al., 2000), that are inhibited by
phosphorylation (Stambolic and Woodgett, 1994). GSK3 is widely expressed, but levels
are greatest in the central nervous system (Woodgett, 1990). Consistent with its role in
cell survival and expression, GSK3, particularly GSK3β, has been implicated in
numerous disorders that are associated with neurodegeneration including Alzhiemer’s
disease (Cai et al., 2012) and depression (Jope and Roh, 2006). A better understanding of
GSK3 regulation will enhance efforts towards therapeutic interventions involving GSK3
inhibition.
GSK3 inhibition is achieved through N-terminus serine 9 (S9 ), and serine 21 (S21 )
phosphorylation of GSK3β and GSK3α respectively, primarily by AKT (Cross et al.,
1995). Multiple second messenger cascades associated with cell survival and
proliferation are promoted by GSK3 inhibition (Jope and Johnson, 2004). Recently, a
novel mechanism for GSK3β inhibition by p38 mitogen activated protein kinase (MAPK)
was demonstrated to be independent of AKT and GSK3α (Thornton et al., 2008). p38
MAPK inhibits GSK3β through phosphorylation of serine 389 (S 389 ) in the C-terminus
(threonine 390 (T390 ) in humans). The function of GSK3β S 389 phosphorylation remains
unclear, though a robust S389 phosphorylation signal in brain, as opposed to S 9
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phosphorylation which is ubiquitously expressed, suggests that S 389 phosphorylation may
serve a specialized function in the brain.
In neuronal cultures GSK3β levels and activity have been observed to increase in
the nucleus in response to diverse cellular stressors including DNA damage (Bijur and
Jope, 2001; Watcharasit et al., 2002; Bijur and Jope, 2003). Additionally,
hyperactivation of GSK3β in neuronal cells increases cell death in response to proapoptotic stimuli (Bijur et al., 2000). Because nuclear changes in GSK3β have been
observed to be independent of S9 regulation these data suggest an alternate mechanism
for nuclear inhibition of GSK3β (Bijur and Jope, 2001; Watcharasit et al., 2002). p38
MAPK levels have also been observed to increase in the nucleus following signals that
induce DNA damage (Wood et al., 2009). Together these findings suggest that p38
MAPK mediated inhibition of GSK3β by S 389 phosphorylation, particularly in the
nucleus, may be an unexplored mechanism mediating cell survival following stress.
Here we demonstrate that GSK3β S 389 is present throughout the brain, and has a
nuclear expression pattern that is distinct from S 9 phosphorylation. Additionally, we
show that GSK3β S9 phosphorylation is absent when S 389 phosphorylation is present, and
that both sites negatively regulate an independent component of GSK3β kinase activity.
Further, we demonstrate that hippocampal and cortical degradation is present in a novel
mutant mouse in which the GSK3β S 389 site was mutated to an alanine, thus blocking
inhibition of GSK3β through the C terminus (GSK3β KI). Finally, we assess anxiety and
depression-like behavior, spatial learning, acoustic startle, and fear conditioning in
GSK3β KI mice and demonstrate a behavioral phenotype that includes augmented
33

auditory fear conditioning despite the degradation observed in brain areas critical for the
task.
Materials and Methods
Subjects
For the generation of GSK3β KI mice, a targeting vector constructed (InGenious
Targeting Laboratory, Inc.) from a 9.27kb region was subcloned from the C57BL/B6
BAC clone (RPCI-23: 454D5) into the vector backbone (2.4kb pSP7 (Promega)). The
long homology arm extended 6.36kb 5’ to the T-G point mutation in exon 11 and the
LoxP/FRT flanked Neo cassette was inserted 511bp 3’ to the T-G point mutation. The
short homology arm extended 2.40 kb 3’ to the loxP flanked Neo cassette. The targeting
vector was constructed using Red/ET recombineering technology and the T-G point
mutation was created by overlap PCR. The linearized targeting vector electroporated into
BA1(C57BL/6 x 129/SvEv) hybrid embryonic stem cells. Following G418 selection,
surviving clones were screened by PCR to identify homologous recombinant clones for
injection into blastocysts. The neomycin cassette was excised by breeding heterozygous
GSK3β KI mice with EIIa-cre mice (Lakso et al., 1996) (Jackson Laboratories). GSK3β
KI mice were backcrossed to C57BL/6 at least seven generations. Wildtype mice (WT)
were purchased from Jackson Laboratories (Bar Harbor, ME).
Prior to experimental manipulation, mice were housed in groups of 4 in acrylic,
wire top cages in an Association for Assessment and Accreditation of Lab Animal Care
(AAALAC) approved animal facility and provided a 7 day acclimation period. A 12
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hour light/dark cycle (0700h-1900h) and ad libitum access to food and water were
maintained throughout experimental procedures. All procedures were approved by the
University of Vermont Animal Care and Use Committee.
Behavioral Tasks
A cohort of male and female WT and GSK3β KI mice (n=5 females, 5 males per
genotype) were examined in the behavioral tasks described below. The order of testing
was acoustic startle, open field, zero maze, auditory fear conditioning, terminating with
forced swim. A separate cohort was used for the water maze experiment (n=8 females, 7
males per genotype).
Open Field and Zero Maze
To examine locomotion and anxiety like behavior the open field and zero maze
were utilized. In the open field, anxiety is measured as avoidance of the center portion of
the arena. Individual mice were placed in the open field apparatus (44cm X 39cm opaque
acrylic container) located in a room that was dimly lit so as not to amplify anxiety- like
behavior. Mice were placed into a corner of the open field and their behavior recorded
on video over 10 minutes. Total distance traveled, frequency of crosses into the center of
the open field and time in the center of the open field were analyzed with EthoVision
software (Noldus Information Technology Inc, Leesburg, VA).
The zero maze is a circular track with opposing walled quadrants. Anxiety-like
behavior is represented by time spent in the walled quadrants of the maze. Open
quadrant time and entries were quantified over a 5 minute period on the zero maze (51cm
35

diameter, 7cm track width, elevated 36cm, track width). Mice were placed into a closed
quadrant of the zero maze to begin the test. Due to issues with video contrast, zero maze
analysis was hand scored. An open quadrant entry was counted only when all four paws
of the animal entered the quadrant.
Water Maze
The water maze task is a spatial learning task that requires the hippocampus
(Morris et al., 1982). The water maze was a circular galvanized steel tank measuring 1-m
in diameter and 61-cm in depth and filled with clear water (22 0 C) to a level of 44 cm (17
cm below the tank rim). The clear acrylic platform (18 cm square) was 0.25 cm below
the surface of the water and was located in a fixed position throughout maze training.
Mice (n=8 females, 7 males per genotype) were given 4 training trials each day for 8
days. For each training trial, the mouse was placed into the water in one of the three
quadrants not containing the platform.

A trial ended when the mouse successfully

climbed on the platform or after 30 seconds of swimming, following which the mouse
was guided to the platform. The interval between trials was 3 minutes. Probe trials, in
which the platform was removed from the pool, were carried out after training days 3 and
8. For probe trials, the mouse was placed into the quadrant opposite to the one that
formerly contained the platform and allowed to swim for a total of 30 seconds. For maze
acquisition and probe trials, swimming was video recorded for offline analysis using
EthoVision software.
Forced Swim
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The forced swim procedure is a regularly used test of depression-like behavior.
Mice were placed into room temperature (~20 ᵒC) containers (30cm diameter) for 6
minutes and assessed for immobility. Containers were filled to a depth that would not
allow the tail of the mouse to touch the bottom of the container. Immobility was defined
as the absence of motion, except that necessary to stay afloat. Immobility was scored
using a time sampling procedure in which a mobility assessment was made every 6
seconds during the 6 minute test. Scoring was conducted by a pair of observers and
averaged to derive an immobility count for each animal, with greater immobility counts
indicative of increased depressive behavior.
Acoustic startle
Acoustic startle was used to assess anxiety following stress and exercise. In
acoustic startle testing a brief noise burst is presented and the animal’s response is
measured. The magnitude of the startle response is interpreted as an index of the
animal’s anxiety with greater startle responses indicating a more anxious phenotype.
Startle was assessed as described previously (Salam et al., 2009). Briefly, mice were
placed individually in an acoustic startle chamber (Med-Associates, St. Albans, VT)
located within a sound attenuating cubicle and administered 30, 20msec duration, startleeliciting noise bursts (10 each at 95, 100 and 105 dB) in a pseudo-random order at a 1minute inter stimulus interval. The average startle amplitude over the 30 trial test is
reported.
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Meta-chlorophenylpiperazine (mCPP) challenge (0.3mg/kg i.p., Sigma Aldrich,
St. Louis, MO) was conducted in a counterbalanced fashion over two days as described
previously (Hare et al., 2012). The change in startle amplitude following mCPP
administration is reported with positive values representing an increase in acoustic startle.
Auditory Fear Conditioning
Auditory fear conditioning utilizes a tone conditioned stimulus paired with a
shock unconditioned stimulus to condition fear, measured by the freezing response, to
both the context paired with shock as well as the conditioned stimulus. These
components of the fear response are then disambiguated by testing in the training context
without tone, and a novel context where the tone is presented. Auditory fear conditioning
was carried out in an acrylic conditioning chamber with a metal grid rod floor located in a
darkened sound-attenuating cubicle (Video Fear Conditioning System MED-VFC-NIRM, Med-Associates, St. Albans, Vermont) scented with the odor of Vicks Vaporub.
Conditioned freezing was measured in both the conditioning chamber as well as a novel
chamber. The novel chamber had walls of a different color than the training chamber,
was illuminated, was scented with anise extract, and had a flat plastic floor. Time spent
freezing was measured with Video Freeze software (Med-Associates, St. Albans,
Vermont) following the recommendations of Anagnostaras et. al. (2010). For fear
conditioning, an individual mouse was placed in the conditioning chamber and given a
two minute baseline period during which no stimuli were presented. Following baseline,
mice were given five tone presentations (75dB, 4500Hz) separated by 30 seconds. Each
tone co-terminated with a 1 second 0.3mA foot shock delivered through the grid floor.
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Conditioned freezing was measured in two, counterbalanced, six minute tests begun 24
hours after fear conditioning and separated by 24 hours. For measurement of contextual
fear conditioning, mice were placed into the training context and no stimuli were
presented. Assessment of conditioned fear to the tone was conducted in a novel context.
The novel context test consisted of a two minute baseline followed by a three minute tone
presentation. A one minute period followed the tone presentation to complete the six
minute novel context test.
Auditory Fear Conditioning p38 MAPK inhibitor experiments
To assess the role of p38 MAPK signaling in auditory fear conditioning, the p38
MAPK inhibitor SB203580 (Tocris Bioscience, Bristol, UK) was centrally administered
prior to, and following, auditory fear conditioning. WT mice were implanted with
intracerebroventricular (ICV, 1mm lateral, 0.4mm posterior, 3mm depth, 26 gauge)
cannula under isoflurane anesthesia and allowed seven to ten days to recover prior to fear
conditioning. Mice were injected with 2.5µL of vehicle (0.9% saline) or 125 µM
SB203580 over 3 minutes, 30 minutes prior to (n=10 males/group), or immediately
following (vehicle n=10 males, SB203580, n=8 males) fear conditioning. The auditory
fear conditioning protocol followed the same method as above except that the shock
intensity was increased to 0.5mA as minimal conditioning was observed in pilot
experiments conducted with cannulated mice using a 0.3mA shock intensity. Following
conditioning, cannula placements were visually confirmed with ICV cresyl violet
injection delivered under anesthesia. In order to assess inhibition of p38 MAPK tissue
from a subset of animals was harvested 30 minutes after a second injection of SB203580
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injection (n=5 per group) administered 3 days after the final fear conditioning test. p38
MAPK inhibition was measured by analyzing the phosphorylation state of GSK3β S 389 .
p38 MAPK phosphorylates GSK3β S 389 (Thornton et al., 2008). As such, reduced S389
phosphorylation would indicate that p38 MAPK was inhibited. GSK3β is rapidly
dephosphorylated by anesthetics and long pre-cooling post mortem intervals (Li et al.,
2005). As such, mice were rapidly decapitated and tissue was rapidly harvested (< 3
minutes) and immediately transferred to centrifuge tubes cooled on dry ice prior to
storage at -80ᵒC. Coronal slices were obtained using a 1mm brain matrix (Stoelting,
Wood Dale, IL). The amgydala (approximate bregma coordinates: anteroposterior -1.06;
mediolateral 2.75; dorsoventral -4.5), and whole hippocampus (approximate bregma
coordinates: anteroposterior -2.06; mediolateral 1.0; dorsoventral -2.0) were extracted
with a 1mm tissue punch (Stoelting, Wood Dale, IL).
Western blot analysis
Whole cell extracts were prepared in Triton lysis buffer and used for Western blot
analysis as we previously described (Derijard et al., 1994; Rincon et al., 1997). Nuclear
and cytosolic extracts were prepared as previously described (Schreiber et al., 1989;
Tugores et al., 1992). For co-immunoprecipitation, nuclear extracts were prepared as
previously described (Jamil et al., 2010). ExactaCruz F immunopreciptiation kit (Santa
Cruz Biotechnology) was used for immunoprecipatiation/Western blot analysis with
rabbit antibodies.

Anti-actin, anti-GAPDH, and anti-GSK3β were purchased from Santa

Cruz Biotechnology.

Anti-phospho-S9 GSK3β was purchased from Cell Signaling

(Danvers, MA). Anti-phospho-S389 GSK3β, and anti-TUJ1 was purchased from
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Millipore (Billerica, MA). Anti-phospho-Thr390 GSK3β rabbit polyclonal antibody was
generated (Proteintech, Inc.) using N-C-ARIQAAASphospho-TPTNATA for
immunization.

Anti-rabbit HRP and anti-mouse HRP (Jackson ImmunoResearch

Laboratories) and anti-goat-HRP (Santa Cruz Biotechnology) were used as secondary
antibodies.
GSK3β Kinase Activity Assays
To determine whether S389 phosphorylation regulated a distinct component of
GSK3β activity, kinase assays were conducted. GSK3β was immunopreciptitated from
cerebral cortex protein lysates and kinase activity was determined as previously
published (Thornton et al., 2008).
Immunolabeling
The primary antibodies used included rabbit anti-phospho-S389 or anti-phosphoT390 GSK3β polyclonal antibodies described above. The secondary antibody used was
highly adsorbed anti-rabbit Alexa Fluor 568 (Invitrogen). Topro-3 (Invitrogen) was used
as a nuclear stain. Images of cells were acquired on a Zeiss LSM-510. Staining of human
tissue was performed as previously described (Long et al., 2011). Paraffin-embedded
sections of mouse brain were similarly stained except that Sudan Black blocking was
excluded. Anti-NeuN (Millipore), anti-TUJ1, and anti-phospho-Ser389 /Thr390 GSK3β
antibodies were used in conjunction with Cy3-conjugated secondary antibodies (Jackson
ImmunoResearch). Images were acquired with identical exposure settings using a SPOT
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RT digital camera. Fluro-Jade C (Millipore) staining was performed according to
manufacturer's instructions.
Statistical Analysis
Data are expressed as means ± standard error of the mean. Brain regions were run
on separate blots and analyses were restricted to within brain regions. Western blot
analysis following SB203580 administration was evaluated by independent samples ttests. Behavioral analysis utilized mixed model ANOVAs followed by LSD protected ttests. Initial analysis included sex. However, only in the mCPP challenge was a sex
difference evident and here the sex difference was not dependent on genotype and
therefore sex was left out of the analysis that follows. Results were analyzed by SPSS
software version 22 (IBM; Armonk, NY). p< 0.05 was considered statistically
significant.
Results
GSK3β phosphorylation at S389 is primarily nuclear and present in all brain regions
examined.
Previous research suggests that, unlike the broad tissue distribution of S 9
phosphorylation of GSK3β, S 389 phosphorylation of GSK3β is restricted primarily to the
brain with a lower levels detected in the thymus and spleen (Thornton et al., 2008). To
determine the distribution of phospho-S389 within the brain, western blot analysis was
performed using lysates from a number of brain regions. Both phospho-S389 GSK3β and
phospho-S9 GSK3β were detected at similar levels in all regions examined (Fig. 1A).
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Immunofluorescent staining of the cerebral cortex revealed a distinct subcellular
localization of phospho-S389 compared to phospho-S9 GSK3β. Phospho-S389 GSK3β
exhibited a punctate nuclear staining pattern while phospho-S9 GSK3β was more diffuse
and appeared to be more abundant in the cytosol than the nucleus (Fig. 1B).
Immunoflorescent staining of postmortem human brain tissue revealed a primarily
nuclear staining for phospho-T390 GSK3β (human equivalent of mouse S 389 , Fig. 1C).
To further explore the cellular localization of phospho-S389 GSK3β, we examined the
subcellular distribution of phospho-S389 GSK3β in brain. Nuclear and cytosolic extracts
from cerebral cortex were examined by Western blot analysis. Phospho-S389 GSK3β was
also predominantly found in the nucleus of murine cerebral cortex samples whereas
phospho-S9 staining was found in nuclear and cytosolic compartments (Fig. 1D).
GSK3β S389 phosphorylation is not detectable when S 9 phosphorylation is present,
and restrains a distinct pool of GSK3β activity.
To address whether phosphorylation on GSK3β S 389 was just an additional
pathway to further inactivate the same pool of GSK3β, or whether these two mechanisms
were targeting different GSK3β pools, we performed co-immunoprecipitation analysis.
Whole cell extracts from cerebral cortex were used to immunoprecipiate phospho-S9
GSK3β and both the immunoprecipitate and flow-through were examined by Western
blot analysis. As expected, phospho-S9 was abundantly present in the immunoprecipitate
but not in the flow-through (Fig. 1E). In contrast, phospho-S389 was not detected in the
immunoprecipitate, but was abundantly present in the flow-through (Fig. 1E). Analysis of
total GSK3β revealed that only a fraction of GSK3β was actually phosphorylated on S 9
43

(Fig. 1E). Thus, phosphorylation of GSK3β on S 389 targets an independent pool of
GSK3β in the brain that is not phosphorylated on S 9 . Together, these results indicate that
phosphorylation of GSK3β at Ser389 (human Thr390 ) occurs independently of
phosphorylation on S9 to reduce nuclear GSK3β activity in the brain.
To investigate the role of this alternative pathway for GSK3β inactivation in the
brain, we examined GSK3β KI mice where S389 of GSK3β was replaced with Ala to
prevent phosphorylation of GSK3β at S 389 (Fig. 2A). Western blot analysis confirmed
the absence of phospho-S389 GSK3β in whole brain extracts from homozygous GSK3β
KI mice while normal levels were present in heterozygous GSK3β KI mice (Fig. 2B). S9
phosphorylation of GSK3β was not affected by the Ser to Ala mutation, further
demonstrating that these two alternative pathways are independent of each other. To
show that phosphorylation on S 389 contributes to restrain the kinase activity of GSK3β in
brain, GSK3β kinase activity in cerebral cortex from WT and GSK3β KI mice was
measured. Despite the already high kinase activity, a significant increase in kinase
activity in the cortex of GSK3β KI mice was detected (t (9)=2.46, p<.05; Fig. 2C). As
control, we corroborated that the levels of phospho-S9 in the cerebral cortex of GSK3β KI
mice were not decreased (Fig. 2C). Thus, phosphorylation of GSK3β on S 389 contributes
to inactivation of GSK3β kinase activity in brain and it is not compensated by
phosphorylation on S9 .
Restricted cellular degradation is evident in mice that cannot inhibit GSK3β
through S389 phosphorylation
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Previous research has demonstrated nuclear accumulation of activated p38 MAPK
in response to DNA damage (Wood et al., 2009). Following DNA damage, active
GSK3β forms a complex with the pro-apoptotic factor p53 that may promote inhibition of
pro-survival transcription factors (Watcharasit et al., 2002). Recent work has shown the
presence of spontaneously generated DNA damage in some neurons diffusely distributed
in the cerebral cortex and hippocampus as a result of normal brain activity (Suberbielle et
al., 2013). Additionally, failure to repair DNA damage is thought to play a key role in
neuronal degradation (Brasnjevic et al., 2008). Thus, preventing inactivation of nuclear
GSK3β through serine to alanine substitution at GSK3β S 389 in KI mice could impact the
viability of the neuronal subset with spontaneous DNA damage.
No discernible differences in gross brain anatomy were observed between GSK3β
KI mice and WT mice. Immunostaining analysis with NeuN and class III -tubulin/Tuj1,
two standard markers for neurons, did not show drastic differences in the number of
neurons within the cerebral cortex and hippocampus of WT and GSK3β KI mice (Fig.
3A). However, histological examination of hematoxylin & eosin (H & E) stained sections
revealed the presence of highly eosinophilic (darker) cells with pyknotic nuclei in some
regions of the cerebral cortex and hippocampus of GSK3β KI mice (Fig. 3B). The
morphology of these cells is characteristic of what in human brain pathology is defined as
“dark neurons” and likely represent neurodegenerative cells (Garman, 2011). The
presence of these dark cells in GSK3β KI mice was evident in the hippocampal CA1
subfield and the hippocampal CA3 subfield as well as cerebellar cortex (Fig. 3B) and
dentate gyrus (not shown). A number of studies have reported that hippocampal CA1 is
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particularly vulnerable to DNA damage (Adamec et al., 1999; Jin et al., 1999; Crowe et
al., 2011), although the mechanism remains unknown.
Next, we examined whether phospho-S389 GSK3β immunostaining in WT mice
was evident in the subregions where the dark cells preferentially accumulate in GSK3β
KI mice. The specificity for the phospho-Ser389 GSK3β staining was demonstrated by its
absence in the brain of GSK3β KI mice (Fig. 3C). The highest levels of phospho-S389
GSK3β immunostaining were found in the hippocampal regions of WT mice that
corresponded with the regions in GSK3β KI mice with higher frequency of dark cells
(Fig. 3C). Similarly, the regions of the cerebral cortex with abundant phospho-S389
GSK3β staining in WT mice also corresponded with the cortical regions with higher
frequency of dark cells in GSK3β KI mice (Fig. 3C).
To demonstrate that the dark cells present in GSK3β KI brains represent
degenerative neurons, brains sections from WT and GSK3β KI mice were stained with
Fluoro-Jade C, the gold-standard dye used to visualize neurodegeneration (Schmued et
al., 2005). Fluoro-Jade staining was nearly undetectable in brains from WT mice (Fig.
3D). In contrast, clear Fluoro-Jade staining was present in regions of the cerebral cortex
and hippocampus in GSK3β KI brain (Fig. 3D) and corresponded with the areas where
the dark cells were abundant. Thus, these results show that failure to inhibit GSK3β
through S389 phosphorylation results in neurodegeneration suggesting that inhibition of
GSK3β through S389 phosphorylation may play a role in neuronal survival.
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Hippocampal degeneration in GSK3β KI mice is not associated with deficits in a
spatial learning task.
The presence of pyknotic cells by H&E staining, and fluoro-jade labeling, in the
hippocampus and cortex of GSK3β KI mice is consistent with neuronal degradation.
Given the hippocampal degradation, we chose to assess performance in the water maze, a
task that requires the hippocampus (Morris et al., 1982). Animals were trained to find a
submerged platform over 8 days, with four trials per day. Performance improved over
sessions (Day f (2,56)=80.75, p<.0001) though there was no effect of genotype (Genotype
f (1,28)=1.338, p>.05) or interaction (Day x Genotype f (2,56)=1.37, p>.05) indicating that
hippocampal spatial learning was similar in GSK3β KI mice and WTs (Fig. 4A). Spatial
memory in the water maze can also be measured by utilizing a probe trial in which the
platform is removed and the time spent in the general area of the platform is quantified.
GSK3β KI and WT mice spent similar time searching in the platform quadrant (t (28)=.45,
p>.05). Additionally, the time spent searching in the appropriate quadrant was above
chance in each group (WT, (t (14)=3.61, p<.01; KI, t (28)=3.36, p<.01; Fig.4B). Further,
when the platform was moved to a new location animals again performed similarly. Over
four trials, distance travelled was reduced (f (3,84)=9.97, p<.0001), again without a
genotype main effect (f (1,28)=.44, p>.05) or interaction (f (3,84)=.63, p>.05; Fig. 4C).
Together, these findings suggest that GSK3β KI mice are capable of performing a
hippocampus based task despite apparent neurodegeneration.
Auditory fear conditioning results in increased contextual and tone conditioning in
GSK3β KI mice.
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As we observed no effect on a hippocampus based task, we sought to understand
whether the neurodegenerative phenotype in GSK3β KI mice might alter behavior in a
task that involves connections between the hippocampus and other limbic brain regions.
Auditory fear conditioning is dependent on amygdala function (LeDoux, 2003; Davis,
2006; Kim and Jung, 2006; Duvarci and Pare, 2014), but is influenced by connections
between the hippocampus and amygdala (Maren, 2001). For auditory fear conditioning,
mice were given pairings of a tone followed by a footshock in a distinctive context.
Beginning twenty-four hours after fear conditioning, mice were tested for freezing to the
conditioning context alone and to the tone in a novel context in a counterbalanced
fashion. Acquisition of tone fear proceeded equivalently in GSK3β KI and WT animals
(Fig. 5A). Each group displayed an increasing fear response to tone presentations
subsequent to the first (f (5,90)=27.99, p<.0001) and there was no genotype effect
(f (1,18)=1.06, p>.05) or interaction (f (5,90)=1.70, p>.05; Fig. 5A). GSK3β KI mice froze
more than WT mice when returned to the conditioning context (t (18)=3.18, p<.01; Fig. 5B)
and also demonstrated greater conditioned fear to the tone in a novel context (t (18)=2.68,
p<.05; Fig. 5C). To further examine this exaggerated conditioned fear, we analyzed
freezing on test days during the first two minutes after placement into the training and
novel contexts. A context effect (f (1,18)=32.20, p<.0001) without an accompanying
interaction (f (1,18)=2.02, p>.05) demonstrates that both groups froze more during the first
two minutes after placement in the training context than in the same time period in the
novel context (GSK3β KI, t (9)=4.25, p<.01; WT, t (14)=3.86, p<.01). However, a genotype
effect (f (1,18)=17.19, p<.01) suggests that GSK3β KI mice overgeneralized fear across
contexts. Not only did GSK3β KI mice freeze more than WTs in the training context
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(t (18)=2.87, p<.01), they also froze more immediately after introduction to the novel
context (t (9)=2.53, p<.05; Fig. 5D). A similar analysis of conditioning to the tone was
conducted. During testing, the tone was presented in a single three minute block.
Analysis of freezing to each minute of the tone, as well as the final minute of the test
when the tone had ended, revealed that each group reduced freezing over the tone
exposure (Minute f (3,54)=28.07, p<.0001; minute X genotype f (3.54)=1.79, p>.05). Similar
to the above results, a genotype effect (f (1,18)=8.19, p<.01) suggests increased fear in
GSK3β KI mice. GSK3β KI and WT mice froze similarly during the first two minutes of
tone presentation. However during the final minute of tone presentation (t (18)=3.62,
p<.01), as well as during the minute after tone termination (t (18)=2.22, p<.05), freezing
was elevated in GSK3β KI mice (Fig. 5E). Together these results demonstrate
exaggerated and overgeneralized freezing in GSK3β KI mice.
Locomotor activity and measures of anxiety and depression are largely similar in
GSK3β KI and WT mice.
It is possible that the exaggerated freezing in GSK3β KI mice is evidence of a
locomotor deficit. However, when subjected to a 10 minute open field test, GSK3β KI
and WT mice travelled similar distances (t (18)=.61, p>.05; Fig. 6A) suggesting no change
in locomotion. Further, each group entered the center of the arena equivalently (t (18)=.71,
p>.05), and spent equal time exploring the center of the open field (t (18)=1.70, p>.05; Fig.
6B) indicating similar anxiety levels. Zero maze results were similar to those in the open
field. Here mice explore a raised circular track with enclosed portions in opposing
quadrants over 5 minutes. Anxiety is defined as reduced open quadrant time or reduced
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open quadrant entries. Open quadrant entries (t (18)=.63, p=.54; Fig. 6C) and open
quadrant time (t (18)=.85, p=.41; Fig. 6D) were similar between GSK3β KI and WT mice
suggesting that GSK3β KI mice are not more anxious than WT mice.
The forced swim test is a commonly used model of depression that measures
behavioral despair through immobility, with increasing immobility time suggestive of
increased depression (Bogdanova et al., 2013). An analysis of forced swim behavior by
minute demonstrated that immobility increased in the later portions of the 6 minute test
(Minute f (5,90)=24.54, p<.0001; Fig.6E) though no genotype effect (Genotype f (1,18)=.23,
p>.05) or interaction (Minute X Genotype f (5,90)=1.11, p>.05) was observed.
A notable phenotype observed in GSK3β KI mice was lower acoustic startle
amplitude (t(18)=3.75, p<.01; Fig. 7A). Acoustic startle is modulated by emotional state
with increased startle amplitude being taken as evidence for increased anxiety (Walker et
al., 2003). Lower startle amplitude was present across the startle test when stimuli were
examined in 6 trial blocks (group f (1,18)=14.087, p<.001; trial f (1,18)=.02, p>.05;
groupXtrial f (1,18)=.293, p>.05; Fig. 7B) demonstrating that the startle reduction observed
in GSK3β KI animals was not a result of more rapid habituation. In order to assess
whether the lower startle amplitude reflected a decrease in emotion-based startle
modulation, GSK3β KI and WT mice were tested for acoustic startle following systemic
injection of the serotonin agonist mCPP. mCPP dose dependently potentiates startle
amplitude and has been used to probe for changes in anxiety responsiveness (Fox et al.,
2008; Hare et al., 2012). The change in acoustic startle amplitude following mCPP
injection was calculated in comparison to vehicle injection in a counterbalanced, within
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subject fashion, separated by 24 hours. Startle potentiation by mCPP was similar in both
GSK3β KI and WT mice (t(18)=.63, p>.05; Fig. 7C) suggesting no difference in
serotonergic startle modulation between genotypes.
p38 MAPK inhibition by SB203580 does not alter auditory fear conditioning.
Activation of p38 MAPK is the sole described mechanism for inhibition of
GSK3β by S389 phosphorylation (Thornton et al., 2008). As such, inhibition of p38
MAPK through SB203580 administration could be expected to reduce GSK3β S 389
phosphorylation and result an auditory fear conditioning effect that mimics that of the
GSK3β KI mice. ICV administration of 125µM SB203580 (2.5µL) 30 minutes prior to
fear conditioning did not alter acquisition of tone fear in WT mice (Tone f (5,90)=103.49,
p<.0001, Treatment f (1,18)=0.00, p>.05, Tone x Treatment f (5,90)=0.50, p>.05; Fig. 8A).
Similarly, context (t (18)=-0.57, p>.05; Fig. 8B) and tone fear (t (18)=-0.99, p>.05; Fig. 8C)
were similar in SB203580 and vehicle treated mice as was context discrimination
(Context f (1,18)= 25.72, p<.0001, Treatment f (1,18)=1.43, p>.05, Context x Treatment
f (1,18)=0.09, p>.05; Fig. 8D). In a separate cohort of animals, SB203580 was administered
immediately following fear conditioning.

Acquisition proceeded equivalently in treated

and untreated mice (Tone f (5,80)=26.69, p<.0001, Treatment f (1,16)=0.05, p>.05, Tone x
Treatment f (5,80)=0.32, p>.05 ). Again, context (t (16)=0.83, p>.05) and tone fear
(t (16)=0.21, p>.05) were similar in SB203580 and vehicle treated mice, as was context
discrimination (Context f (1,16)= 30.51, p<.0001, Treatment f (1,16)=1.39, p>.05, Context x
Treatment f (1,16)=0.26, p>.05).
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While this dose of SB203580 has previously been shown to be effective in
altering fear conditioning after immune challenge (Gonzalez et al., 2013), and a much
lower dose was effective in regulating swim stress behavior (Bruchas et al., 2007), we
sought to understand the effects of SB203580 manipulation through analysis of
downstream targets of active p38 MAPK. p38 MAPK inhibits GSK3β through S 389
phosphorylation (Thornton et al., 2008). Therefore, inhibiting p38 MAPK should elevate
levels of GSK3β S389 phosphorylation. However, by western blot analysis no change in
GSK3β S389 phosphorylation was observed in the amygdala (t (5)=0.57, p>.05) or
hippocampus (t (7)=0.01, p>.05) 30 minutes after SB203580 administration (data not
shown).
Discussion
Previous investigations into the inhibition of GSK3 have largely focused on the
well characterized inhibition of GSK3β by S 9 phosphorylation and GSK3α by S 21
phosphorylation (Stambolic and Woodgett, 1994; Cross et al., 1995). The recently
discovered inhibitory GSK3β phosphorylation site at S389 was shown to be independent
of GSK3α and mediated by p38 MAPK rather than AKT (Thornton et al., 2008). Here
we have extended those results showing that GSK3β S389 phosphorylation has a cellular
localization pattern that is distinct from S 9 phosphorylation.

Further, we have

demonstrated that GSK3β S389 phosphorylation occurs on GSK3β only when S9
phosphorylation is absent and represents a means of inhibiting an independent nuclear
pool of GSK3β activity.

Additionally, we describe a pattern of neuronal degradation and

behavioral phenotype that includes exaggerated fear conditioning in GSK3β KI mice that
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cannot inhibit GSK3β through S 389 phosphorylation. Together, these results demonstrate
that GSK3β S389 phosphorylation may play a unique role in the cellular response to stress
by limiting the activity of a nuclear pool of GSK3β, that if unrestrained, promotes
neuronal degradation.
As a multifunctional kinase, GSK3β must be precisely regulated. Consistent with
this, dysregulation of GSK3β has been implicated in a variety of diseases including those
associated with neuronal degeneration such as Alzheimer’s disease and depression.
GSK3β can promote or inhibit apoptosis making it a critical regulator of cell death
(Beurel and Jope, 2006). Of primary importance here is the consistent finding that
GSK3β activity promotes apoptosis following insults that activate the intrinsic apoptotic
pathway such as DNA damage, oxidative stress, or excitotoxic challenges. For instance,
an interaction between active GSK3β and p53, a pro-apoptotic signaling molecule, forms
in the nucleus after DNA damage and is associated with increased caspase-3, a key driver
of the execution phase of apoptosis (Watcharasit et al., 2002). Notably, observed
changes in GSK3β levels in the nucleus after cellular insults including DNA damage
(Watcharasit et al., 2002) and excitotoxic challenge (Elyaman et al., 2002) have not been
associated with changes in nuclear inhibitory regulation of GSK3β S 9 phosphorylation.
Differentiated neurons cannot be replaced. Thus, these findings suggest that a means of
reducing nuclear GSK3β activity that does not involve S 9 phosphorylation must exist to
protect differentiated neurons from the apoptotic implications of GSK3β activation by
cellular stress.
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Our data suggest that nuclear GSK3β S 389 phosphorylation may play a role in
restraining GSK3β activity and maintaining neuronal viability that is independent of S 9
phosphorylation. GSK3β S389 phosphorylation was shown to be primarily nuclear as
opposed to the S9 which was distributed in the cytoplasmic and nuclear compartments.
The pool of GSK3β phosphorylated at S 9 was shown to lack S389 phosphorylation.
Kinase assay results demonstrated increased GSK3β activity when S 389 phosphorylation
was absent. Finally, the fluoro jade labelling in GSK3β KI mice suggests that a deficit in
GSK3β S389 inhibition promotes neurodegeneration, a finding attributable to that
component of GSK3β activity regulated by S 389 phosphorylation. The nuclear
association between GSK3β and p53 was proposed to mediate negative regulation of
neuroprotective transcription factors (Watcharasit et al., 2002). One such neuroprotective
transcription factor, β-catenin, was shown to be reduced in the nucleus of mice that
conditionally overexpress GSK3β and the reduction was associated with increased
markers of apoptosis (Lucas et al., 2001). β-catenin was shown to accumulate through
inhibition of GSK3β by S389 phosphorylation (Thornton et al., 2008) suggesting that
regulation of S389 phosphorylation may play a role in the neuronal phenotype observed by
Lucas et al. (2001). Future work is necessary to determine the components of
neuroprotective signaling preserved by GSK3β S 389 phosphorylation, as well as how such
GSK3β inhibition may be protective after cellular insult.
The fear phenotype observed in the GSK3β KI animals suggests that there is an as
yet undetermined specificity to the degenerating neurons observed in GSK3β KI mice.
We observed that GSK3β KI mice acquired tone fear at a similar rate as WT mice.
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However, contextual and tone associated freezing was increased in GSK3β KI mice. The
increase was evident as a prolongation of the fear response, as well as an increase in
generalized fear between the training context and a novel context. Overgeneralization of
fear, and failure to extinguish responses to fear associated cues, are found in anxiety
disorders (Lissek et al., 2014), post-traumatic stress disorder (PTSD) (Wessa and Flor,
2007), and are hallmarks of stress exposure models used in rodents to model these
disorders (Izquierdo et al., 2006; Baran et al., 2009; Hoffman et al., 2014). A well
delineated brain circuitry involving the amygdala, hippocampus, and frontal cortex is
involved in fear learning and extinction. Within this circuitry stress may have opposite
effects, degrading dendritic arborization in the hippocampus (Watanabe et al., 1992) and
frontal cortex (Radley et al., 2008), while driving dendritic hypertrophy in subregions of
the amygdala (Vyas et al., 2004).
The hippocampal and frontal cortex degradation observed in rodent stress models
is proposed to be a driving factor in the reduced hippocampal and frontal cortex volumes
observed in stress associated disorders such as PTSD (Gilbertson et al., 2002; Shin et al.,
2006). Within stress associated disorders, amygdala hyperactivation is also commonly
observed (Shin et al., 2004; Savitz and Drevets, 2009). Ghosh and colleagues (Ghosh et
al., 2013) observed increased interactions between amygdala and hippocampal CA1
following stress concurrent with reduced interaction between hippocampal CA3 and
CA1. Another recent study observed hyperactivation of both amygdala and hippocampal
CA1 during fear retrieval after stress exposure (Hoffman et al., 2014) suggesting that
stress increases amygdalar control over behavior. We observed neuronal degradation in
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the CA1 and CA3 fields of the hippocampus. Fluoro Jade labeling limits our
interpretation of this finding to a neuronal phenotype. However, determining whether a
specific neuronal subtype is disproportionately affected by loss of GSK3β S 389 inhibition,
and how such loss might result in the observed fear conditioning phenotype could aid in
understanding the relationship between the complex changes in neuronal morphology and
activation observed in models of stress associated disorders.
The behavioral phenotype observed in GSK3β KI animals further indicates a
distinct role for S389 regulation of GSK3β as opposed to S 9 . Mice with alanine
substitutions at S9 and S21 , rendering GSK3β and GSK3α constitutively active, are more
active in an open field, spend more time immobile in forced swim and tail suspension
tests, and reduced time in the open arms of an elevated plus maze, suggestive of an
increased anxiety and depression-like phenotype, though it is unclear what the
contributions of the individual isoforms are to this phenotype (Polter et al., 2010). These
mice also display a complex fear phenotype that is evident as increased contextual fear,
better context discrimination, and similar tone fear. In contrast, we observed elevated
contextual fear, context generalization, and increased tone fear. Mice with GSK3β S 9
alone rendered constitutively active are more active in an open field, have elevated
acoustic startle amplitude, and reduced forced swim immobility time (Prickaerts et al.,
2006). Consistent with the locomotor hyperactivity observed in GSK3β S9 mutants,
reduced GSK3β S9 phosphorylation has previously been associated with locomotor
sensitization produced by amphetamine (Enman and Unterwald, 2012). In contrast, we
observed no change in locomotor behavior in the GSK3β KI mice described here. Thus,
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increased locomotor activity may be unique to manipulations that render the S 9 site on
GSK3β constitutively active. The increased acoustic startle observed following S 9
manipulation (Prickaerts et al., 2006) is in contrast to the reduction we observed in
GSK3β KI mice. The acoustic startle response is driven by a well-defined circuit
(Yeomans and Frankland, 1995) and modulated by limbic brain regions (Davis et al.,
1997). It is unclear whether the neurodegenerative phenotype observed here extends to
the primary acoustic startle circuit and might therefore drive the reduction in startle
amplitude. Thus, at this time we would not suggest that the reduction in startle amplitude
is evidence of reduced anxiety in GSK3β KI mice. However, our observation that the
anxiogenic 5HT-2c agonist mCPP modulates startle to a similar extent in WT and GSK3β
KI mice suggests that the ability to modulate the emotional response is preserved in
GSK3β KI mice.
Inhibition of p38 MAPK was not found to replicate the phenotype observed in
GSK3β S389 mice. Previous research has utilized an ICV injection of SB203580 at an
order of magnitude lower concentration to regulate the dysphoric effects of stressor
exposure (Bruchas et al., 2007) suggesting that the dose utilized in the current experiment
was sufficient to inhibit some portion of p38 MAPK activity. Others have utilized a
concentration similar to that reported here, injected directly into the hippocampus, to
protect against the impairing effects of inflammatory cytokine injection on fear
conditioning (Gonzalez et al., 2013). Further research is necessary to understand the
requirements for p38 MAPK mediated inhibition of GSK3β, as well as the developmental
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effects of deficient GSK3β S 389 phosphorylation that may underlie the observed fear
phenotype.
The data reported here demonstrate a distinct nuclear localization of GSK3β S 389
phosphorylation, as well as an independent role of S389 phosphorylation in limiting
GSK3β activity.

Further, the novel GSK3β KI animals reported here demonstrate a fear

conditioning phenotype that mimics that observed in models of stress associated
disorders. Based on the fear conditioning findings, and neurodegenerative phenotype
observed in GSK3β KI animals, the relationship between GSK3β S389 phosphorylation
and stress deserves further investigation.
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Figures

Figure 1. GSK3β serine 389 phosphorylation is expressed in a primarily nuclear fashion and present in all
brain areas examined. A. Western blot demonstrating phosphorylation of serine 9 (P-S9 ) and serine 389 (PS389 ) in all examined brain areas. Immunolabeling demonstrates a unique cellular distribution of GSK3β PS389 and P-S9 in B. murine, and C. human (P-T390 is human S389 equivalent) tissue. D. Western blot data
confirms a nuclear (N) localization of the P-S389 signal, P-S9 is evident in nuclear and cytosolic (C)
compartments. E. Immunoprecipitation of P-S9 demonstrates that GSK3β phosphorylated at S 9 was not
simultaneously phosphorylated at S389 .
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Figure 2. Characterization of the GSK3β serine 389 to alanine mutant mouse. A. Diagram depicting the
GSK3β Ser389 Ala knockin (KI) construct, the endogenous GSK3β allele containing exon 11 (black box),
the targeted allele with the neomycin selection cassette still present and the targeted allele with the
neomycin cassette removed by Cre recombinase. White no tched arrow heads represent LoxP sites. B.
Western blot image of whole cell lysates from brains of wildtype (WT), heterozygous (Het) and
homozygous GSK3β KI mice demonstrate lack of serine 389 phosphorylation (p -S389 ) in GSK3β KI mice.
C. GSK3β kinase activity and western blot analysis for P-S389 and P-S9 demonstrating increased GSK3β
activity in cerebral cortex of KI mice.
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Figure 3. Limited neuronal degradation, without apparent neuronal loss, is observed in GSK3β mutant
mice. A. Immunolabelling of NeuN and TUJ-1 demonstrates no overt neuronal loss in GSK3β KI mice.
B. Dark neurons indicative of neurodegeneration are evident in haematoxylin and eosin stained cortical and
hippocampal tissue of GSK3β KI mice. C. GSK3β serine 389 phosphorylation (P-S389 ) is evident in brain
regions where dark neurons are present. D. Fluoro jade labeling in cortex and hippocampus further
demonstrates neuronal degradation in GSK3β KI mice.
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Figure 4. Assessment of spatial learning by Morris water maze in wild type (W T) and GSK3β S389 knockin (KI) mice. A. Water maze acquisition proceeded similarly. B. Time spent searching for the platform in
the target quadrant during a probe trial was similar in WT and KI mice. Both groups demonstrated greater
than chance performance (dotted line) C. Reversal test performance was similar in WT and KI mice. Data
are Mean±SEM.
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Figure 5. Auditory fear conditioning in wild type (WT) and GSK3β S389 knock-in (KI) mice. A.
Acquisition of fear conditioning proceeded similarly in WT and KI mice. KI mice demonstrated greater B.
contextual, and C. tone fear. D. Context discrimination was evident in KI and WT mice, though KI mice
froze more than WT mice in the first two minutes of exposure to the training and novel context after
conditioning. E. Decay of tone fear was more rapid in WT than KI mice. Data are Mean±SEM, *p<.05,
**p<.01
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Figure 6. Assessment of anxiety and depression-like behavior in wild type (WT) and GSK3β S389 knockin (KI) mice. A. Open field distance and B. center time were similar in WT and KI mice. C. Zero maze
open quadrant time D. and open quadrant entries were also similar. E. Forced swim immobility counts
were similar in WT and KI mice across the 6 minute test. Data are Mean±SEM.
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Figure 7. Acoustic startle assessment in wild type (WT) and GSK3β S389 knock-in (KI) mice. A.
Acoustic startle was reduced in KI mice. B. The acoustic startle response was lower in KI mice across the
entire startle session. C. mCPP administration produced a similar elevation in startle amplitude in KI and
WT mice. Data are Mean±SEM, **p<.01

Figure 8. Pre-training intracerebroventricular injection of SB203580 did not alter auditory fear
conditioning in wild type mice. A. Training B. Contextual and C. Tone fear were unchanged after drug
administration. D. Context discrimination was evident and similar in drug and vehicle treated mice. E.
Decay of tone fear was similar in drug and vehicle treated mice.
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Abstract
Stress associated psychiatric disorders affect millions worldwide. In rodents, variate
stress exposure models the negative effects of stress, while voluntary exercise typically
confers stress-resistance. p38 mitogen associated protein kinase (p38 MAPK) is
implicated in the cellular response to stress, and has recently been implicated in the
behavioral response to stressors in rodents, though its regulation by exercise is unknown.
Downstream targets of p38 MAPK following stress are only beginning to be elucidated.
A novel inhibitory phosphorylation site on glycogen synthase kinase 3β (GSK3β) was
recently shown to be sensitive to p38 MAPK activity. Here we examine the
phosphorylation state of p38 MAPK and GSK3β in stress-sensitive brain regions
following variate stress and voluntary exercise. Variate stress increased p38 MAPK
levels in the hippocampus, bed nucleus of the stria terminalis, amygdala, and frontal
cortex. In contrast, voluntary exercise increased p38 MAPK levels only in the amygdala.
GSKβ regulation largely mirrored that of p38 MAPK in a phosphorylation site specific
fashion suggesting a novel association between the kinases following stress. Variate
stress and exercise were also associated with increased histone H2A-variant-X (ϒH2A.X)
indicative of DNA damage. Notably, acute stress did not increase ϒH2A.X indicating
that the increase observed following variate stress may represent accumulation of DNA
damage. Our findings extend the association between behavioral challenges and DNA
damage, and suggest that activation of the p38MAPK/GSK3β pathway may be
protective, engaged in response to DNA damage to prevent central nervous system cell
loss.
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Introduction
Psychiatric disorders precipitated by stress, such as anxiety and depression, affect
approximately 25% of the population and are often found to be comorbid (Kessler et al.,
2005). In animals, variate stress exposure, in which the stressor is varied over multiple
days, leads to increased anxiety and depression like behaviors (Hammack et al., 2009; Li
et al., 2011), while voluntary exercise mitigates the negative consequences of stress
exposure (Greenwood et al., 2003; Greenwood et al., 2005a). Recent work suggests that
activation of p38 mitogen associated protein kinase (p38 MAPK) may mediate the
aversive effects of stress exposure (Bruchas et al., 2007; Bruchas et al., 2011).
Though p38 MAPK has been implicated in stress effects, examination of its
downstream targets is limited, and its regulation by exercise is unknown. Recent work
identified glycogen synthase kinase 3β (GSK3β) as a substrate of p38 MAPK (Thornton
et al., 2008). GSKβ regulates cell properties including structure, gene expression, and
apoptosis (Kaidanovich-Beilin and Woodgett, 2011). Inhibitory phosphorylation of
GSK3β at the serine 9 (S9 ) residue has been implicated in the therapeutic effects of
lithium (Klein and Melton, 1996), selective serotonin reuptake inhibitors (Li et al., 2004),
and ketamine (Beurel et al., 2011; Liu et al., 2013). p38 MAPK inhibition of GSK3β is
independent of the traditionally studied S 9 residue, and rather, exclusively achieved by
phosphorylation of the recently discovered serine 389 (S 389 ) residue (Thornton et al.,
2008). p38 MAPK accumulates in the nucleus, and nuclear GSKβ activity is increased in
response to DNA damage (Watcharasit et al., 2002; Wood et al., 2009). Cell survival
following such damage may be enhanced by p38 MAPK activation and GSK3β inhibition
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(Mikhailov et al., 2004; Phong et al., 2010; Yang et al., 2011; Tan et al., 2014; Wang et
al., 2014). GSK3β S9 phosphorylation is unchanged following DNA damage, suggesting
that GSK3β inhibition through p38 MAPK mediated S 389 phosphorylation may function
to limit GSK3β activity and facilitate the DNA damage response.
Accumulation of DNA damage may lead to neurodegeneration (Brasnjevic et al.,
2008), which could result in the neuronal atrophy observed in variate stress models (Li et
al., 2011). However, recent reports suggest that neuronal activity is sufficient to produce
DNA damage in activated circuits (Suberbielle et al., 2013), suggesting that any
challenge sufficient to result in neuronal activation may produce DNA damage. Thus,
stress, as well as voluntary exercise, challenges that produce neuronal activation and
engage numerous brain regions, may be expected to result in DNA damage and
regulation of p38 MAPK and GSK3β S389 phosphorylation. However, to date such
associations have not been made. Here we show that variate stress and exercise regulate
p38 MAPK levels in stress-sensitive brain regions including the hippocampus, amygdala,
bed nucleus of the stria terminalis (BNST) and frontal cortex concurrent with increased
inhibitory GSK3β S389 phosphorylation . In addition, we demonstrate that each challenge
is associated with increased H2A-variant-X (ϒH2A.X) phosphorylation, a marker of
DNA damage (Rogakou et al., 1998).
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Materials and Methods
Subjects
Male C57BL6/J mice (Jackson Laboratories, Bar Harbor, ME) were obtained at
six weeks of age and provided a 7-day acclimation period prior to experimental
manipulation. Prior to experimental manipulation, mice were housed in groups of 4 in
acrylic wire top cages in an Association for Assessment and Accreditation of Lab Animal
Care (AAALAC) approved animal facility. Following group assignment, mice
undergoing variate stress were single housed. A 12 hour light/dark cycle (0700h-1900h)
and ad libitum access to food and water were maintained throughout experimental
procedures. All procedures were approved by the University of Vermont Animal Care
and Use Committee.
Acoustic startle
Acoustic startle was used to assess anxiety following stress and exercise. Startle
was assessed as described previously (Salam et al., 2009). Briefly, mice were placed
individually in an acoustic startle chamber (Med-Associates, St. Albans, VT) located
within a sound attenuating cubicle and administered 30, 20msec duration, startle-eliciting
noise bursts (10 each at 90, 95 and 105 dB) at a 1-minute inter stimulus interval. The
average startle amplitude over the 30 trial test is reported.
Variate stress and voluntary exercise
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Following the 7-day acclimation period, acoustic startle was assessed in all mice
as described above. The average startle amplitude for each mouse was used to assign
mice to control, exercise, and variate stress groups. Mice assigned to the control (n=10)
and exercise (n=10) conditions were group housed whereas mice assigned to the variate
stress condition (n=10) were individually housed immediately after the baseline startle
test. The variate stress procedure was adapted from previous studies (Hammack et al.,
2009; Hare et al., 2012) and was 14 days in duration. Stressors used were exposure to a 5
minute forced swim followed by 30 minutes in a bedding free cage, exposure to two
0.5mA 5 second foot shocks, 30 minutes of 1Hz oscillation, 60 minutes of restraint in an
overturned 50ml beaker, and 30 minutest on an elevated pedestal (20 cm W X 20 cm D X
60 cm H). Stressors were varied across the stress days to prevent response habituation
using a pseudorandom sequence in which all stressors were performed before a stressor
was repeated. Swim stress was conducted only on days 1 and 14. Mice in the control
and variate stress groups were weighed daily to assess stress-associated attenuation of
weight gain (Hare et al., 2012). The exercise group was provided ad libitum access to a
running wheel (Superpet, 11.4cm diameter) in the home cage for 14 days. Distance run
was measured daily using bicycle pedometers (Cateye Enduro 8, Osaka, Japan).
Acoustic startle was measured on day 15 in all groups and followed by tissue harvest.
Tissue Harvest
GSK3β is rapidly dephosphorylated by anesthetics and long pre-cooling post
mortem intervals (Li et al., 2005). As such, mice were rapidly decapitated and tissue was
rapidly harvested (< 3 minutes) and immediately transferred to centrifuge tubes cooled on
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dry ice prior to storage at -80F. Coronal slices were obtained using a 1mm brain matrix
(Stoelting, Wood Dale, IL). The amgydala (approximate bregma coordinates:
anteroposterior -1.06; mediolateral 2.75; dorsoventral -4.5), bed nucleus of the stria
terminalis (BNST) (approximate bregma coordinates: anteroposterior 0.26; mediolateral
1.0; dorsoventral -4.25), dentate gyrus of the hippocampus (approximate bregma
coordinates: anteroposterior -2.06; mediolateral 1.0; dorsoventral -2.0; punched in a
posterior to anterior fashion), and frontal cortex (approximate bregma coordinates:
anteroposterior 1.34; mediolateral 0.25; dorsoventral -3.0; punched in a posterior to
anterior fashion) were localized extracted with a 1mm tissue punch (Stoelting, Wood
Dale, IL). Tissue was harvested 24 hours after the single forced swim exposure, and 24
hours after the final stressor in control, variate stress, and exercised mice. All tissue
harvest was performed between 1200h and 1300h, and all animals were age matched at
the time of harvest.
Western blot analysis
Western blot analysis was performed using crude whole cell lysates as described
previously (Lluri et al., 2008), except the tissue was homogenized in RIPA buffer (50
mM Tris-HCl pH 8.0, 150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, and 0.1%
sodium dodecyl sulfate). Densitometry was performed as described previously (Long et
al., 2013).
Immunohistochemistry
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Brains were rapidly dissected, blocks with exposed BNST and amygdala
generated, and submersion fixed in 10% buffered formalin (Fisher Scientific) for 4 hrs
prior to paraffin embedding. Sections (8 m) were mounted onto gelatin-coated slides
and processed for immunohistochemistry (IHC) as described previously (Long et al.,
2011), except the use of Sudan Black was excluded.
Antibodies
Rabbit anti-human phospho-GSK3 (ser9) (7,500X for blots, 800X for IHC;
9323), rabbit anti-human phospho p38 MAPK (Thr180/Tyr182) (1,000X, 9215), rabbit
anti-human p38 MAPK (1,000X, 9212), and rabbit anti-human phospho-histone H2A.X
(Ser139) (1,000x for blots, 2577) were obtained from Cell Signaling Technology
(Danvers, MA). Rabbit anti-mouse phospho-GSK3 (Ser389) (3,000 for blots, 400X for
IHC; 07-2275) and mouse anti-human phospho-histone H2A.X (Ser139) (500X for IHC,
05-636) were obtained from Millipore (Billerica, MA), while mouse anti-chicken tubulin (50,000X, T6199) was obtained from Sigma (St. Louis, MO). Species-specific
horseradish peroxidase-conjugated (3,000X), Cy3-conjugated (500X) and Cy2conjugated (100X) secondary antibodies were from Jackson ImmunoResearch (West
Grove, PA).
Statistical Analysis
Data are expressed as means ± standard error of the mean. Due to lane limits
(n=4-6/group) in the western blot apparatus, brain regions were run on separate blots and
analyses were restricted to within brain regions. Western blot analysis following variate
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stress or exercise was evaluated with ANOVA followed by LSD protected independent
samples t-tests exclusively between experimental groups (variate stress or exercise) and
the control group. Western blot analyses of acute challenges were by independent sample
t-tests. Behavioral analysis utilized mixed model ANOVAs with day as the within
subject factor and group as the between subject factor. Mixed model ANOVAs were
followed by lower order ANOVAs, independent samples t-tests, and paired sample ttests. A single animal in the voluntary exercise group was removed from startle analysis
due to results greater 2.3 standard deviations from the group mean. Results were
analyzed by SPSS software version 22 (IBM; Armonk, NY). p< 0.05 was considered
statistically significant.
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Results
Variate stress reduces weight gain and increases acoustic startle amplitude.
We have shown previously that variate stress reduces weight gain in mice (Hare
et al., 2012). Body weight was similar in control and stressed mice on the first day of
stress exposure (t (18)=0.24, p=.82). A group by day repeated measures ANOVA produced
significant main effects for day (F(13,234)=8.42, p<.0001) and group (F(1,18)=14.29, p=.001)
along with a significant interaction (F(13,234)=5.94, p<.0001) demonstrating that mice in
the control condition gained weight over the fourteen day stress period at a greater rate
than those in the stress condition (Fig.1A). Control (day 1 v day 14, t (9)=5.53, p<.0001),
but not stressed mice, showed an increase in normalized body weight over the 14 days
(day 1 v day 14, t (9)=1.17, p=.26). At day 14, control mice weighed more as a percentage
of their body weight than stressed mice (t (18)=3.08, p=.006).
Acoustic startle was assessed prior to the initiation of variate stress and following
termination of stress (Fig. 1B). Stressed (day1 v day 14, t (9)=2.68, p=.013), but not
control mice (day 1 v day 14, t (9)=.29, p=.78) showed an increase in acoustic startle over
these two tests. At 14 days, acoustic startle amplitude was greater in stressed than in
control mice (t (18)=2.79, p=.01) suggesting an anxiogenic effect of stress.
Voluntary exercise increases weight gain and decreases acoustic startle amplitude.
Mice, housed in groups of four, averaged 14.55±.78 km of wheel running per day
(data not shown). As is typical, mice increased wheel activity over days (F(13,26) =
9.79, p<.001), with no significant differences in running observed after the seventh day
81

of wheel access. A post hoc comparison indicated that mice in the voluntary exercise
condition gained more weight than those in the control condition during the fourteen days
of wheel access (exercise v control, day 14, t (18)=2.73, p=.01).
To assess the anxiety reducing effects of voluntary exercise (Fox et al., 2008;
Salam et al., 2009; Hare et al., 2013), mice were tested for acoustic startle before and 14
days after the introduction of the running wheels (Fig.1B). In contrast to the increase in
acoustic startle amplitude observed following stress, exercising mice showed lower
startle amplitude than control mice at 14 days (t (17)=2.51, p=.02), and reduced startle
amplitude when compared to their own pre-exercise baseline (day 1 v day 14, t (8)=3.37,
p=.002).
Stress and exercise regulate p38 MAPK in stress responsive brain areas
To examine the regulation of p38 MAPK by variate stress or voluntary exercise,
tissue homogenates were analyzed by western blot. We chose to examine p38 MAPK in
stress-sensitive brain regions where p38 immunoreactivity has been previously observed
(Lee et al., 2000; Beardmore et al., 2005; Reus et al., 2014; Robles et al., 2014). Analysis
of total (t-p38MAPK) and phosphorylated p38 MAPK (p-p38 MAPK) suggests
regulation by stress across all sampled regions, while exercise resulted in a more
restricted activation of p38 MAPK (Fig.2). Stress resulted in increased p-p38 MAPK
(Fig.2A) and t-p38 MAPK (Fig.2B) levels in the amygdala (stress v control, t-p38
MAPK/tubulin, t (6)=2.59, p=.03; p-p38 MAPK/tubulin, t (6)=2.80, p=.021). Similarly,
stress resulted in an increase in t-p38 MAPK and p-p38 MAPK in the BNST (stress v
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control, t-p38 MAPK/tubulin, t (6)=5.85, p<.001; p-p38 MAPK/tubulin, t (6)=4.85, p=.001).
Previous research demonstrated no change in p38 MAPK in whole hippocampal
homogenates following stress (Li et al., 2009). However, dentate gyrus homogenates in
the current study produced significantly increased t-p38 MAPK and p-p38 MAPK levels
following stress (stress v control, t-p38 MAPK/tubulin, t (6)=4.62, p=.001; p-p38
MAPK/tubulin, t (6)=2.91, p=.02). Stress also increased t-p38 MAPK and p-p38 MAPK
levels in the frontal cortex (stress v control, t-p38 MAPK/tubulin, t (6)=3.04, p=.01; p-p38
MAPK/tubulin, t (6)=2.43, p=.04).
In contrast to stress, a limited regulation of p38 MAPK was observed following
exercise (Fig.2A,B). Exercise increased levels of t-p38 MAPK as well as p-p38 MAPK
in the amygdala (exercise v control, t-p38 MAPK/tubulin, t (6)=4.66, p=.001; p-p38
MAPK/tubulin, t (6)=3.92, p=.004). Exercise produced a trend toward increased t-p38
MAPK and p-p38 in the BNST (exercise v control, t-p38 MAPK/tubulin, t (6)=2.16, p=.06;
p-p38 MAPK/tubulin, t (6)=1.94, p=.08). In the hippocampus exercise failed to regulate tp38 MAPK or p-p38 MAPK (exercise v control, t-p38 MAPK/tubulin, t (6)=85, p=.42, pp38 MAPK/tubulin, t (6)=.71, p=.50). In the frontal cortex exercise increased t-p38
MAPK though p-p38 MAPK was unchanged (exercise v control, t-p38 MAPK/tubulin,
t (6)=2.8, p=.02; p-p38 MAPK/tubulin, t (6)=1.40, p=.20)
Changes in GSK3β Serine 389 phosphorylation mirror observed increases in p38
MAPK activity following stress and exercise
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Catalytic activity of GSK3β is inhibited by phosphorylation. The majority of
GSK3β research has focused on inhibition of its activity by N-terminus S9
phosphorylation. GSK3β C-terminus serine S389 phosphorylation was recently
demonstrated to be target p38 MAPK (Thornton et al., 2008). Phosphorylation of S389 by
p38 MAPK was demonstrated to be site specific as pharmacological inhibition of p38
MAPK reduced S389 phosphorylation while leaving S 9 phosphorylation unchanged. Here
we sought to identify GSK3β S 389 phosphorylation in brain regions where p38 MAPK
regulation was evident following stress or exercise. GSK3β S 389 phosphorylation has
been demonstrated in whole brain homogenate but has yet to be examined in a region
specific fashion. GSK3β S389 phosphorylation, as well as GSK3β S 9 phosphorylation,
was evident by western blot (Fig. 3B). To further confirm our western blot analysis brain
areas were examined by immunofluorescence. Fluorescence signal for GSK3β S 389 and
S9 phosphorylation was evident in all brain areas examined (Fig. 3C).
Following demonstration of GSK3β S 389 and S9 phosphorylation in our regions of
interest, we aimed to associate S389 phosphorylation with stress and exercise p38 MAPK
regulation. Increased GSK3β S 389 phosphorylation was identified in brain regions that
demonstrated increased p38 MAPK levels following stress (Fig. 4A). Specifically,
increased GSK3β S389 phosphorylation was observed in the amygdala (stress v control,
t (6)=5.06, p=.001), BNST (stress v control, t (6)=3.09, p=.01), and hippocampus (stress v
control, t (6)=3.55, p=.006) following stress. Only in the frontal cortex was an observed
increase in p-p38 MAPK not associated with increased GSK3β S 389 phosphorylation
(stress v control, t (6)=.99, p=.35) following stress. GSK3β S389 regulation by voluntary
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exercise was similarly examined (Fig. 4A). Following exercise GSK3β S 389
phosphorylation was increased only in the amygdala (exercise v control, t (6)=3.93,
p=.003), though consistent with stress results this was the only brain region in which an
increase in p-p38 MAPK was observed following exercise. Notably, a trend towards
increased S389 phosphorylation was observed in the BNST (exercise v control, t (6)=1.86,
p=.10). A similar trend towards increased t-p38 MAPK and p-p38 MAPK were observed
in the same region.
Regulation S9 phosphorylation was observed following both stress and exercise
(Fig. 4B). Consistent with previous reports demonstrating the independence of GSK3β
S9 and S389 phosphorylation (Thornton et al., 2008), the pattern of regulation was
different when compared to S 389 phosphorylation and p-p38 MAPK regulation. Reduced
GSK3β S9 phosphorylation was observed in the amygdala following both stress (stress v
control, t (6)=-4.13, p=.003) and exercise (exercise v control, t (6)=-3.06, p=.014). In
contrast, GSK3β S9 phosphorylation in the BNST was increased following both stress
(stress v control, t (6)=4.14, p=.003) and exercise (exercise v control, t (6)=4.27, p=.002).
Exercise increased GSK3β S9 phosphorylation in the frontal cortex (t (6)=2.79, p=.02).
Previous work has shown that acute stress (Meller et al., 2003; Shen et al., 2004)
does not regulate p38 MAPK, and that increased p-p38 MAPK produced by a pair of
forced swim stressors separated by 24 hours is transient, decaying within 6 hours
(Bruchas et al., 2007). Similarly, studies have shown that acute restraint stress does not
regulate GSK3β (Kozlovsky et al., 2002; Batandier et al., 2014) though these studies
were focused on S9 phosphorylation. To determine whether the observed increase in
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GSK3β S389 phosphorylation after stress was due to the repeated stress exposure of the
variate stress paradigm or was regulated by the final stressor administered, a cohort of
animals was subjected to a single forced swim stressor and tissue was collected 24 hours
later. GSK3β S389 phosphorylation was unchanged in the amygdala, BNST,
hippocampus, or frontal cortex 24 hr following acute swim stress (t (10)<1.03, p.34 for all
comparisons, data not shown). This finding suggests that the increase in S 389
phosphorylation observed following multiple stressors is indeed due to variate stress
exposure rather than regulation by the final stressor in the paradigm.
Region specific increases in ϒH2A.X are evident following exercise and variate
stress
ϒH2A.X is rapidly induced following DNA damage inducing stimuli (Rogakou et
al., 1998). p38 MAPK levels are increased by stimuli that produce DNA damage
(Mikhailov et al., 2004; Wood et al., 2009; Phong et al., 2010). Active GSK3β has been
shown to slow DNA repair (Yang et al., 2011), though GSK3β accumulation in the
nucleus following DNA damage inducing stimuli is not associated with increased
inhibitory S9 phosphorylation (Watcharasit et al., 2002). Thus, the p38 MAPK regulation
and increased inhibitory GSK3β S 389 phosphorylation observed here may be evidence of
a response to DNA damage following variate stress or exercise initiated to facilitate DNA
repair. Though increased ϒH2A.X was observed in all brain regions following variate
stress or exercise, only in the BNST did results achieve significance (Fig. 5A). In
comparison to controls, both stress (stress v control, t (6)=2.46, p=.04) and exercise
(exercise v control, t (6)=2.29, p=.05) increased ϒH2A.X in the BNST. To further
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understand this observed increase in ϒH2A.X following stress BNST samples from
animals subjected to acute forced swim were analyzed for ϒH2A.X and compared to a
second cohort of stress animals (Fig. 5B). Consistent with results demonstrating no
change in GSK3β S389 phosphorylation after acute forced swim, no changes in ϒH2A.X
were observed in the BNST 24 hours after acute forced swim (acute stress v control,
t (6)=.04, p=.97). Increased ϒH2A.X was again observed following the variate stress
paradigm (stress v control, t (9)=3.16, p=.01), suggesting that DNA damage is
accumulating over the variate stress period. Immunoblotting is the least sensitive means
of assessing ϒH2A.X accumulation in response to DNA damage (Sharma et al., 2012).
ϒH2A.X forms dense foci around DNA damage sites that can be observed by
immunofluorescence. Fluorescence images obtained from BNST tissue are consistent
with the western blot analysis observation of increased ϒH2A.X signal following stress
or exercise (Fig.5C).
Discussion
Cellular stress promotes activity of p38 MAPK though to date the literature on
physical and psychological stress regulation of p38 MAPK is limited. The current study
demonstrates increased p38 MAPK activity in brain regions associated with stress driven
plasticity. Further, we demonstrate that increased GSK3β S 389 phosphorylation, a
recently identified substrate of p38 MAPK, is evident following stress and exercise.
Finally, our data are the first to demonstrate that ϒH2A.X an indicator of DNA damage is
increased following stress and exercise. These observations are consistent with in-vitro,
and peripheral in-vivo work demonstrating a relationship between p38 MAPK and
87

GSK3β S389 phosphorylation (Thornton et al., 2008) but are the first to demonstrate such
an association in limbic brain regions in response to challenge.
Consistent with previous reports (Hare et al., 2012; Roman et al., 2012) stress
resulted in reduced weight gain and increased acoustic startle amplitude, suggestive of an
increased depressive and anxiety- like phenotype following stress. In contrast, voluntary
exercise reduced acoustic startle amplitude suggestive of reduced anxiety. We observed
increased t-p38 MAPK and p-p38 MAPK largely in stressed mice. Stress associated
increases in GSK3β S389 phosphorylation were observed in the amygdala, BNST, and
hippocampus of stressed mice, brain regions that also demonstrated increased p38 MAPK
activity. In contrast, acute stress produced no change in GSK3β S 389 phosphorylation in
the brain regions examined. While increased ϒH2A.X was observed in multiple brain
regions only in the BNST was ϒH2A.X significantly increased. Surprisingly, this
increase was evident following stress and exercise. Consistent changes in GSK3β S 9
phosphorylation were observed following stress and exercise in the BNST, and amygdala
though regulation was directionally different with increased GSK3β S 9 evident in the
BNST and decreased S9 evident in the amygdala. The differences observed in GSK3β S 9
and S389 regulation provide in-vivo support for previous work suggesting the
independence of activity across the pair of phosphorylation sites (Thornton et al., 2008).
p38 MAPK activity plays a role in a number of cellular responses associated with
stress pathology including synaptic destabilization (Collingridge et al., 2010) and
inflammation (Correa and Eales, 2012). Stress has previously been demonstrated to
increase phosphorylated p38 MAPK immediately following a series of forced swim
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exposures over 48 hours (Bruchas et al., 2007). Here we observed increased p38 MAPK
activity following stress in the amygdala, BNST, and hippocampus. As opposed to the
previous studies where phosphorylated p38 MAPK immunoreactivity was elevated for
approximately 6 hours, the increased immunoreactivity present here was observed 24
hours after the final stress exposure demonstrating sustained activation of p38 MAPK
following chronic challenge. Inhibition of p38 MAPK has been demonstrated to reduce
the negative behavioral effects of acute stress (Bruchas et al., 2007; Sharma et al., 2011)
and serotonin specific knock out of p38 MAPK is protective against depression like
behavior in a social stress model (Bruchas et al., 2011) suggesting that inhibition of p38
MAPK may have therapeutic benefit in stress associated disorders. However, numerous
reports suggest that p38 MAPK activity is increased in response to stimuli that induce
DNA damage, and that such activity may be protective (Phong et al., 2010; Tan et al.,
2014; Wang et al., 2014) potentially through GSK3β inhibition (Yang et al., 2011). The
findings reported here, and previous work demonstrating that GSK3β inhibitory S389
phosphorylation (Thornton et al., 2008), and basal p38 MAPK activity (Lee et al., 2000),
are elevated in brain compared to peripheral cells, suggests that the association between
p38 MAPK and GSK3β S389 phosphorylation may be protective in central nervous
system cells that are not subject to replacement if lost. Further work is clearly necessary
to understand this novel association between these multifunctional kinases, as well as
how extracellular and intracellular stress signals may differentially modulate their
individual and associated activity.
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That both stress and exercise were associated with DNA damage as indicated by
ϒH2A.X expression is novel and deserves further investigation. Experience associated
transcription and translation in neurons results in high rates of metabolism, mitochondrial
activity, and associated reactive oxygen species that may damage mitochondrial and
neuronal DNA (Barzilai et al., 2008). Unrepaired DNA damage may result in cell death,
and accumulated DNA damage is hypothesized to underlie numerous pathologies
(Brasnjevic et al., 2008). However, a recent report of DNA damage in activated neuronal
populations postulated that the repair process may play a necessary role in chromatin
remodeling and resulting experience associated modification of gene expression
(Suberbielle et al., 2013). Such epigenetic modulation is likely to play an important role
in stress outcomes (Covington et al., 2009; Vialou et al., 2013) and is also evident
following voluntary exercise (Gomez-Pinilla et al., 2011; Intlekofer et al., 2013). We
observed the strongest increase in ϒH2A.X within the BNST, a site of robust plasticity
during stress exposure (Vyas et al., 2003), and voluntary exercise (Greenwood et al.,
2005a), and therefore a region that may be particularly susceptible to neuronal activity
associated DNA damage. Directly tying p38 MAPK inhibition of GSK3β to the DNA
damage response, as well as determining whether such damage is playing a role in stress
or exercise associated behavioral outcomes are compelling targets for further
investigation.
Our results suggest that DNA damage was accumulating in stressed animals as
chronic but not acute stress exposure increased ϒH2A.X signal. It should be noted that
exercise was not terminated 24 hours prior to tissue harvest as stress exposure was, and
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damage after an acute bout of exercise was not measured. Therefore, it cannot be
suggested that DNA damage is accumulating in exercising animals, only that increased
signal associated with damage was present. Voluntary exercise in rodents takes place
during the dark phase of the circadian cycle and therefore would be expected to terminate
approximately five to seven hours prior to tissue harvest. Thus, in animals that exercised
it is possible that elevated ϒH2A.X signal represents a response to the prior period of
running rather than an accumulation of DNA damage. There is evidence that locking a
wheel 24 hours prior to tissue harvest may itself be stressful (Greenwood et al., 2012a)
therefore time-locking of the manipulations utilized here may itself confound results. To
our knowledge this is the first demonstration of increased DNA damage following
exercise, though it is notable that recent work suggests that the commonly observed
increase in brain derived neurotrophic factor following exercise was recently associated
with increased transcription of AP endonuclease 1, a protein associated with DNA repair,
in exercising animals (Yang et al., 2014). Thus, while exercise may produce DNA
damage it is conceivable that the same activity may result in more efficient repair.
Indeed stress hormones are associated with slowed DNA repair in-vitro (Flint et al.,
2007) and thus the time course of repair may be expected to be different following stress
or exercise. Work is currently underway in our laboratory to assess changes in the time
course of DNA repair following stress or exercise.
Here we have demonstrated an anxiogenic effect of stress and anxiolytic effect of
exercise though protein regulation was similar in many cases. It is important to consider
that while stress and exercise produce divergent behavioral outcomes, as demonstrated
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here, each is a metabolic challenge that activates the hypothalamic pituitary adrenal
(HPA) axis though activation by each challenge is associated with opposite hedonic states
(Wosiski-Kuhn and Stranahan, 2012). Exercise is associated with reduced anxiety and
depression (Binder et al., 2004; Salam et al., 2009; Sciolino et al., 2012), while activation
of the HPA axis in a negative context is associated with increased anxiety and depression
(Li et al., 2011). These findings suggest experiences, both positive and negative, may act
through similar systems to produce divergent behavioral outcomes based on the
contextual milieu associated with the experience. Each of the kinases examined here is
known to provide a regulatory hub for convergent signaling pathways upstream of
transcription factor activation.

Plasticity following transcription factor activation

brought about by stress or exercise could be gated in a fashion that is dictated by the
respective experience. For example, anxiogenic and anxiolytic behavioral effects in the
BNST have been observed through optical stimulation of glutamatergic and GABAergic
projection neurons respectively (Jennings et al., 2013).

Identifying the neuronal

populations affected by exercise and stress manipulations would provide clarification of
these effects that tissue punches and western blot analysis fail to capture.
The research presented here demonstrates stress regulation of p38 MAPK activity
across stress-sensitive brain regions. Further, we demonstrate that the understudied
GSK3β S389 phosphorylation site is regulated in a fashion consistent with p38 MAPK
activity. Finally, our results are the first to demonstrate DNA damage, by stress and
exercise, in a brain region that is known to be involved in stress and exercise associated
plasticity. Understanding the role the described pathway plays in behavioral outcomes
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following stress or exercise, as well as the DNA damage response will require a better
understanding of kinases involved. Further work is necessary to delineate the causes of
DNA damage in stress and exercise, and demonstrate that inhibition of p38 MAPK
activity or GSK3β S389 phosphorylation exacerbates challenge associated DNA damage.
Additionally an understanding of whether a specific p38 MAPK isoform, for example
p38β which is preferentially expressed in the nucleus (Lee et al., 2000), is driving the
increase in p38 MAPK activity observed here requires additional work.
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Figures

Figure 1. Stress reduces weight gain, exercise and stress differentially affect startle amplitude. A, Effect of
variate stress (stress) on body weight over the 14 day variate stress period. B, Opposing effect of stress or
voluntary exercise on acoustic startle amplitude. Data are means ± SEM, **p<.01 v control, *p<.05 v
control
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Figure 2. Regulation of p38 MAPK by stress and exercise. A. Representative western blots from analysis
of phosphorylated p38 MAPK (p-p38 MAPK), total p38 MAPK (t-p38 MAPK), and α-tubulin (tubulin) in
control, voluntary exercise (exer), and variate stress (stress) animals. B. Comparison of relative p-p38
MAPK immunoreactivity in regional lysates following exercise and variate stress. C. Comparison of
relative t-p38 MAPK immunoreacitivty in regional lysates following exercise and variate stress. All data
are Mean ± SEM, ***p<.001 v control, **p<.01 v control, *p<.05 v control.
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Figure 3. Demonstration of GSK3β phosphorylation in amygdala, BNST, hippocampus, and frontal cortex.
A. Representative western blot samples from analysis of GSK3β S 389 phosphorylation (p-S389 ), and S9
phosphorylation (p-S9 ), α-tubulin loading control (tubulin). B. Relative GSK3β p-S389 and S9 expression
across sampled brain regions. C. Immunofluorescence images confirming GSK3β p-S389 and S9 expression
in sampled brain regions. Left panel for each phosphorylation site is representative 20x magnification
image, right panel is 40x magnification of same image. Scale bar = 50µM.
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Figure 4. GSK3β phosphorylation state analysis by western blot following stress or exercise. A.
Representative western blot samples relative expression from regional analysis of GSK3β S 389
phosphorylation (p-S389 ). B. Representative western blot samples and relative expression from regional
analysis of GSK3β S9 phosphorylation (p-S9 ). All samples normalized to α-tubulin (tubulin) for analysis.
Data are Mean ± SEM, **p<.01 v control, *p<.05 v control.
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Figure 5. Evidence for DNA damage following stress and exercise. A. ϒH2A.X analysis by western blot
following variate stress (stress) or exercise. A. ϒH2A.X analysis by western blot following variate stress
(stress) or exercise. B. A comparison of ϒH2A.X 24 hours after an acute forced swim experience or 14
days of variate stress terminating with forced swim. C. ϒH2A.X foci that reliably mark DNA damage can
be observed in representative BNST immunofluorescence images following variate s tress (stress) or
exercise confirming western blot analysis. All samples normalized to α-tubulin (tubulin) for analysis. Data
expressed as mean ± SEM. *p<.05 v control. Fluorescence images are 20x magnification with expanded
sample. Scale bar = 50µM.
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CHAPTER 4: GENERAL DISCUSSION
The initial investigation into inhibition of GSK3β by S 389 phosphorylation
produced findings that made understanding regulation of S 389 phosphorylation a
compelling research target (Thornton et al., 2008). First, inhibition of GSK3β through
S389 phosphorylation was found to be mediated by p38 MAPK rather than AKT, which is
known to phosphorylate the S9 site (Stambolic and Woodgett, 1994) indicating that the
two sites may be regulated by separable signaling pathways activated by similar, or
different, stimuli. Second, GSK3β S389 phosphorylation was especially apparent in brain
tissue suggesting a specialized role in the central nervous system. Finally, inhibition of
GSK3β by S389 phosphorylation was correlated with accumulation of β-catenin
suggesting that S389 phosphorylation may play a role in cell survival. The findings
reported here further suggest that GSK3β S389 phosphorylation may be involved in
neuroprotection. GSK3β S9 and S389 phosphorylation were found to have different
cellular distributions. GSK3β S389 phosphorylation was found to have a nuclear
distribution, while S9 phosphorylation was apparent throughout the cell. GSK3β activity
was found to be increased in GSK3β KI animals, and this was associated with a pattern of
neurodegeneration in the hippocampus and cortex that was not evident in WT mice.
These findings suggest a neuroprotective role for S389 phosphorylation within the central
nervous system. Despite the observed hippocampal degeneration, GSK3β KI mice were
found to perform normally in the water maze, a task that requires the hippocampus
(Morris et al., 1982). However, auditory fear conditioning was exaggerated and
contextual fear was overgeneralized in GSK3β KI mice suggesting that the
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neurodegeneration observed may influence fear conditioning circuitry perhaps through
hippocampal connections with the amygdala (Maren, 2001).
The auditory fear conditioning phenotype observed in GSK3β KI animals was
similar to what might be expected in stressed animals (Izquierdo et al., 2006; Baran et al.,
2009; Hoffman et al., 2014). The effect of stress on GSK3β S 389 phosphorylation had not
been examined, nor had regulation of GSK3β by stress been examined outside of the
hippocampus or frontal cortex. This paucity of research prompted assessment of GSK3β
regulation by stress, and exercise, a behavior with stress protective effects, in brain
regions associated with regulation of the stress response. We observed that two weeks of
variate stress, and exercise, produced divergent effects on anxiety- like behavior, but
regulated GSK3β phosphorylation in a largely similar fashion. Notably, stress and
exercise increased GSK3β S389 phosphorylation. GSK3β S9 phosphorylation was
positively, and negatively, regulated in a region-dependent manner further supporting
separable roles for the inhibitory phosphorylation sites. Phosphorylated p38 MAPK
would be expected to mediate the increase in GSK3β S389 phosphorylation and indeed,
we observed an increase in p38 MAPK phosphorylation in brain regions where S 389
phosphorylation was increased. Previous work suggests that DNA damage may produce
a cellular context in which p38 MAPK mediated inhibition of GSK3β would promote
neuronal survival (Watcharasit et al., 2002; Wood et al., 2009). ϒH2A.X, a marker of
DNA damage (Rogakou et al., 1998), was found in both stressed and exercising animals
in brain regions where GSK3β S 389 phosphorylation was elevated, suggesting that the
increased inhibition may be a response to DNA damage. We observed no change in
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GSK3β S389 phosphorylation or ϒH2A.X signal when animals were exposed to a single
stressor indicating the increased ϒH2A.X signal observed after two weeks of stress or
exercise may represent an accumulation of DNA damage that necessitates increased
GSK3β S389 phosphorylation to prevent neurodegeneration as observed in GSK3β KI
animals.
Incorporation of GSK3β KI neurodegeneration and the observed regulation of GSK3β by
stress and exercise
The results reported here suggest that deficient inhibition of GSK3β through S 389
phosphorylation results in neurodegeneration. Importantly, fluoro jade labelled
degeneration occurs prior to cell death, and can represent shrinkage of cell bodies and
cellular processes (Ehara and Ueda, 2009). Stress exposure is regularly associated with
retractions of the dendritic arbor, spine loss, and labeling of shrunken neurons (Uno et al.,
1989; Watanabe et al., 1992; Magarinos and McEwen, 1995), suggesting that deficient
GSK3β S389 phosphorylation may play a role in stress associated plasticity. This loss of
complexity is particularly evident in the hippocampal CA3 field, a region in which we
observed evidence of neurodegeneration in GSK3β KI mice. Previous research supports
a role for loss of trophic factor support in the morphological changes brought about by
stress (Duman and Monteggia, 2006; Magarinos et al., 2011). On the other hand,
exercise enhances expression of multiple trophic factors (Neeper et al., 1996; LlorensMartin et al., 2010), and is associated with structural changes in neurons that oppose
those of stress (Yau et al., 2011; Baj et al., 2012). If GSK3β S389 phosphorylation plays a
role in the dendritic remodeling associated with stress and exercise, one might predict
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that exercise would result in decreased GSK3β activity by increasing S389
phosphorylation to promote plasticity, while the loss of trophic support in stressed
animals would be associated with increased GSK3β activity through reduced S389
phosphorylation. However, our results demonstrate that 14 days of stress or exercise are
each associated with increased GSK3β S 389 phosphorylation. Thus it seems that GSK3β
inhibition is a neuroprotective response to the increase in DNA damage evident in both
conditions (Fig. 1).

Figure 1. Regulation of GSK3β by stress or exercise. DNA damage signaling further inhibits nuclear
GSK3β through p38 MAPK phosphorylation of the S389 site. Under prolonged conditions that inhibit
DNA repair DNA damage may accumulate leading to neurodegeneration (dashed arrows). Cytoplasmic
GSK3β S9 phosphorylation is regulated in a region specific fashion that may lead to changes in cellular
plasticity.

The underlying cause of dendritic remodeling by stress is not known though
excitotoxicity, mitochondrial dysfunction, altered gene transcription and exposure to
reactive oxygen species have been proposed (Sapolsky, 2000; Duman and Monteggia,
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2006; Popoli et al., 2012; Picard et al., 2014). Neuronal activity, high rates of
metabolism and associated reactive oxygen species, and experience driven gene
transcription have similarly been proposed to produce DNA damage suggesting that such
damage might be a central factor in neuronal degradation (Brasnjevic et al., 2008;
Barzilai, 2010; Suberbielle et al., 2013; Aymard et al., 2014). Accumulated DNA
damage and impaired repair processing are thought to underlie a number of
neurodegenerative disorders (Brasnjevic et al., 2008) though an association with stress
has not previously been made. Increased ϒH2A.X, a marker of DNA damage, was
observed following exercise and stress, though only in the stress condition can we say
that DNA damage accumulated as 14 days, but not 1 day, of stress resulted in increased
levels of ϒH2A.X. The damage associated with exercise may reflect the previous night’s
activity rather than an accumulation of damage over the 14 day wheel access period. In
either case, the suggestion would be that failure to repair the damage may eventually lead
to the neuronal degradation observed in GSK3β KI mice (Fig. 1).
Elevated levels of ϒH2A.X in exercise and stress conditions may be induced by a
similar mechanism, experience associated neuronal activation, metabolism, and gene
transcription, but the repair outcome may be quite different. The cellular context
associated with stress has previously been suggested to impair DNA repair (Jenkins et al.,
2014), and in contrast, that associated with exercise may enhance repair. BDNF, which is
elevated in exercising mice (Neeper et al., 1996), has been associated with more rapid
DNA repair (Yang et al., 2014). Exercising animals terminate stress responses more
rapidly (Hare et al., 2013), and habituate to stressors faster (Sasse et al., 2008; Campeau
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et al., 2010; Nyhuis et al., 2010), suggesting reduced exposure to stress hormones which
have been demonstrated to slow DNA repair (Flint et al., 2007). In contrast, stress
reduces BDNF (Nibuya et al., 1995), and impairs the organisms ability to limit the stress
response (O'Connor et al., 2003; Mizoguchi et al., 2008) potentially setting up a situation
in which DNA repair is less efficient and more likely to lead to degeneration. A
purposeful physiological process may represent a second similar mechanism to account
for the DNA damage signal observed following stress and exercise. Induction of DNA
damage has been proposed to represent a physiological process through which gene
transcription may be regulated by experience (Suberbielle et al., 2013; O'Hagan, 2014).
Such purposeful damage could lead to opposing patterns of gene expression following
stress and exercise (Duman and Monteggia, 2006) while providing a similar ϒH2A.X
signal.
The degeneration observed in GSK3β KI animals led to an initial hypothesis that
stress would lead to a reduction in GSK3β S 389 phosphorylation. If deficiency in GSK3β
S389 phosphorylation does lead to stress associated changes in neuronal morphology in
response to DNA damage, it is possible that the 14 day stress protocol employed may not
have been sufficient to result in the type of structural changes seen with longer stress
protocols. Three, but not two, weeks of stress has been shown to produce dendritic
remodeling in the hippocampus (Magarinos and McEwen, 1995). Three week protocols
also result in stress associated changes in neuronal morphology in the frontal cortex
(Radley et al., 2006; Radley et al., 2008). However, a single stressor has been
demonstrated to alter spine morphology in the frontal cortex (Sciolino et al., 2015),
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though this may represent a more subtle effect than the changes in dendritic arbor
observed after longer stress paradigms. If stress impairs DNA repair processes (Jenkins
et al., 2014), and sufficient accumulation of DNA damage leads to neurodegeneration
(Brasnjevic et al., 2008), one may expect that stress paradigms of sufficient duration may
eventually lead to the increased nuclear GSK3β activity observed in in-vitro neuronal
studies of DNA damage associated apoptotic signaling (Watcharasit et al., 2002). Indeed,
accumulated DNA damage may very well be a component of the allostatic load that stress
places on the nervous system and eventually result in initiation of degenerative signaling
cascades of which active GSK3β would likely be a part. These cascades could be
apoptotic in nature (Watcharasit et al., 2002), or result in GSK3β activation of proteins
such as tau that can function to destabilize structural proteins (Hanger et al., 1992; Lucas
et al., 2001). In contrast, in the pro-repair environment of an exercising animal DNA
damage may not accumulate sufficiently to lead to GSK3β activation.
It should also be acknowledged that the result of neuronal remodelling need not
be negative. Research into the beneficial effects of exercise has focused on increased
neuronal complexity and increased trophic factor support, while that into stress has
largely focused on the opposite. However, there is evidence that stress associated
changes are regionally specific and can produce the type of physiological changes
typically associated with exercise. Stress increases BDNF expression and dendritic
complexity in the BNST (Vyas et al., 2003; Hammack et al., 2009), while having
degenerative effects on frontal cortex projections to the BNST (Radley et al., 2013).
Increased amygdala activation is observed in patients with stress associated disorders yet
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in many cases decreased volume is observed (Savitz and Drevets, 2009). In these cases it
is unclear whether the decreased volume is a developmental outcome that predisposes for
the disorder or is caused by the disorder, but the possibility is present that the observed
increase in activity is the result of degeneration in an as yet unknown neuronal subtype.
A very complex pattern of results can be seen in stress associated amygdala plasticity that
seems to be stressor and neuronal subtype specific (Vyas et al., 2002), and can result in
increased and decreased complexity. Changes in neuronal complexity associated with
exercise have focused on increased complexity in the hippocampus and frontal cortex as
mediating the beneficial effects of exercise (Yau et al., 2011; Sciolino et al., 2015).
However, posterior hypothalamic, periaqueductal grey, and nucleus tractus solitaris
dendritic complexity is observed to be reduced in animals that exercise as adults (Nelson
et al., 2010). This reduced dendritic complexity is thought to contribute to the beneficial
effect of exercise by reducing sympathetic tone. However, it is notable that the brain
regions involved play a role in defensive behaviors, and have projections to areas that
control the stress response such as the BNST and amygdala (Bienkowski and Rinaman,
2013). Thus, should DNA damage be associated with neuronal degradation following
stress and exercise, the functional outcome of such changes should be examined in a
region and cell type specific fashion before the finding is interpreted in a negative or
positive light.
Regulation of p38 MAPK by stress
While the finding of increased DNA damage and regulation of associated second
messengers suggests a specific, protective role for nuclear p38 MAPK activity in
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inhibiting GSK3β by S389 phosphorylation, as with GSK3β, consideration of the
localization of p38 MAPK’s regulation by stress is warranted. We observed a robust
increase in both total and phosphorylated p38 MAPK levels across all brain regions
examined in the stress group, and a much more limited increase in exercising mice. p38
MAPK has multiple isoforms that have been reported to display different distributions
(Lee et al., 2000). p38α MAPK is thought to inhibit GSK3β by S389 phosphorylation
(Rincon and Thornton unpublished observations). p38α is localized in the nucleus as
well as the cytoplasm (Lee et al., 2000). Synaptic p38 MAPK signaling is implicated in
the depressive and anxiogenic effects of acute stress exposure. Indeed, deletion of p38α
MAPK in the dorsal raphe was shown to reduce social avoidance, a measure of
depression, after social defeat (Bruchas et al., 2011). Inhibition of p38 MAPK similarly
attenuated the increase in forced swim immobility time observed 24 hours after an initial
swim exposure (Bruchas et al., 2007). The effect of p38 MAPK inhibition was likely due
to disrupting second messenger signaling occurring after activation of kappa opioid
receptors by stress (McLaughlin et al., 2003; Bruchas et al., 2006; McLaughlin et al.,
2006a; McLaughlin et al., 2006b; Bruchas et al., 2007). These findings, suggest that
understanding the role of p38 MAPK in mediating stress effects, such as the changes in
anxiety- like behavior or changes in GSK3β phosphorylation observed here, will require
an understanding of how stress signals are interacting with p38 MAPK in a location
specific fashion.
We observed a stress-like phenotype in GSK3β KI animals given auditory fear
conditioning. As p38 MAPK is the only known regulator of GSK3β S389
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phosphorylation, p38 MAPK activity increases GSK3β S389 phosphorylation levels
(Thornton et al., 2008), it was expected that inhibition of p38 MAPK by central
administration of SB203580 in WT mice would replicate the exaggerated, and
overgeneralized fear observed in GSK3β KI mice that cannot phosphorylate S 389 . We
observed no change in fear conditioning when 125uM SB203580 was administered prior
to or immediately following fear conditioning. However, we observed no change in
GSK3β S389 phosphorylation 30 minutes after SB203580 administration in the
hippocampus or amygdala. As such, this result is inconclusive as to the effect of p38
MAPK inhibition on fear conditioning, as well as the role GSK3β S 389 phosphorylation
might play in fear conditioning. Bruchas et. al. (2007) disrupted stress effects with a
25nM ICV injection of SB203580 along a similar time-course and volume, and Gonzalez
et. al. (2013) observed a facilitation of fear conditioning after IL-1β challenge when
125uM SB203580 was administered directly into the hippocampus. In contrast, impaired
contextual discrimination was observed when ~2mM SB203580 was administered into
the hippocampus prior to habituation, conditioning, and testing. These findings
demonstrate that the effect of p38 MAPK on behavior is likely specific to injection
timing, dose, region, and cellular context. As such, identification of an injection protocol
that alters GSK3β S389 phosphorylation is valuable as it provides a target p38 MAPK
substrate that has been identified to play a role in fear behavior. Disruption of GSK3β
phosphorylation by p38 MAPK was observed after a series of injections (Rincon and
Thornton personal communications). A new fear conditioning series is underway that
will examine whether such a protocol will reduce GSK3β S 389 phosphorylation and
mimic the GSK3β KI phenotype. Alternatively, the fear phenotype observed in GSK3β
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KI animals may be due to developmental or compensatory changes that occur with
deficient S389 phosphorylation. Future work is necessary to determine what those
changes might be, but it is known that similar genetic manipulations to block GSK3β S 9
phosphorylation paradoxically increase BDNF levels (Prickaerts et al., 2006) suggesting
that compensatory changes may be similarly taking place in GSK3β KI animals.
Conclusion
The set of data presented here suggests a fundamentally different role for GSK3β
S389 and S9 inhibitory phosphorylation. Analysis of GSK3β KI animals demonstrated a
behavioral phenotype that was dissimilar to that reported in animals with deficient S 9
phosphorylation. Regulation of GSK3β phosphorylation by stress and exercise also
demonstrated that S9 regulation was more dynamic, showing regional increases and
reductions, while S389 levels increased, in association with a pathway likely initiated by
DNA damage. Given that GSK3β has well over 50 substrates (Kaidanovich-Beilin and
Woodgett, 2011), this work provides an exciting avenue to pursue a therapeutic target
that may serve to regulate a smaller portion of GSK3β activity.
The necessity of targeting the cellular pathway directly associated with the
therapeutic need being addressed is exemplified in findings assessing the effects of the
GSK3β ATP competitive inhibitor SB216763 that would limit GSK3β activity
indiscriminately. The actions of SB216763 are neuroprotective when co-infused with an
amyloid-beta peptide that mimics some neurodegenerative aspects of Alzheimer’s
disease, but produce a similar phenotype to the amyloid-beta peptide when injected alone
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(Hu et al., 2009). Similarly, the rapid-antidepressant actions of ketamine are enhanced by
GSK3β inhibition (Beurel et al., 2011; Liu et al., 2013), but GSK3β inhibition alone does
not produce beneficial effects when initiated after stress exposure (Wilkinson et al., 2011;
Ma et al., 2013). These findings suggest that modulation of GSK3β needs to be taking
place on an active pathway at the time of insult, rather than broadly administered after the
fact. Lithium, a compound that directly inhibits GSK3β activity only in part due to
inhibitory S9 phosphorylation (De Sarno et al., 2002), is used as a treatment for bipolar
depression and has protective effects against development of dementia and Alzheimer’s
disease in depressed patients when compared to disease rates in depressed patients that
did not take lithium (Nunes et al., 2007; Kessing et al., 2010) . Each of these disorders
displays neurodegenerative characteristics (Sheline et al., 1999; Vakili et al., 2000; Savitz
and Drevets, 2009; Medina et al., 2011), suggesting that similar pathways may be
engaged. Given the findings reported here it is intriguing to consider that the direct
inhibition of GSK3β by lithium may be in part targeting that portion of GSK3β activity
regulated by S389 phosphorylation, and that a S389 specific inhibitor may provide a better
therapeutic target.
The foundational work reported here demonstrates that dysregulated inhibition of
GSK S389 phosphorylation may play an important role in neurodegenerative disorders.
Further studies would benefit from the ability to conditionally manipulate GSK3β S 389
phosphorylation to ensure similar developmental backgrounds between subjects. Direct
comparisons between similar manipulations of the GSK3β S 9 phosphorylation site would
help to clarify the individual roles of the inhibitory phosphorylation sites. Though
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research into multifunctional protein kinases is complex, utilizing tools that allow a
clearer dissection of activity in neuronal subtypes, or cellular compartments, of interest
will allow for clearer interpretation of results. Given the number of disorders associated
with neuronal degradation continued investigation into the role of GSK3β S389
phosphorylation in the brain is warranted.

117

COMPREHENSIVE BIBLIOGRAPHY
Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS (2000) Peripheral
infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus.
The Journal of neuroscience : the official journal of the Society for Neuroscience
20:2896-2903.
Ackermann TF, Kempe DS, Lang F, Lang UE (2010) Hyperactivity and enhanced
curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3
(GSK-3). Cellular physiology and biochemistry : international journal of
experimental cellular physiology, biochemistry, and pharmacology 25:775-786.
Adamec E, Vonsattel JP, Nixon RA (1999) DNA strand breaks in Alzheimer's disease.
Brain Res 849:67-77.
Adlard PA, Cotman CW (2004) Voluntary exercise protects against stress-induced
decreases in brain-derived neurotrophic factor protein expression. Neuroscience
124:985-992.
Ahn YM, Seo MS, Kim SH, Kim Y, Yoon SC, Juhnn YS, Kim YS (2005) Increased
phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat
frontal cortex after MK-801 intraperitoneal injection. The international journal of
neuropsychopharmacology / official scientific journal of the Collegium
Internationale Neuropsychopharmacologicum (CINP) 8:607-613.
Alonso R, Griebel G, Pavone G, Stemmelin J, Le Fur G, Soubrie P (2004) Blockade of
CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in
a mouse model of depression. Mol Psychiatry 9:278-286, 224.
Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, Ben-Neriah Y,
Alkalay I (2002) Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a
molecular switch for the Wnt pathway. Genes & development 16:1066-1076.
Anagnostaras SG, Wood SC, Shuman T, Cai DJ, Leduc AD, Zurn KR, Zurn JB, Sage JR,
Herrera GM (2010) Automated assessment of pavlovian conditioned freezing and
shock reactivity in mice using the video freeze system. Frontiers in behavioral
neuroscience 4.
Aymard F, Bugler B, Schmidt CK, Guillou E, Caron P, Briois S, Iacovoni JS, Daburon
V, Miller KM, Jackson SP, Legube G (2014) Transcriptionally active chromatin
recruits homologous recombination at DNA double-strand breaks. Nature
structural & molecular biology.
Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, Craighead
WE, Baldewicz TT, Krishnan KR (2000) Exercise treatment for major depression:
maintenance of therapeutic benefit at 10 months. Psychosom Med 62:633-638.
118

Baj G, D'Alessandro V, Musazzi L, Mallei A, Sartori CR, Sciancalepore M, Tardito D,
Langone F, Popoli M, Tongiorgi E (2012) Physical exercise and antidepressants
enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a
spatial code for BDNF splice variants. Neuropsychopharmacology 37:1600-1611.
Baran SE, Armstrong CE, Niren DC, Hanna JJ, Conrad CD (2009) Chronic stress and sex
differences on the recall of fear conditioning and extinction. Neurobiol Learn
Mem 91:323-332.
Barzilai A (2010) DNA damage, neuronal and glial cell death and neurodegeneration.
Apoptosis : an international journal on programmed cell death 15:1371-1381.
Barzilai A, Biton S, Shiloh Y (2008) The role of the DNA damage response in neuronal
development, organization and maintenance. DNA repair 7:1010-1027.
Batandier C, Poulet L, Hininger I, Couturier K, Fontaine E, Roussel AM, Canini F (2014)
Acute stress delays brain mitochondrial permeability transition pore opening.
Journal of neurochemistry.
Bayod S, Del Valle J, Canudas AM, Lalanza JF, Sanchez-Roige S, Camins A,
Escorihuela RM, Pallas M (2011) Long-term treadmill exercise induces
neuroprotective molecular changes in rat brain. Journal of applied physiology
(Bethesda, Md : 1985) 111:1380-1390.
Bayod S, Menella I, Sanchez-Roige S, Lalanza JF, Escorihuela RM, Camins A, Pallas M,
Canudas AM (2014) Wnt pathway regulation by long-term moderate exercise in
rat hippocampus. Brain Res 1543:38-48.
Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, McIlrath J,
Carr JM, Armit LJ, Clacher C, Malone L, Kollias G, Arthur JS (2005) Generation
and characterization of p38beta (MAPK11) gene-targeted mice. Molecular and
cellular biology 25:10454-10464.
Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC,
Gainetdinov RR, Caron MG (2008) Role of GSK3 beta in behavioral
abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A
105:1333-1338.
Beaulieu S, Di Paolo T, Barden N (1986) Control of ACTH secretion by the central
nucleus of the amygdala: implication of the serotoninergic system and its
relevance to the glucocorticoid delayed negative feedback mechanism.
Neuroendocrinology 44:247-254.
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH
(2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry
47:351-354.
119

Bersudsky Y, Shaldubina A, Kozlovsky N, Woodgett JR, Agam G, Belmaker RH (2008)
Glycogen synthase kinase-3beta heterozygote knockout mice as a model of
findings in postmortem schizophrenia brain or as a model of behaviors mimicking
lithium action: negative results. Behavioural pharmacology 19:217-224.
Beurel E, Jope RS (2006) The paradoxical pro- and anti-apoptotic actions of GSK3 in the
intrinsic and extrinsic apoptosis signaling pathways. Progress in Neurobiology
79:173-189.
Beurel E, Song L, Jope RS (2011) Inhibition of glycogen synthase kinase-3 is necessary
for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 16:10681070.
Bienkowski MS, Rinaman L (2013) Common and distinct neural inputs to the medial
central nucleus of the amygdala and anterior ventrolateral bed nucleus of stria
terminalis in rats. Brain Struct Funct 218:187-208.
Bijur GN, Jope RS (2001) Proapoptotic stimuli induce nuclear accumulation of glycogen
synthase kinase-3 beta. The Journal of biological chemistry 276:37436-37442.
Bijur GN, Jope RS (2003) Glycogen synthase kinase-3 beta is highly activated in nuclei
and mitochondria. Neuroreport 14:2415-2419.
Bijur GN, De Sarno P, Jope RS (2000) Glycogen synthase kinase-3beta facilitates
staurosporine- and heat shock-induced apoptosis. Protection by lithium. The
Journal of biological chemistry 275:7583-7590.
Binder E, Droste SK, Ohl F, Reul JMHM (2004) Regular voluntary exercise reduces
anxiety-related behaviour and impulsiveness in mice. Behavioural Brain Research
155:197-206.
Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R,
Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR
(1999) Effects of exercise training on older patients with major depression.
Archives of Internal Medicine 159:2349-2356.
Bogdanova OV, Kanekar S, D'Anci KE, Renshaw PF (2013) Factors influencing
behavior in the forced swim test. Physiol Behav 118:227-239.
Boku S, Nakagawa S, Masuda T, Nishikawa H, Kato A, Kitaichi Y, Inoue T, Koyama T
(2009) Glucocorticoids and lithium reciprocally regulate the proliferation of adult
dentate gyrus-derived neural precursor cells through GSK-3beta and betacatenin/TCF pathway. Neuropsychopharmacology 34:805-815.
Brasnjevic I, Hof PR, Steinbusch HW, Schmitz C (2008) Accumulation of nuclear DNA
damage or neuron loss: molecular basis for a new approach to understanding
120

selective neuronal vulnerability in neurodegenerative diseases. DNA repair
7:1087-1097.
Bruchas MR, Macey TA, Lowe JD, Chavkin C (2006) Kappa opioid receptor activation
of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. The
Journal of biological chemistry 281:18081-18089.
Bruchas MR, Land BB, Aita M, Xu M, Barot SK, Li S, Chavkin C (2007) Stress-induced
p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent
dysphoria. The Journal of neuroscience : the official journal of the Society for
Neuroscience 27:11614-11623.
Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, Land BB, Lemos
JC, Hagan CE, Neumaier JF, Quintana A, Palmiter RD, Chavkin C (2011)
Selective p38alpha MAPK deletion in serotonergic neurons produces stress
resilience in models of depression and addiction. Neuron 71:498-511.
Bullock BP, Habener JF (1998) Phosphorylation of the cAMP response element binding
protein CREB by cAMP-dependent protein kinase A and glycogen synthase
kinase-3 alters DNA-binding affinity, conformation, and increases net charge.
Biochemistry 37:3795-3809.
Burghardt PR, Fulk LJ, Hand GA, Wilson MA (2004) The effects of chronic treadmill
and wheel running on behavior in rats. Brain Res 1019:84-96.
Cai Z, Zhao Y, Zhao B (2012) Roles of glycogen synthase kinase 3 in Alzheimer's
disease. Current Alzheimer research 9:864-879.
Campbell JE, Rakhshani N, Fediuc S, Bruni S, Riddell MC (2009) Voluntary wheel
running initially increases adrenal sensitivity to adrenocorticotrophic hormone,
which is attenuated with long-term training. Journal of Applied Physiology
(Bethesda, Md: 1985) 106:66-72.
Campeau S, Nyhuis TJ, Sasse SK, Kryskow EM, Herlihy L, Masini CV, Babb JA,
Greenwood BN, Fleshner M, Day HEW (2010) Hypothalamic pituitary adrenal
axis responses to low-intensity stressors are reduced after voluntary wheel
running in rats. Journal of Neuroendocrinology 22:872-888.
Carro E, Nunez A, Busiguina S, Torres-Aleman I (2000) Circulating insulin- like growth
factor I mediates effects of exercise on the brain. The Journal of neuroscience :
the official journal of the Society for Neuroscience 20:2926-2933.
Cetinkaya C, Sisman AR, Kiray M, Camsari UM, Gencoglu C, Baykara B, Aksu I, Uysal
N (2013) Positive effects of aerobic exercise on learning and memory functioning,
which correlate with hippocampal IGF-1 increase in adolescent rats. Neurosci
Lett 549:177-181.
121

Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001) Increased
hippocampal BDNF immunoreactivity in subjects treated with antidepressant
medication. Biol Psychiatry 50:260-265.
Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK (2000) Enhancement of
hippocampal neurogenesis by lithium. Journal of neurochemistry 75:1729-1734.
Chen MJ, Russo-Neustadt AA (2005) Exercise activates the phosphatidylinositol 3kinase pathway. Molecular Brain Research 135:181-193.
Chen YC, Tan QR, Dang W, Wang HN, Zhang RB, Li ZY, Lin H, Liu R (2012) The
effect of citalopram on chronic stress-induced depressive-like behavior in rats
through GSK3beta/beta-catenin activation in the medial prefrontal cortex. Brain
Res Bull 88:338-344.
Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C,
McEwen BS, Hempstead BL, Lee FS (2006) Genetic variant BDNF (Val66Met)
polymorphism alters anxiety-related behavior. Science 314:140-143.
Cheng CM, Mervis RF, Niu SL, Salem N, Jr., Witters LA, Tseng V, Reinhardt R, Bondy
CA (2003) Insulin- like growth factor 1 is essential for normal dendritic growth. J
Neurosci Res 73:1-9.
Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP (2007)
Bed nucleus of the stria terminalis subregions differentially regulate
hypothalamic-pituitary-adrenal axis activity: implications for the integration of
limbic inputs. The Journal of neuroscience : the official journal of the Society for
Neuroscience 27:2025-2034.
Collingridge GL, Peineau S, Howland JG, Wang YT (2010) Long-term depression in the
CNS. Nat Rev Neurosci 11:459-473.
Conrad CD, Galea LA, Kuroda Y, McEwen BS (1996) Chronic stress impairs rat spatial
memory on the Y maze, and this effect is blocked by tianeptine pretreatment.
Behavioral Neuroscience 110:1321-1334.
Correa SA, Eales KL (2012) The Role of p38 MAPK and Its Substrates in Neuronal
Plasticity and Neurodegenerative Disease. Journal of signal transduction
2012:649079.
Cotman CW, Engesser-Cesar C (2002) Exercise enhances and protects brain function.
Exercise and Sport Sciences Reviews 30:75-79.
Courousse T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet AM,
Gardier AM, Schinkel AH, Giros B, Gautron S (2014) Brain organic cation
122

transporter 2 controls response and vulnerability to stress and GSK3beta
signaling. Mol Psychiatry.
Covington HE, 3rd, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM,
Renthal W, Rush AJ, 3rd, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C,
Haggarty SJ, Nestler EJ (2009) Antidepressant actions of histone deacetylase
inhibitors. The Journal of neuroscience : the official journal of the Society for
Neuroscience 29:11451-11460.
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of
glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature
378:785-789.
Crowe SL, Tsukerman S, Gale K, Jorgensen TJ, Kondratyev AD (2011) Phosphorylation
of histone H2A.X as an early marker of neuronal endangerment following
seizures in the adult rat brain. The Journal of neuroscience : the official journal of
the Society for Neuroscience 31:7648-7656.
Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ (1995) Pattern and time
course of immediate early gene expression in rat brain following acute stress.
Neuroscience 64:477-505.
Dahlhoff M, Siegmund A, Golub Y, Wolf E, Holsboer F, Wotjak CT (2010) AKT/GSK3beta/beta-catenin signalling within hippocampus and amygdala reflects
genetically determined differences in posttraumatic stress disorder like symptoms.
Neuroscience 169:1216-1226.
Davis M (2006) Neural systems involved in fear and anxiety measured with fearpotentiated startle. American Psychologist November:741-756.
Davis M, Walker DL, Lee Y (1997) Amygdala and bed nucleus of the stria terminalis:
differential roles in fear and anxiety measured with the acoustic startle reflex.
Philosophical Transactions of the Royal Society of London Series B, Biological
Sciences 352:1675-1687.
de Kloet ER, Joëls M, Holsboer F (2005) Stress and the brain: from adaptation to disease.
Nature Reviews Neuroscience 6:463-475.
De Moor MHM, Beem AL, Stubbe JH, Boomsma DI, De Geus EJC (2006) Regular
exercise, anxiety, depression and personality: A population-based study.
Preventive Medicine 42:273-279.
De Sarno P, Li X, Jope RS (2002) Regulation of Akt and glycogen synthase kinase-3 beta
phosphorylation by sodium valproate and lithium. Neuropharmacology 43:11581164.
123

Dhabhar FS (2009) Enhancing versus suppressive effects of stress on immune function:
implications for immunoprotection and immunopathology.
Neuroimmunomodulation 16:300-317.
Ding VW, Chen RH, McCormick F (2000) Differential regulation of glycogen synthase
kinase 3beta by insulin and Wnt signaling. The Journal of biological chemistry
275:32475-32481.
Diorio D, Viau V, Meaney MJ (1993) The role of the medial prefrontal cortex (cingulate
gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. The
Journal of neuroscience : the official journal of the Society for Neuroscience
13:3839-3847.
Dishman RK, Renner KJ, White-Welkley JE, Burke KA, Bunnell BN (2000) Treadmill
exercise training augments brain norepinephrine response to familiar and novel
stress. Brain Research Bulletin 52:337-342.
Droste SK, Schweizer MC, Ulbricht S, Reul JMHM (2006) Long-Term Voluntary
Exercise and the Mouse Hypothalamic-Pituitary-Adrenocortical Axis: Impact of
Concurrent Treatment with the Antidepressant Drug Tianeptine. Journal of
Neuroendocrinology 18:915-925.
Droste SK, Chandramohan Y, Hill LE, Linthorst ACE, Reul JMHM (2007) Voluntary
exercise impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at
the adrenal level. Neuroendocrinology 86:26-37.
Droste SK, Gesing A, Ulbricht S, Muller MB, Linthorst ACE, Reul JMHM (2003)
Effects of Long-Term Voluntary Exercise on the Mouse Hypothalamic-PituitaryAdrenocortical Axis. Endocrinology 144:3012-3023.
Du J, Wei Y, Liu L, Wang Y, Khairova R, Blumenthal R, Tragon T, Hunsberger JG,
Machado-Vieira R, Drevets W, Wang YT, Manji HK (2010) A kinesin signaling
complex mediates the ability of GSK-3beta to affect mood-associated behaviors.
Proc Natl Acad Sci U S A 107:11573-11578.
Duman CH, Schlesinger L, Russell DS, Duman RS (2008) Voluntary Exercise Produces
Antidepressant and Anxiolytic Behavioral Effects in Mice. Brain Research
1199:148-158.
Duman CH, Schlesinger L, Terwilliger R, Russell DS, Newton SS, Duman RS (2009)
Peripheral insulin- like growth factor-I produces antidepressant- like behavior and
contributes to the effect of exercise. Behavioural brain research 198:366-371.
Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood
disorders. Biol Psychiatry 59:1116-1127.
124

Duvarci S, Pare D (2014) Amygdala microcircuits controlling learned fear. Neuron
82:966-980.
Ehara A, Ueda S (2009) Application of Fluoro-Jade C in acute and chronic
neurodegeneration models: utilities and staining differences. Acta histochemica et
cytochemica 42:171-179.
Elyaman W, Terro F, Wong NS, Hugon J (2002) In vivo activation and nuclear
translocation of phosphorylated glycogen synthase kinase-3beta in neuronal
apoptosis: links to tau phosphorylation. Eur J Neurosci 15:651-660.
Embi N, Rylatt DB, Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal
muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase
kinase. European journal of biochemistry / FEBS 107:519-527.
Engin E, Treit D, Dickson CT (2009) Anxiolytic- and antidepressant-like properties of
ketamine in behavioral and neurophysiological animal models. Neuroscience
161:359-369.
Enman NM, Unterwald EM (2012) Inhibition of GSK3 attenuates amphetamine- induced
hyperactivity and sensitization in the mouse. Behav Brain Res 231:217-225.
Eom TY, Jope RS (2009) Blocked inhibitory serine-phosphorylation of glycogen
synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation.
Biol Psychiatry 66:494-502.
Fabel K, Fabel K, Tam B, Kaufer D, Baiker A, Simmons N, Kuo CJ, Palmer TD (2003)
VEGF is necessary for exercise-induced adult hippocampal neurogenesis. The
European Journal of Neuroscience 18:2803-2812.
Fang ZH, Lee CH, Seo MK, Cho H, Lee JG, Lee BJ, Park SW, Kim YH (2013) Effect of
treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed
rats. Neurosci Res 76:187-194.
Fediuc S, Campbell JE, Riddell MC (2006) Effect of voluntary wheel running on
circadian corticosterone release and on HPA axis responsiveness to restraint stress
in Sprague-Dawley rats. Journal of Applied Physiology (Bethesda, Md: 1985)
100:1867-1875.
Flint MS, Baum A, Chambers WH, Jenkins FJ (2007) Induction of DNA damage,
alteration of DNA repair and transcriptional activation by stress hormones.
Psychoneuroendocrinology 32:470-479.
Fornal CA, Stevens J, Barson JR, Blakley GG, Patterson-Buckendahl P, Jacobs BL
(2007) Delayed suppression of hippocampal cell proliferation in rats following
inescapable shocks. Brain Res 1130:48-53.
125

Fox JH, Hammack SE, Falls WA (2008) Exercise is associated with reduction in the
anxiogenic effect of mCPP on acoustic startle. Behavioral Neuroscience 122:943948.
Frame S, Cohen P, Biondi RM (2001) A common phosphate binding site explains the
unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol
Cell 7:1321-1327.
Fuster-Matanzo A, Llorens-Martin M, de Barreda EG, Avila J, Hernandez F (2011)
Different susceptibility to neurodegeneration of dorsal and ventral hippocampal
dentate gyrus: a study with transgenic mice overexpressing GSK3beta. PLoS One
6:e27262.
Garcia LS, Comim CM, Valvassori SS, Reus GZ, Barbosa LM, Andreazza AC, Stertz L,
Fries GR, Gavioli EC, Kapczinski F, Quevedo J (2008) Acute administration of
ketamine induces antidepressant- like effects in the forced swimming test and
increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol
Psychiatry 32:140-144.
Garman RH (2011) Histology of the central nervous system. Toxicologic pathology
39:22-35.
Garza JC, Guo M, Zhang W, Lu XY (2012) Leptin restores adult hippocampal
neurogenesis in a chronic unpredictable stress model of depression and reverses
glucocorticoid- induced inhibition of GSK-3beta/beta-catenin signaling. Mol
Psychiatry 17:790-808.
Ghosh S, Laxmi TR, Chattarji S (2013) Functional connectivity from the amygdala to the
hippocampus grows stronger after stress. The Journal of neuroscience : the
official journal of the Society for Neuroscience 33:7234-7244.
Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK
(2002) Smaller hippocampal volume predicts pathologic vulnerability to
psychological trauma. Nat Neurosci 5:1242-1247.
Gold PW, Chrousos GP (2002) Organization of the stress system and its dysregulation in
melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry
7:254-275.
Gomez-Pinilla F, Zhuang Y, Feng J, Ying Z, Fan G (2011) Exercise impacts brainderived neurotrophic factor plasticity by engaging mechanisms of epigenetic
regulation. Eur J Neurosci 33:383-390.
Gonzalez P, Machado I, Vilcaes A, Caruso C, Roth GA, Schioth H, Lasaga M,
Scimonelli T (2013) Molecular mechanisms involved in interleukin 1-beta (IL126

1beta)-induced memory impairment. Modulation by alpha-melanocytestimulating hormone (alpha-MSH). Brain, behavior, and immunity 34:141-150.
Greenwood BN, Foley TE, Burhans D, Maier SF, Fleshner M (2005a) The consequences
of uncontrollable stress are sensitive to duration of prior wheel running. Brain
Research 1033:164-178.
Greenwood BN, Loughridge AB, Sadaoui N, Christianson JP, Fleshner M (2012a) The
protective effects of voluntary exercise against the behavioral consequences of
uncontrollable stress persist despite an increase in anxiety following forced
cessation of exercise. Behavioural Brain Research 233:314-321.
Greenwood BN, Foley TE, Day HEW, Burhans D, Brooks L, Campeau S, Fleshner M
(2005b) Wheel running alters serotonin (5-HT) transporter, 5-HT1A, 5-HT1B,
and alpha 1b-adrenergic receptor mRNA in the rat raphe nuclei. Biological
Psychiatry 57:559-568.
Greenwood BN, Foley TE, Day HEW, Campisi J, Hammack SH, Campeau S, Maier SF,
Fleshner M (2003) Freewheel running prevents learned helplessness/behavioral
depression: role of dorsal raphe serotonergic neurons. The Journal of
Neuroscience: The Official Journal of the Society for Neuroscience 23:28892898.
Greenwood BN, Strong PV, Loughridge AB, Day HE, Clark PJ, Mika A, Hellwinkel JE,
Spence KG, Fleshner M (2012b) 5-HT2C receptors in the basolateral amygdala
and dorsal striatum are a novel target for the anxiolytic and antidepressant effects
of exercise. PLoS One 7:e46118.
Hajszan T, Dow A, Warner-Schmidt JL, Szigeti-Buck K, Sallam NL, Parducz A, Leranth
C, Duman RS (2009) Remodeling of hippocampal spine synapses in the rat
learned helplessness model of depression. Biol Psychiatry 65:392-400.
Hammack SE, Cheung J, Rhodes KM, Schutz KC, Falls WA, Braas KM, May V (2009)
Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP)
and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed
nucleus of the stria terminalis (BNST): roles for PACAP in anxiety- like behavior.
Psychoneuroendocrinology 34:833-843.
Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH (1992) Glycogen synthase
kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of
paired helical filament epitopes and neuronal localisation of the kinase. Neurosci
Lett 147:58-62.
Hare BD, D'Onfro KC, Hammack SE, Falls WA (2012) Prior stress interferes with the
anxiolytic effect of exercise in c57bl/6j mice. Behavioral neuroscience 126:850856.
127

Hare BD, Beierle JA, Toufexis DJ, Hammack SE, Falls WA (2013) Exercise-Associated
Changes in the Corticosterone Response to Acute Restraint Stress: Evidence for
Increased Adrenal Sensitivity and Reduced Corticosterone Response Duration.
Neuropsychopharmacology.
Harvey S, Hotopf M, Øverland S, Mykletun A (2010) Physical activity and common
mental disorders. The British Journal of Psychiatry 197:357-364.
Herman JP, Cullinan WE, Watson SJ (1994) Involvement of the bed nucleus of the stria
terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP
mRNA expression. J Neuroendocrinol 6:433-442.
Herman JP, Dolgas CM, Carlson SL (1998) Ventral subiculum regulates hypothalamopituitary-adrenocortical and behavioural responses to cognitive stressors.
Neuroscience 86:449-459.
Herman JP, Ostrander MM, Mueller NK, Figueiredo H (2005) Limbic system
mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis.
Progress in Neuro-Psychopharmacology & Biological Psychiatry 29:1201-1213.
Hernandez F, Langa E, Cuadros R, Avila J, Villanueva N (2010) Regulation of GSK3
isoforms by phosphatases PP1 and PP2A. Molecular and cellular biochemistry
344:211-215.
Hetman M, Hsuan SL, Habas A, Higgins MJ, Xia Z (2002) ERK1/2 antagonizes
glycogen synthase kinase-3beta-induced apoptosis in cortical neurons. The
Journal of biological chemistry 277:49577-49584.
Hettema JM, Kuhn JW, Prescott CA, Kendler KS (2006) The impact of generalized
anxiety disorder and stressful life events on risk for major depressive episodes.
Psychological medicine 36:789-795.
Hill LE, Droste SK, Nutt DJ, Linthorst AC, Reul JM (2010) Voluntary exercise alters
GABA(A) receptor subunit and glutamic acid decarboxylase-67 gene expression
in the rat forebrain. Journal of psychopharmacology (Oxford, England) 24:745756.
Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR (2000) Requirement for
glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature
406:86-90.
Hoffman AN, Lorson NG, Sanabria F, Foster Olive M, Conrad CD (2014) Chronic stress
disrupts fear extinction and enhances amygdala and hippocampal Fos expression
in an animal model of post-traumatic stress disorder. Neurobiol Learn Mem
112:139-147.
128

Hoffman BM, Babyak MA, Craighead WE, Sherwood A, Doraiswamy PM, Coons MJ,
Blumenthal JA (2011) Exercise and pharmacotherapy in patients with major
depression: one-year follow-up of the SMILE study. Psychosomatic Medicine
73:127-133.
Holsboer F (2001) Stress, hypercortisolism and corticosteroid receptors in depression:
implicatons for therapy. Journal of Affective Disorders 62:77-91.
Hu S, Begum AN, Jones MR, Oh MS, Beech WK, Beech BH, Yang F, Chen P, Ubeda
OJ, Kim PC, Davies P, Ma Q, Cole GM, Frautschy SA (2009) GSK3 inhibitors
show benefits in an Alzheimer's disease (AD) model of neurodegeneration but
adverse effects in control animals. Neurobiology of disease 33:193-206.
Intlekofer KA, Berchtold NC, Malvaez M, Carlos AJ, McQuown SC, Cunningham MJ,
Wood MA, Cotman CW (2013) Exercise and sodium butyrate transform a
subthreshold learning event into long-term memory via a brain-derived
neurotrophic factor-dependent mechanism. Neuropsychopharmacology 38:20272034.
Izquierdo A, Wellman CL, Holmes A (2006) Brief uncontrollable stress causes dendritic
retraction in infralimbic cortex and resistance to fear extinction in mice. The
Journal of neuroscience : the official journal of the Society for Neuroscience
26:5733-5738.
Jamil S, Stoica C, Hackett TL, Duronio V (2010) MCL-1 localizes to sites of DNA
damage and regulates DNA damage response. Cell Cycle 9:2843-2855.
Jenkins FJ, Van Houten B, Bovbjerg DH (2014) Effects on DNA Damage and/or Repair
Processes as Biological Mechanisms Linking Psychological Stress to Cancer
Risk. Journal of applied biobehavioral research 19:3-23.
Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, Kash TL, Stuber GD (2013)
Distinct extended amygdala circuits for divergent motivational states. Nature
496:224-228.
Jho E, Lomvardas S, Costantini F (1999) A GSK3beta phosphorylation site in axin
modulates interaction with beta-catenin and Tcf-mediated gene expression.
Biochemical and biophysical research communications 266:28-35.
Jiang C, Salton SR (2013) The Role of Neurotrophins in Major Depressive Disorder.
Translational neuroscience 4:46-58.
Jin K, Chen J, Nagayama T, Chen M, Sinclair J, Graham SH, Simon RP (1999) In situ
detection of neuronal DNA strand breaks using the Klenow fragment of DNA
polymerase I reveals different mechanisms of neuron death after global cerebral
ischemia. Journal of neurochemistry 72:1204-1214.
129

Joëls M, Karst H, DeRijk R, de Kloet ER (2008) The coming out of the brain
mineralocorticoid receptor. Trends in Neurosciences 31:1-7.
Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3.
Trends in biochemical sciences 29:95-102.
Jope RS, Roh MS (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and
therapeutic interventions. Current drug targets 7:1421-1434.
Jourdi H, Hsu YT, Zhou M, Qin Q, Bi X, Baudry M (2009) Positive AMPA receptor
modulation rapidly stimulates BDNF release and increases dendritic mRNA
translation. The Journal of neuroscience : the official journal of the Society for
Neuroscience 29:8688-8697.
Kaidanovich-Beilin O, Woodgett JR (2011) GSK-3: Functional Insights from Cell
Biology and Animal Models. Frontiers in molecular neuroscience 4:40.
Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A,
Majik MS, Jeong LS, Banasr M, Son H, Duman RS (2012) Decreased expression
of synapse-related genes and loss of synapses in major depressive disorder. Nat
Med 18:1413-1417.
Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R (2005) Neurotrophin levels in
postmortem brains of suicide victims and the effects of antemortem diagnosis and
psychotropic drugs. Brain research Molecular brain research 136:29-37.
Kendler KS, Karkowski LM, Prescott CA (1999) Causal relationship between stressful
life events and the onset of major depression. The American journal of psychiatry
156:837-841.
Kessing LV, Forman JL, Andersen PK (2010) Does lithium protect against dementia?
Bipolar disorders 12:87-94.
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence,
severity, and comorbidity of 12-month DSM-IV disorders in the National
Comorbidity Survey Replication. Arch Gen Psychiatry 62:617-627.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters
EE, Wang PS (2003) The epidemiology of major depressive disorder: results from
the National Comorbidity Survey Replication (NCS-R). Jama 289:3095-3105.
Kim JJ, Jung MW (2006) Neural circuits and mechanisms involved in Pavlovian fear
conditioning: a critical review. Neuroscience & Biobehavioral Reviews 30:188202.

130

Kim WY, Snider WD (2011) Functions of GSK-3 Signaling in Development of the
Nervous System. Frontiers in molecular neuroscience 4:44.
Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on
development. Proc Natl Acad Sci U S A 93:8455-8459.
Kondratiuk I, Devijver H, Lechat B, Van Leuven F, Kaczmarek L, Filipkowski RK
(2013) Glycogen synthase kinase-3beta affects size of dentate gyrus and speciestypical behavioral tasks in transgenic and knockout mice. Behav Brain Res
248:46-50.
Koo JW, Duman RS (2008) IL-1beta is an essential mediator of the antineurogenic and
anhedonic effects of stress. Proc Natl Acad Sci U S A 105:751-756.
Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS (2010) Nuclear factor-kappaB is
a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc
Natl Acad Sci U S A 107:2669-2674.
Kozlovsky N, Belmaker RH, Agam G (2002) Lack of effect of acute, subchronic, or
chronic stress on glycogen synthase kinase-3beta protein levels in rat frontal
cortex. Prog Neuropsychopharmacol Biol Psychiatry 26:1309-1312.
Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, Lee E, Alt FW, Westphal H
(1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote
stage. Proc Natl Acad Sci U S A 93:5860-5865.
Lawlor DA, Hopker SW (2001) The effectiveness of exercise as an intervention in the
management of depression: systematic review and meta-regression analysis of
randomised controlled trials. BMJ (Clinical research ed) 322:763-767.
LeDoux J (2003) The emotional brain, fear, and the amygdala. Cellular & Molecular
Neurobiology 23:727-738.
Lee SH, Park J, Che Y, Han PL, Lee JK (2000) Constitutive activity and differential
localization of p38alpha and p38beta MAPKs in adult mouse brain. J Neurosci
Res 60:623-631.
Lee Y, Davis M (1997) Role of the hippocampus, the bed nucleus of the stria terminalis,
and the amygdala in the excitatory effect of corticotropin-releasing hormone on
the acoustic startle reflex. The Journal of neuroscience : the official journal of the
Society for Neuroscience 17:6434-6446.
Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS (2014) BDNF Release Is
Required for the Behavioral Actions of Ketamine. The international journal of
neuropsychopharmacology / official scientific journal of the Collegium
Internationale Neuropsychopharmacologicum (CINP).
131

Li H, Zhang L, Huang Q (2009) Differential expression of mitogen-activated protein
kinase signaling pathway in the hippocampus of rats exposed to chronic
unpredictable stress. Behav Brain Res 205:32-37.
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS
(2010) mTOR-dependent synapse formation underlies the rapid antidepressant
effects of NMDA antagonists. Science 329:959-964.
Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY, Aghajanian G, Duman RS
(2011) Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse
behavioral and synaptic deficits caused by chronic stress exposure. Biol
Psychiatry 69:754-761.
Li X, Friedman AB, Roh MS, Jope RS (2005) Anesthesia and post-mortem interval
profoundly influence the regulatory serine phosphorylation of glycogen synthase
kinase-3 in mouse brain. Journal of neurochemistry 92:701-704.
Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS (2004) In vivo regulation
of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse
brain. Neuropsychopharmacology 29:1426-1431.
Lissek S, Kaczkurkin AN, Rabin S, Geraci M, Pine DS, Grillon C (2014) Generalized
anxiety disorder is associated with overgeneralization of classically conditioned
fear. Biol Psychiatry 75:909-915.
Liu RJ, Lee FS, Li X-Y, Bambico F, Duman RS, Aghajanian GK (2012) BDNF
Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in
prefrontal cortex. Biological Psychiatry 71:996-1005.
Liu RJ, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK (2013) GSK3 inhibition potentiates the synaptogenic and antidepressant- like effects of
subthreshold doses of ketamine. Neuropsychopharmacology 38:2268-2277.
Llorens-Martin M, Torres-Aleman I, Trejo JL (2009) Mechanisms mediating brain
plasticity: IGF1 and adult hippocampal neurogenesis. The Neuroscientist : a
review journal bringing neurobiology, neurology and psychiatry 15:134-148.
Llorens-Martin M, Torres-Aleman I, Trejo JL (2010) Exercise modulates insulin- like
growth factor 1-dependent and -independent effects on adult hippocampal
neurogenesis and behaviour. Molecular and cellular neurosciences 44:109-117.
Llorens-Martin M, Fuster-Matanzo A, Teixeira CM, Jurado-Arjona J, Ulloa F, Defelipe J,
Rabano A, Hernandez F, Soriano E, Avila J (2013) GSK-3beta overexpression
causes reversible alterations on postsynaptic densities and dendritic morphology
of hippocampal granule neurons in vivo. Mol Psychiatry 18:451-460.
132

Lluri G, Langlois GD, Soloway PD, Jaworski DM (2008) Tissue inhibitor of
metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression
in vitro. Experimental cell research 314:11-24.
Lochhead PA, Kinstrie R, Sibbet G, Rawjee T, Morrice N, Cleghon V (2006) A
chaperone-dependent GSK3beta transitional intermediate mediates activationloop autophosphorylation. Mol Cell 24:627-633.
Long PM, Stradecki HM, Minturn JE, Wesley UV, Jaworski DM (2011) Differential
aminoacylase expression in neuroblastoma. International journal of cancer Journal
international du cancer 129:1322-1330.
Long PM, Tighe SW, Driscoll HE, Moffett JR, Namboodiri AM, Viapiano MS, Lawler
SE, Jaworski DM (2013) Acetate supplementation induces growth arrest of
NG2/PDGFRalpha-positive oligodendroglioma-derived tumor-initiating cells.
PLoS One 8:e80714.
Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased
nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK3beta conditional transgenic mice. The EMBO journal 20:27-39.
Luo YW, Xu Y, Cao WY, Zhong XL, Duan J, Wang XQ, Hu ZL, Li F, Zhang JY, Zhou
M, Dai RP, Li CQ (2015) Insulin-like growth factor 2 mitigates depressive
behavior in a rat model of chronic stress. Neuropharmacology 89:318-324.
Ma XC, Dang YH, Jia M, Ma R, Wang F, Wu J, Gao CG, Hashimoto K (2013) Longlasting antidepressant action of ketamine, but not glycogen synthase kinase-3
inhibitor SB216763, in the chronic mild stress model of mice. PLoS One
8:e56053.
Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A (2000)
Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry
47:1043-1049.
Magarinos AM, McEwen BS (1995) Stress-induced atrophy of apical dendrites of
hippocampal CA3c neurons: comparison of stressors. Neuroscience 69:83-88.
Magarinos AM, Li CJ, Gal Toth J, Bath KG, Jing D, Lee FS, McEwen BS (2011) Effect
of brain-derived neurotrophic factor haploinsufficiency on stress-induced
remodeling of hippocampal neurons. Hippocampus 21:253-264.
Mai L, Jope RS, Li X (2002) BDNF-mediated signal transduction is modulated by
GSK3beta and mood stabilizing agents. Journal of neurochemistry 82:75-83.

133

Malberg JE, Duman RS (2003) Cell proliferation in adult hippocampus is decreased by
inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology
28:1562-1571.
Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment
increases neurogenesis in adult rat hippocampus. The Journal of Neuroscience:
The Official Journal of the Society for Neuroscience 20:9104-9110.
Maren S (2001) Neurobiology of Pavlovian fear conditioning. Annual Review of
Neuroscience 24:897-931.
Marlatt MW, Lucassen PJ, van Praag H (2010) Comparison of neurogenic effects of
fluoxetine, duloxetine and running in mice. Brain Research 1341:93-99.
Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylationdependent factor CREB. Nature reviews Molecular cell biology 2:599-609.
McAllister AK, Katz LC, Lo DC (1997) Opposing roles for endogenous BDNF and NT-3
in regulating cortical dendritic growth. Neuron 18:767-778.
McEwen BS (2007) Physiology and neurobiology of stress and adaptation: central role of
the brain. Physiological reviews 87:873-904.
McLaughlin JP, Marton-Popovici M, Chavkin C (2003) Kappa opioid receptor
antagonism and prodynorphin gene disruption block stress-induced behavioral
responses. The Journal of neuroscience : the official journal of the Society for
Neuroscience 23:5674-5683.
McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C (2006a) Prior activation of kappa
opioid receptors by U50,488 mimics repeated forced swim stress to potentiate
cocaine place preference conditioning. Neuropsychopharmacology 31:787-794.
McLaughlin JP, Li S, Valdez J, Chavkin TA, Chavkin C (2006b) Social defeat stressinduced behavioral responses are mediated by the endogenous kappa opioid
system. Neuropsychopharmacology 31:1241-1248.
McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR
(2005) Role that phosphorylation of GSK3 plays in insulin and Wnt signalling
defined by knockin analysis. The EMBO journal 24:1571-1583.
Medina M, Garrido JJ, Wandosell FG (2011) Modulation of GSK-3 as a Therapeutic
Strategy on Tau Pathologies. Frontiers in molecular neuroscience 4:24.
Meller E, Shen C, Nikolao TA, Jensen C, Tsimberg Y, Chen J, Gruen RJ (2003) Regionspecific effects of acute and repeated restraint stress on the phosphorylation of
mitogen-activated protein kinases. Brain Res 979:57-64.
134

Mikhailov A, Shinohara M, Rieder CL (2004) Topoisomerase II and histone deacetylase
inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint
pathway. The Journal of cell biology 166:517-526.
Mizoguchi K, Shoji H, Ikeda R, Tanaka Y, Tabira T (2008) Persistent depressive state
after chronic stress in rats is accompanied by HPA axis dysregulation and reduced
prefrontal dopaminergic neurotransmission. Pharmacology Biochemistry and
Behavior 91:170-175.
Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation impaired in rats
with hippocampal lesions. Nature 297:681-683.
Neeper SA, Gómez-Pinilla F, Choi J, Cotman CW (1996) Physical activity increases
mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain.
Brain Research 726:49-56.
Nelson AJ, Juraska JM, Ragan BG, Iwamoto GA (2010) Effects of exercise training on
dendritic morphology in the cardiorespiratory and locomotor centers of the mature
rat brain. Journal of applied physiology (Bethesda, Md : 1985) 108:1582-1590.
Ng SS, Mahmoudi T, Danenberg E, Bejaoui I, de Lau W, Korswagen HC, Schutte M,
Clevers H (2009) Phosphatidylinositol 3-kinase signaling does not activate the
wnt cascade. The Journal of biological chemistry 284:35308-35313.
Niblock MM, Brunso-Bechtold JK, Riddle DR (2000) Insulin- like growth factor I
stimulates dendritic growth in primary somatosensory cortex. The Journal of
neuroscience : the official journal of the Society for Neuroscience 20:4165-4176.
Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat
brain by chronic electroconvulsive seizure and antidepressant drug treatments.
The Journal of neuroscience : the official journal of the Society for Neuroscience
15:7539-7547.
Nibuya M, Takahashi M, Russell DS, Duman RS (1999) Repeated stress increases
catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 267:81-84.
Norrholm SD, Ouimet CC (2001) Altered dendritic spine density in animal models of
depression and in response to antidepressant treatment. Synapse (New York, NY)
42:151-163.
Nunes PV, Forlenza OV, Gattaz WF (2007) Lithium and risk for Alzheimer's disease in
elderly patients with bipolar disorder. The British journal of psychiatry : the
journal of mental science 190:359-360.
Nyhuis TJ, Masini CV, Sasse SK, Day HEW, Campeau S (2010) Physical activity, but
not environmental complexity, facilitates HPA axis response habituation to
135

repeated audiogenic stress despite neurotrophin mRNA regulation in both
conditions. Brain Research 1362:68-77.
O'Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S, Klein PS (2004)
Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and
molecular effects of lithium. The Journal of neuroscience : the official journal of
the Society for Neuroscience 24:6791-6798.
O'Brien WT, Huang J, Buccafusca R, Garskof J, Valvezan AJ, Berry GT, Klein PS
(2011) Glycogen synthase kinase-3 is essential for beta-arrestin-2 complex
formation and lithium-sensitive behaviors in mice. The Journal of clinical
investigation 121:3756-3762.
O'Connor KA, Johnson JD, Hammack SE, Brooks LM, Spencer RL, Watkins LR, Maier
SF (2003) Inescapable shock induces resistance to the effects of dexamethasone.
Psychoneuroendocrinology 28:481-500.
O'Hagan HM (2014) Chromatin modifications during repair of environmental exposureinduced DNA damage: a potential mechanism for stable epigenetic alterations.
Environmental and molecular mutagenesis 55:278-291.
Omata N, Chiu CT, Moya PR, Leng Y, Wang Z, Hunsberger JG, Leeds P, Chuang DM
(2011) Lentivirally mediated GSK-3beta silencing in the hippocampal dentate
gyrus induces antidepressant- like effects in stressed mice. The international
journal of neuropsychopharmacology / official scientific journal of the Collegium
Internationale Neuropsychopharmacologicum (CINP) 14:711-717.
Ostrander MM, Richtand NM, Herman JP (2003) Stress and amphetamine induce Fos
expression in medial prefrontal cortex neurons containing glucocorticoid
receptors. Brain Res 990:209-214.
Park SW, Phuong VT, Lee CH, Lee JG, Seo MK, Cho HY, Fang ZH, Lee BJ, Kim YH
(2011) Effects of antipsychotic drugs on BDNF, GSK-3beta, and beta-catenin
expression in rats subjected to immobilization stress. Neurosci Res 71:335-340.
Peeke PM, Chrousos GP (1995) Hypercortisolism and Obesity. Annals of the New York
Academy of Sciences 771:665-676.
Peineau S, Nicolas CS, Bortolotto ZA, Bhat RV, Ryves WJ, Harwood AJ, Dournaud P,
Fitzjohn SM, Collingridge GL (2009) A systematic investigation of the protein
kinases involved in NMDA receptor-dependent LTD: evidence for a role of GSK3 but not other serine/threonine kinases. Molecular brain 2:22.
Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E,
Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL
136

(2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron
53:703-717.
Pham K, Nacher J, Hof PR, McEwen BS (2003) Repeated restraint stress suppresses
neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate
gyrus. Eur J Neurosci 17:879-886.
Phong MS, Van Horn RD, Li S, Tucker-Kellogg G, Surana U, Ye XS (2010) p38
mitogen-activated protein kinase promotes cell survival in response to DNA
damage but is not required for the G(2) DNA damage checkpoint in human cancer
cells. Molecular and cellular biology 30:3816-3826.
Picard M, Juster RP, McEwen BS (2014) Mitochondrial allostatic load puts the 'gluc'
back in glucocorticoids. Nat Rev Endocrinol 10:303-310.
Polter A, Beurel E, Yang S, Garner R, Song L, Miller CA, Sweatt JD, McMahon L,
Bartolucci AA, Li X, Jope RS (2010) Deficiency in the inhibitory serinephosphorylation of glycogen synthase kinase-3 increases sensitivity to mood
disturbances. Neuropsychopharmacology 35:1761-1774.
Polter AM, Yang S, Jope RS, Li X (2012) Functional significance of glycogen synthase
kinase-3 regulation by serotonin. Cellular signalling 24:265-271.
Popoli M, Yan Z, McEwen BS, Sanacora G (2012) The stressed synapse: the impact of
stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13:22-37.
Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, Daneels G,
Bouwknecht JA, Steckler T (2006) Transgenic mice overexpressing glycogen
synthase kinase 3beta: a putative model of hyperactivity and mania. The Journal
of neuroscience : the official journal of the Society for Neuroscience 26:90229029.
Radley JJ, Sawchenko PE (2011) A common substrate for prefrontal and hippocampal
inhibition of the neuroendocrine stress response. The Journal of neuroscience : the
official journal of the Society for Neuroscience 31:9683-9695.
Radley JJ, Anderson RM, Hamilton BA, Alcock JA, Romig-Martin SA (2013) Chronic
stress-induced alterations of dendritic spine subtypes predict functional
decrements in an hypothalamo-pituitary-adrenal- inhibitory prefrontal circuit. The
Journal of neuroscience : the official journal of the Society for Neuroscience
33:14379-14391.
Radley JJ, Rocher AB, Miller M, Janssen WG, Liston C, Hof PR, McEwen BS, Morrison
JH (2006) Repeated stress induces dendritic spine loss in the rat medial prefrontal
cortex. Cerebral cortex (New York, NY : 1991) 16:313-320.
137

Radley JJ, Rocher AB, Rodriguez A, Ehlenberger DB, Dammann M, McEwen BS,
Morrison JH, Wearne SL, Hof PR (2008) Repeated stress alters dendritic spine
morphology in the rat medial prefrontal cortex. J Comp Neurol 507:1141-1150.
Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser
JC, Roth BL, Stockmeier CA (1999) Morphometric evidence for neuronal and
glial prefrontal cell pathology in major depression. Biol Psychiatry 45:1085-1098.
Reul JM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain:
microdistribution and differential occupation. Endocrinology 117:2505-2511.
Reus GZ, Vieira FG, Abelaira HM, Michels M, Tomaz DB, dos Santos MA, Carlessi AS,
Neotti MV, Matias BI, Luz JR, Dal-Pizzol F, Quevedo J (2014) MAPK signaling
correlates with the antidepressant effects of ketamine. Journal of psychiatric
research 55:15-21.
Rincon M, Derijard B, Chow CW, Davis RJ, Flavell RA (1997) Reprogramming the
signalling requirement for AP-1 (activator protein-1) activation during
differentiation of precursor CD4+ T-cells into effector Th1 and Th2 cells. Genes
and function 1:51-68.
Robles CF, McMackin MZ, Campi KL, Doig IE, Takahashi EY, Pride MC, Trainor BC
(2014) Effects of kappa opioid receptors on conditioned place aversion and social
interaction in males and females. Behav Brain Res 262:84-93.
Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded
breaks induce histone H2AX phosphorylation on serine 139. The Journal of
biological chemistry 273:5858-5868.
Roman CW, Lezak KR, Kocho-Schellenberg M, Garret MA, Braas K, May V, Hammack
SE (2012) Excitotoxic lesions of the bed nucleus of the stria terminalis (BNST)
attenuate the effects of repeated stress on weight gain: evidence for the
recruitment of BNST activity by repeated, but not acute, stress. Behavioural Brain
Research 227:300-304.
Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW (2000) Physical activity and
antidepressant treatment potentiate the expression of specific brain-derived
neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101:305312.
Sairanen M, Lucas G, Ernfors P, Castren M, Castren E (2005) Brain-derived neurotrophic
factor and antidepressant drugs have different but coordinated effects on neuronal
turnover, proliferation, and survival in the adult dentate gyrus. The Journal of
neuroscience : the official journal of the Society for Neuroscience 25:1089-1094.

138

Salam JN, Fox JH, Detroy EM, Guignon MH, Wohl DF, Falls WA (2009) Voluntary
exercise in C57 mice is anxiolytic across several measures of anxiety.
Behavioural Brain Research 197:31-40.
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J,
Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal
neurogenesis for the behavioral effects of antidepressants. Science 301:805-809.
Sapolsky RM (2000) The possibility of neurotoxicity in the hippocampus in major
depression: a primer on neuron death. Biological Psychiatry 48:755-765.
Sapolsky RM, Krey LC, McEwen BS (1985) Prolonged glucocorticoid exposure reduces
hippocampal neuron number: implications for aging. The Journal of neuroscience
: the official journal of the Society for Neuroscience 5:1222-1227.
Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress
responses? Integrating permissive, suppressive, stimulatory, and preparative
actions. Endocrine Reviews 21:55-89.
Sapolsky RM, Uno H, Rebert CS, Finch CE (1990) Hippocampal damage associated with
prolonged glucocorticoid exposure in primates. The Journal of neuroscience : the
official journal of the Society for Neuroscience 10:2897-2902.
Sasse SK, Greenwood B, Masini CV, Nyhuis TJ, Fleshner M, Day HEW, Campeau S
(2008) Chronic voluntary wheel running facilitates corticosterone response
habituation to repeated audiogenic stress exposure in male rats. Stress
(Amsterdam, Netherlands) 11:425-437.
Savitz J, Drevets WC (2009) Bipolar and major depressive disorder: neuroimaging the
developmental-degenerative divide. Neurosci Biobehav Rev 33:699-771.
Schaaf MJ, de Jong J, de Kloet ER, Vreugdenhil E (1998) Downregulatio n of BDNF
mRNA and protein in the rat hippocampus by corticosterone. Brain Res 813:112120.
Schaeffer EL, Cerulli FG, Souza HO, Catanozi S, Gattaz WF (2014) Synergistic and
additive effects of enriched environment and lithium on the generation of new
cells in adult mouse hippocampus. Journal of neural transmission (Vienna,
Austria : 1996) 121:695-706.
Schmued LC, Stowers CC, Scallet AC, Xu L (2005) Fluoro-Jade C results in ultra high
resolution and contrast labeling of degenerating neurons. Brain Res 1035:24-31.
Schoenfeld TJ, Gould E (2012) Stress, stress hormones, and adult neurogenesis.
Experimental Neurology 233:12-21.
139

Schoenfeld TJ, Rada P, Pieruzzini PR, Hsueh B, Gould E (2013) Physical exercise
prevents stress-induced activation of granule neurons and enhances local
inhibitory mechanisms in the dentate gyrus. The Journal of neuroscience : the
official journal of the Society for Neuroscience 33:7770-7777.
Schreiber E, Matthias P, Muller MM, Schaffner W (1989) Rapid detection of octamer
binding proteins with 'mini-extracts', prepared from a small number of cells.
Nucleic acids research 17:6419.
Sciolino NR, Dishman RK, Holmes PV (2012) Voluntary exercise offers anxiolytic
potential and amplifies galanin gene expression in the locus coeruleus of the rat.
Behavioural Brain Research 233:191-200.
Sciolino NR, Smith JM, Stranahan AM, Freeman KG, Edwards GL, Weinshenker D,
Holmes PV (2015) Galanin mediates features of neural and behavioral stress
resilience afforded by exercise. Neuropharmacology 89:255-264.
Shansky RM, Morrison JH (2009) Stress-induced dendritic remodeling in the medial
prefrontal cortex: effects of circuit, hormones and rest. Brain Res 1293:108-113.
Sharma A, Singh K, Almasan A (2012) Histone H2AX phosphorylation: a marker for
DNA damage. Methods in molecular biology (Clifton, NJ) 920:613-626.
Sharma V, Gilhotra R, Dhingra D, Gilhotra N (2011) Possible underlying influence of
p38MAPK and NF-kappaB in the diminished anti-anxiety effect of diazepam in
stressed mice. J Pharmacol Sci 116:257-263.
Sheline YI, Sanghavi M, Mintun MA, Gado MH (1999) Depression duration but not age
predicts hippocampal volume loss in medically healthy women with recurrent
major depression. The Journal of neuroscience : the official journal of the Society
for Neuroscience 19:5034-5043.
Shen CP, Tsimberg Y, Salvadore C, Meller E (2004) Activation of Erk and JNK MAPK
pathways by acute swim stress in rat brain regions. BMC Neurosci 5:36.
Shin LM, Rauch SL, Pitman RK (2006) Amygdala, medial prefrontal cortex, and
hippocampal function in PTSD. Ann N Y Acad Sci 1071:67-79.
Shin LM, Orr SP, Carson MA, Rauch SL, Macklin ML, Lasko NB, Peters PM, Metzger
LJ, Dougherty DD, Cannistraro PA, Alpert NM, Fischman AJ, Pitman RK (2004)
Regional cerebral blood flow in the amygdala and medial prefrontal cortex during
traumatic imagery in male and female Vietnam veterans with PTSD. Arch Gen
Psychiatry 61:168-176.
Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived
neurotrophic factor produces antidepressant effects in behavioral models of
140

depression. The Journal of neuroscience : the official journal of the Society for
Neuroscience 22:3251-3261.
Silva R, Mesquita AR, Bessa J, Sousa JC, Sotiropoulos I, Leao P, Almeida OF, Sousa N
(2008) Lithium blocks stress-induced changes in depressive-like behavior and
hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience
152:656-669.
Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect
the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in
the hippocampus. The Journal of neuroscience : the official journal of the Society
for Neuroscience 15:1768-1777.
Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA (2011) Adult hippocampal
neurogenesis buffers stress responses and depressive behaviour. Nature 476:458461.
Soares J, Holmes PV, Renner KJ, Edwards GL, Bunnell BN, Dishman RK (1999) Brain
noradrenergic responses to footshock after chronic activity-wheel running.
Behavioral Neuroscience 113:558-566.
Stambolic V, Woodgett JR (1994) Mitogen inactivation of glycogen synthase kinase-3
beta in intact cells via serine 9 phosphorylation. The Biochemical journal 303 ( Pt
3):701-704.
Steib K, Schaffner I, Jagasia R, Ebert B, Lie DC (2014) Mitochondria modify exerciseinduced development of stem cell-derived neurons in the adult brain. The Journal
of neuroscience : the official journal of the Society for Neuroscience 34:66246633.
Stein-Behrens B, Mattson MP, Chang I, Yeh M, Sapolsky R (1994) Stress exacerbates
neuron loss and cytoskeletal pathology in the hippocampus. The Journal of
neuroscience : the official journal of the Society for Neuroscience 14:5373-5380.
Suberbielle E, Sanchez PE, Kravitz AV, Wang X, Ho K, Eilertson K, Devidze N,
Kreitzer AC, Mucke L (2013) Physiologic brain activity causes DNA doublestrand breaks in neurons, with exacerbation by amyloid-beta. Nat Neurosci
16:613-621.
Szymanska M, Suska A, Budziszewska B, Jaworska-Feil L, Basta-Kaim A, Leskiewicz
M, Kubera M, Gergont A, Kroczka S, Kacinski M, Lason W (2009) Prenatal
stress decreases glycogen synthase kinase-3 phosphorylation in the rat frontal
cortex. Pharmacological reports : PR 61:612-620.

141

Tan W, Yu HG, Luo HS (2014) Inhibition of the p38 MAPK pathway sensitizes human
gastric cells to doxorubicin treatment in vitro and in vivo. Molecular medicine
reports 10:3275-3281.
Tanapat P, Hastings NB, Rydel TA, Galea LA, Gould E (2001) Exposure to fox odor
inhibits cell proliferation in the hippocampus of adult rats via an adrenal
hormone-dependent mechanism. J Comp Neurol 437:496-504.
Tang M, Shi S, Guo Y, Xu W, Wang L, Chen Y, Wang Z, Qiao Z (2014) GSK-3/CREB
pathway involved in the gx-50's effect on Alzheimer's disease.
Neuropharmacology 81:256-266.
Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, Clements JL, Sabio G,
Davis RJ, Matthews DE, Doble B, Rincon M (2008) Phosphorylation by p38
MAPK as an alternative pathway for GSK3beta inactivation. Science 320:667670.
Toy WA, Petzinger GM, Leyshon BJ, Akopian GK, Walsh JP, Hoffman MV, Vuckovic
MG, Jakowec MW (2014) Treadmill exercise reverses dendritic spine loss in
direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Neurobiology of disease 63:201-209.
Trejo JL, Llorens-Martin MV, Torres-Aleman I (2008) The effects of exercise on spatial
learning and anxiety-like behavior are mediated by an IGF-I-dependent
mechanism related to hippocampal neurogenesis. Molecular and cellular
neurosciences 37:402-411.
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G,
Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM,
Balasubramani GK, Fava M (2006) Evaluation of outcomes with citalopram for
depression using measurement-based care in STAR*D: implications for clinical
practice. The American journal of psychiatry 163:28-40.
Tugores A, Alonso MA, Sanchez-Madrid F, de Landazuri MO (1992) Human T cell
activation through the activation-inducer molecule/CD69 enhances the activity of
transcription factor AP-1. J Immunol 148:2300-2306.
Uno H, Tarara R, Else JG, Suleman MA, Sapolsky RM (1989) Hippocampal damage
associated with prolonged and fatal stress in primates. The Journal of
neuroscience : the official journal of the Society for Neuroscience 9:1705-1711.
Vakili K, Pillay SS, Lafer B, Fava M, Renshaw PF, Bonello-Cintron CM, Yurgelun-Todd
DA (2000) Hippocampal volume in primary unipolar major depression: a
magnetic resonance imaging study. Biol Psychiatry 47:1087-1090.
142

Valvezan AJ, Klein PS (2012) GSK-3 and Wnt Signaling in Neurogenesis and Bipolar
Disorder. Frontiers in molecular neuroscience 5:1.
van Praag H, Kempermann G, Gage FH (1999a) Running increases cell proliferation and
neurogenesis in the adult mouse dentate gyrus. Nature Neuroscience 2:266-270.
van Praag H, Christie BR, Sejnowski TJ, Gage FH (1999b) Running enhances
neurogenesis, learning, and long-term potentiation in mice. Proceedings of the
National Academy of Sciences of the United States of America 96:13427-13431.
Vialou V, Feng J, Robison AJ, Nestler EJ (2013) Epigenetic mechanisms of depression
and antidepressant action. Annual review of pharmacology and toxicology 53:5987.
Vogt MA, Inta D, Luoni A, Elkin H, Pfeiffer N, Riva MA, Gass P (2014) Inducible
forebrain-specific ablation of the transcription factor Creb during adulthood
induces anxiety but no spatial/contextual learning deficits. Frontiers in behavioral
neuroscience 8:407.
Vyas A, Bernal S, Chattarji S (2003) Effects of chronic stress on dendritic arborization in
the central and extended amygdala. Brain Res 965:290-294.
Vyas A, Pillai AG, Chattarji S (2004) Recovery after chronic stress fails to reverse
amygdaloid neuronal hypertrophy and enhanced anxiety- like behavior.
Neuroscience 128:667-673.
Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S (2002) Chronic stress induces
contrasting patterns of dendritic remodeling in hippocampal and amygdaloid
neurons. The Journal of Neuroscience: The Official Journal of the Society for
Neuroscience 22:6810-6818.
Walker DL, Toufexis DJ, Davis M (2003) Role of the bed nucleus of the stria terminalis
versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463:199-216.
Wang X, Wang XL, Chen HL, Wu D, Chen JX, Wang XX, Li RL, He JH, Mo L, Cen X,
Wei YQ, Jiang W (2014) Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting
excessive autophagy through AMPK and p38-MAPK. Biochemical pharmacology
88:334-350.
Watanabe Y, Gould E, McEwen BS (1992) Stress induces atrophy of apical dendrites of
hippocampal CA3 pyramidal neurons. Brain Res 588:341-345.
Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GVW,
Jope RS (2002) Direct, activating interaction between glycogen synthase kinase3β and p53 after DNA damage. Proceedings of the National Academy of Sciences
99:7951-7955.
143

Wessa M, Flor H (2007) Failure of extinction of fear responses in posttraumatic stress
disorder: evidence from second-order conditioning. The American journal of
psychiatry 164:1684-1692.
Wilkinson MB, Dias C, Magida J, Mazei-Robison M, Lobo M, Kennedy P, Dietz D,
Covington H, 3rd, Russo S, Neve R, Ghose S, Tamminga C, Nestler EJ (2011) A
novel role of the WNT-dishevelled-GSK3beta signaling cascade in the mouse
nucleus accumbens in a social defeat model of depression. The Journal of
neuroscience : the official journal of the Society for Neuroscience 31:9084-9092.
Wood CD, Thornton TM, Sabio G, Davis RA, Rincon M (2009) Nuclear localization of
p38 MAPK in response to DNA damage. International journal of biological
sciences 5:428-437.
Woodgett JR (1990) Molecular cloning and expression of glycogen synthase kinase3/factor A. The EMBO journal 9:2431-2438.
Wosiski-Kuhn M, Stranahan AM (2012) Opposing effects of positive and negative stress
on hippocampal plasticity over the lifespan. Ageing research reviews 11:399-403.
Xia Y, Wang CZ, Liu J, Anastasio NC, Johnson KM (2010) Brain-derived neurotrophic
factor prevents phencyclidine- induced apoptosis in developing brain by parallel
activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology
58:330-336.
Yang ES, Nowsheen S, Wang T, Thotala DK, Xia F (2011) Glycogen synthase kinase
3beta inhibition enhances repair of DNA double-strand breaks in irradiated
hippocampal neurons. Neuro-oncology 13:459-470.
Yang JL, Lin YT, Chuang PC, Bohr VA, Mattson MP (2014) BDNF and exercise
enhance neuronal DNA repair by stimulating CREB-mediated production of
apurinic/apyrimidinic endonuclease 1. Neuromolecular Med 16:161-174.
Yau SY, Lau BW, Tong JB, Wong R, Ching YP, Qiu G, Tang SW, Lee TM, So KF
(2011) Hippocampal neurogenesis and dendritic plasticity support runningimproved spatial learning and depression-like behaviour in stressed rats. PLoS
One 6:e24263.
Yeomans JS, Frankland PW (1995) The acoustic startle reflex: neurons and connections.
Brain Res Brain Res Rev 21:301-314.
Yu H, Wang DD, Wang Y, Liu T, Lee FS, Chen ZY (2012) Variant brain-derived
neurotrophic factor Val66Met polymorphism alters vulnerability to stress and
response to antidepressants. The Journal of neuroscience : the official journal of
the Society for Neuroscience 32:4092-4101.
144

Zhang D, Guo M, Zhang W, Lu XY (2011) Adiponectin stimulates proliferation of adult
hippocampal neural stem/progenitor cells through activation of p38 mitogenactivated protein kinase (p38MAPK)/glycogen synthase kinase 3beta (GSK3beta)/beta-catenin signaling cascade. The Journal of biological chemistry
286:44913-44920.
Zhang K, Song X, Xu Y, Li X, Liu P, Sun N, Zhao X, Liu Z, Xie Z, Peng J (2013)
Continuous GSK-3beta overexpression in the hippocampal dentate gyrus induces
prodepressant-like effects and increases sensitivity to chronic mild stress in mice.
J Affect Disord 146:45-52.
Zhao Z, Sabirzhanov B, Wu J, Faden AI, Stoica BA (2014) Voluntary exercise
preconditioning activates multiple anti-apoptotic mechanisms and improves
neurological recovery after experimental traumatic brain injury. Journal of
neurotrauma.

145

